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This work describes the structural analysis of four mouse genomic clones 
which had previously been shown by electron m icroscopic heteroduplex 
analysis to contain actin-like genes, each with a single interruption. The 
objective of this work was to determine the nature of these interruptions.
The first part of this work involved the characterisation of the actin-like 
DNA of three of these clones (^mA82, XmA118, and A,mA119), in order to 
determine whether they were functional genes or pseudogenes. Restriction 
analysis of these clones was carried out and provided evidence to suggest that 
two of these clones, XmA82 and XmA119, were overlapping sequences from the 
same genomic region. ^m A 119 was chosen for further analysis because it 
contains more genomic DNA. The actin-like sequences in A,mA118 and A.mA119 
were determined by the chemical method, and were found to resemble genes 
specify ing  the cytoplasm ic  y-actin  isoform. However, both contained 
mutations that would prevent them encoding a functional y-actin. It was 
concluded therefore that 7,mA118 and X,mA119 are pseudogenes, and the 
absence of multiple introns indicated that these were of the processed type.
The sequence of the actin pseudogene in ^m A 118 extended only from 
amino-acid 5 , suggesting generation from an incomplete reverse transcript, as 
had been found previously for another y-actin processed pseudogene. This 
suggests that there may be extensive secondary structure at the 5' end of the 
mRNA. The 3' untranslated region of ?imA119 only extended for 108 of an 
expected 700 nucleotides, suggesting that it had suffered a deletion after 
integration. Making the assumption that these processed pseudogenes have 
accumulated neutral changes at a constant rate, free from any selective 
pressure, then the times at which XmA118 and ?imA119 arose were estimated to 
be 6.8  and 4.4 million years ago, respectively. Comparison of three pseudogene 
sequences with the y-actin cDNA sequence allowed certain of the differences 
found in ?tmA118 to be ascribed to silent mutations in the functional gene that
(xi)
have occurred since XmA118 arose. The ratio o f  mutations in functional gene 
and pseudogene was consistent with a similar rate of mutation in the silent 
positions of the functional gene and in the pseudogene as a whole, in contrast 
to the results for some other pseudogenes. Examination of the proportion of 
mutations in A,mA118 in positions corresponding to the silent and replacement 
positions of the functional gene showed an unexpected deviation from the 
ratio expected for totally neutral evolution of a pseudogene. This could be 
accounted for by a distorting effect of frequent transitions from CG doublets, 
thought to be due to deamination of 5-methyl cytosine.
The second part of this work involved the structural analysis of the DNA 
regions corresponding to the loops interrupting the genomic clones A. m A l 18 
and XmA119, and that interrupting XmA36, which had been shown by another
worker also to contain a y-actin  processed pseudogene. The nucleotide 
sequences of the inserted elements (IEs) of A,mA36, XmA118, and XmAl 19 were 
determined. Each was found to interrupt the actin-like DNA at a different 
position, none of which corresponded to that of an intron in the gene of any 
actin isoform yet sequenced. Furthermore, in no case was there a perfect 
match to the consensus sequence o f  intron/exon splice sites. The inserted 
elements were, however, flanked by short (4 to 6 base pair) direct repeats of 
actin-like sequence. Thus the inserted elements did not appear to represent 
residual introns, but rather transposon-like sequences that had inserted into 
the pseudogenes at staggered breaks.
It was found that IE 36 was 500 base pairs in length and was related to the 
long terminal repeat (LTR) of the retroviral-like intracisternal A-particle. 
This is the first such intracisternal A-particle solo LTR to be reported. 
However, IE 36 differs from a normal intracisternal A-particle LTR in 
contain ing a 46 nucleotide region which has undergone 5 successive 
duplications together with a subsequent deletion. This had occurred in the R
region of the LTR, which appears particularly prone to rearrangement in
intracisternal A-particle genes. It was estimated that there are 1,900 copies
related to IE 36 per mouse haploid genome, consistent with the values for 
intracisternal A-particle genes estimated by others.
IE 119 was found to be 501 base pairs in length and was also related to
(xii)
LTRs of the recently-described MS57 (632 base pairs in length) and GLN-3 (430 
base pairs in length) retroviral-like elements. In the case of this family of 
retroviral-like genes, expansion appears to occur in the U3 region of the LTR. 
There are approximately 2,300 copies of IE 119 per mouse haploid genome.
IE 118 was found to be 865 base pairs in length and repeated 1,000 to 2,000 
times in the mouse genome. Computer searches of the GenBank and EMBL
nucleotide sequence databanks did not reveal any sequence of significant 
similarity to IE 118. However, several of the functionally important sequence 
motifs found in retroviral LTRs could be recognised in IE 118, albeit in an 
imperfect form. Therefore, the most likely possibility is that IE 118 is also a 
solo LTR of a hitherto  unrecognised fam ily of mouse retroviruses or 
retroviral-like elements. IE 118 also possesses a stretch of 27 out of 28
nucleotides identical to a region of the flanking actin pseudogene but in the
opposite orientation. This may have arisen by a gene conversion event after
the integration of IE 118 into its target pseudogene.
INTRODUCTION
The concerns of  this thesis are mouse actin genes and pseudogenes, and 
possible mobile elements associated with them. This is the basis for the choice 
of topics that are dealt with in this Introduction.
1.1  Actins and their Genes
1 .1 .1  A ct in s
Actin is an abundant, highly conserved protein that is found in all
eukaryotic cells. In animals, actin is primarily involved in muscle contraction 
in differentiated striated and smooth muscle tissues. In non-muscle animal 
cells, actin is involved in a variety of processes, including maintenance of 
cytoskeletal structure, ce llu lar  motility, cell-surface mobility, intracellular 
transport, cytoplasm ic  s tream ing, cy tokinesis , exocytosis, clot retraction, 
microvillar movement and, possibly, chromosomal condensation and mitosis 
(Schliwa, 1981; Lloyd, 1983; Ponte et al., 1983; Stossel, 1984). Isoelectric 
focusing allowed resolution of isoforms of actin with different isoelectric 
points. Three different positions of migration ( a ,  8 and y) were observed, with 
striated muscle actins migrating as a, smooth muscle actins as a  and y, and non­
muscle actins as 8 and y. Amino-acid sequencing studies of actins from
mammalian sources have further shown the presence of at least three distinct
a-actins (a-skeletal, a-cardiac and a-smooth) and two distinct y-actins (y-smooth
and y-cytoplasmic), bringing the number of known functional mammalian
actin genes to six (Vandekerckhove and Weber, 1978a and 1978b). In birds and 
amphibians a third cytoplasmic isoform has been identified (Vandekerckhove 
et al., 1981a; Bergsma et al., 1985).
Each of the four muscle actins tends to predominate in a particular muscle 
tissue. Thus the tissue distribution of a-skeletal and a -ca rd iac  actins reflects 
their names, and the d ifferen t smooth muscle tissues tend to possess
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predominantly either a  or y-smooth muscle actins. The striated muscle isoforms 
may, however, be coexpressed in a tissue under some circumstances. For 
example, the mouse a -card iac  actin is expressed not only in the adult cardiac 
muscle but also (along with the more abundant a  -skeletal form) in foetal 
skeletal muscle (Minty et al., 1982); and the human a -ske le ta l  and a - c a r d i a c  
actin genes are coexpressed in skeletal and cardiac muscles (Gunning, et al., 
1983). The smooth muscle actins appear to be similarly coexpressed, although 
in the genital and gastrointestinal tracts, y-smooth muscle actin predominates, 
whereas in vascular tissue, such as aorta, a -sm oo th  muscle actin is the primary 
isoform (Vandekerckhove and Weber, 1979a and 1984; Vandekerckhove et al., 
1981a; Gabbiani et al., 1981). Cytoplasmic actins show an even more 
pronounced pattern of coexpression, with no non-muscle cell-type known to 
express predominantly either ft or y-isoform (Vandekerckhove et al., 1981b).
The vertebrate actin isoforms contain slight differences in their amino- 
acid sequences, and these are primarily located in the amino-terminal end of 
the proteins (Vandekerckhove and Weber, 1979a). The positions in the amino- 
acid sequence at which differences exist between the six actin isoforms are 
shown in Table 1.1. There are from 4 to 8 amino-acid differences between the 
four different muscle isoforms; 4 differences between the two cytoplasmic 
isoforms; and up to 25 differences between the cytoplasmic and muscle isoforms 
(Vandekerckhove and W eber, 1979a). Thus the m uscle isoforms and 
cytoplasmic isoforms are more closely related to themselves than to one 
another. The amino-acid sequences for a single isoform of actin from diverse 
organisms are extremely similar. For example, chicken, bovine, and rabbit 
skeletal muscle actins have identical amino-acid sequences (Vandekerckhove 
and Weber, 1979a and 1979b). It is clear that among vertebrates the amino-acid 
sequences of actins are isoform specific, rather than species specific.
All eukaryotes synthesize  one or more cytoplasm ic actin isoform 
(V andekerckhove et al., 1981b). The vertebrate cytoplasmic ft and y-actin are 
considered functionally and evolutionarily more closely related to the actins 
found in the lower eukaryotes. For example, yeast actin differs from the
m am m alian  cy toplasm ic  y-isoform in 41 positions, but from the a - s k e le ta l  
muscle isoform in 49 positions, out of a total of 375 (Gallwitz and Sures, 1980; Ng 
and Abelson, 1980). In D r o s o p h i la  m e la n o g a s te r , actins with amino-acid 
sequences similar to the vertebrate cytoplasmic actins are utilised to form the
actin filaments of sarcomeric muscle (Fyrberg et al., 1981). It has been
proposed that during early chordate evolution a novel actin isoform arose
2
l a  big 1.1 D if fe rences  in the  am in o -ac id  sequences  o f  a c t in  iso form s
R e s i d u e A c t in  i so fo rm s
n u m b e r
S keleta l Cardiac Sm ooth  Sm ooth N o n -m u sc le
m usc le m u sc le m u sc le  m u sc le
(s to m a c h )  ( a o r ta )  B -type  y-tyPe
1 Asp Asp - Glu Met -
2 Glu Asp Glu GLu Asp Glu
3 Asp .Glu Glu Glu Asp Glu
4 Glu Glu Glu Asp Asp Glu
5 T h r T h r T h r Ser He
6 T h r T h r T h r T h r Ala
10 Cys Cys Cys Cys Val He
16 Leu Leu Leu Leu Met
17 Val Val Cys Cys Cys
76 lie He He He Val
89 T h r T h r S.gr Ser T h r
103 T h r T h r T h r T h r Val
129 Val Val Val Val T h r
153 Leu Leu Leu Leu Met
162 A sn Asn Asn Asn T h r
176 Met Met Met Met Leu
201 Val Val Val Val T h r
225 Asn Asn Asn A sn Gin
259 T h r T h r T h r T h r Ala
266 lie He He He Leu
271 Ala Ala Ala Ala Cys
278 Tyr Tyr Tyr Tyr Phe
286 He He He He Val
296 A sn Asn Asn A sn T h r
298 Met Leu Leu Leu Leu
357 T h r Ser Ser Ser Ser
364 Ala Ala Ala Ala Ser
The table indicates the positions in the amino-acid sequence at which 
exchanges  have been de tec ted  betw een the d iffe ren t actin  isoforms. 
Numbering of positions of the amino-acids in the actin sequence is made by 
analogy to rabbit skeletal muscle actin (Collins and Elzinga, 1975; Lu and 
Elzinga, 1977; Vandekerckhove and Weber, 1978c). Amino-acid residues in 
which the four muscle actins differ among themselves are underlined.
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which now functions in the sarcomeres of muscle cells (Vandekerckhove et  
al.,  1983). In the time before the divergence of mammals and birds, this gene 
apparently underwent two successive duplications to produce the four muscle-
actin isoforms found in mammals and birds today (Vandekerckhove et al.,
1983). Thus the muscle-actin isoforms must have been under strong selection 
pressure to maintain their amino-acid sequence since they arose.
1 .1 .2  Actin Genes
Actin cDNA clones that are specific for particular isoforms have been 
isolated (Ponte et al., 1983; Gunning et al., 1983), and have been used as 
hybrid isation  probes to assay the number and o rganisa tion  o f  sequences 
related to actins in the genomes of different organisms, and to isolate individual 
genomic sequences.
(i) The Number of Actin Genes
Southern  ana lysis  and hybrid isa t ion  of the genom ic DNA with 
appropriate actin probes under low stringency washing conditions has allowed 
the estimation of the number of recognisable actin genes in different genomes. 
It was found that the number of actin genes in higher eukaryotes varies
considerably. It was estimated that in chicken there are 4 to 7 actin genes
(Cleveland et al., 1980); in man, 20 to 30 actin genes (Moos and Gallwitz, 1983; 
Engel et al., 1982); in rat, 12 or more actin genes (Nudel et al., 1982); and in 
mouse, more than 20 actin genes (Minty et al., 1983). In mammals these 
numerous actin sequences are scattered on different chromosomes throughout
the genome (Soriano et al., 1982). The number of actin genes in lower
eukaryotes also varies between organisms. Drosophila melanogaster  co n ta in s  
6 actin genes (Fyrberg et al., 1981), yeast contains 1 actin gene (Gallwitz and
Sures, 1980; Ng and Abelson, 1980), Dictyostelium  discoideum  contains 17 actin 
genes (McKeown and Firtel, 1981), and sea urchin contains 11 actin genes
(Scheller et al., 1981).
When genomic DNA from higher eukaryotes was analysed by Southern 
blotting under high stringency conditions, so that only sequences highly
homologous to the cDNA probe remain hybridised, single bands were obtained 
for a number of different isoforms (Minty et al., 1983; Weydert et al., 1983; 
Robert et al., 1984). It is assumed that these represent the corresponding
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functional genes, which, like those for most other structural proteins, appear 
to be present in a single copy per haploid genome (Minty et al., 1983; Ponte et 
al., 1983; Robert et al., 1984).
In this kind of analysis, many of the multiple actin-related sequences
detected under low stringency in the mammalian genome have been found to 
hybridise preferentially to probes for the cytoplasmic isoforms of actins. Thus
it is more difficult to determine the number of functional genes for the 
cytoplasmic actin isoforms. However, it seems likely that these too are present
as single copies, the related sequences being processed pseudogenes (see 
section 1.2.3) which are thought to be derived from B or y-actin mRNAs by
reverse transcription and reintegration of the complementary DNA into the 
genome (Minty et al., 1983; Moos and Gallwitz, 1982; Carmon et al., 1982). The 
extent to which these sequences have diverged from the actin coding sequence
and, hence, the time which has elapsed since their integration, varies. A 
family of highly diverged sequences of this type has been isolated from the 
mouse genome. These closely related sequences are probably the result of a 
recent amplification of a 17 kb region of mouse DNA containing a diverged 
actin pseudogene (Minty et al., 1983). The high number of sequences related 
to actin is apparently restricted to the mammalian genome; in birds (Cleveland 
et al., 1980) or in D r o s o p h i la  (Fyrberg et al., 1980), for example, the number 
of genomic actin sequences corresponds to the number of known proteins.
( i i)  Structural Features of Actin Genes
As already mentioned, the coding sequences of the actin genes are highly 
conserved. On the other hand, the non-coding parts of the actin genes are
quite divergent when compared along a wide evolutionary range. For example, 
the sizes of introns and their locations vary considerably. In protostomes such 
variability in intron positions is most apparent (Fyrberg et al., 1981), although 
this is less so in deuterostomes (Fornwald et al., 1982; Zakut et al., 1982; see 
Table 1.2).
The heterogeneity in the location and number of introns in actin genes 
has led to the question of whether introns have been deleted or inserted during 
evolution. The available data are not sufficient to answer this question
conclusively , although they have been in terpreted  in favour of intron 
deletion. A comparison of the intron positions in the actin genes of 
deuterostomes with those found in the recently sequenced a -sm o o th  muscle
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XaMfi— h i  Position gf_. introns in the actin genes of  various organisms
Actin
gene
O r g a n i sm
5 'UTR 4 1 / 4 2
Intron posit ion
8 4 / 8 5  1 2 1 / 1 2 2  150 204 267 3 2 7 / 3 2 8
a - s m o o th c h i c k e n l  • • •  •  •  • •  •
a - s m o o th h u m a n 2  ? • •  • • • •  •
a - s k e le ta l m oused , • 
c h ic k e n ^ ,  rat^
• • « • •
a -c a rd iac c h ic k e n ^ • •  • • •
a -ca rd iac h u m a n 7  ? • •  • •  •
f l-c y to p la sm ic  c h ic k e n ^ ,  •
ra t9 ,  humanlO
• • •  •
SpG28 sea urchin 11 •  • •  •
SpG17 sea u rchin l 1 • •
SfA sea u rc h in l2 • •
The intron positions in actin genes from various organisms are shown, the 
num bering  being of the codons in terrupted  (re lative to the vertebrate 
sequence). The key to references is :
1) Carroll et al., (1986)
2) Ueyama et al., (1984)
3) Hu et al., (1986)
4) Fornwald et al., (1982)
5) Zakut et al., (1982)
6 ) Chang et al., (1985)
7) Hamada et al., (1982)
8 ) Kost et al., (1983)
9) Nudel et al., (1983)
10) Ng et al., (1985)
11) Cooper and Crain, (1982)
12) Foran et al., (1985)
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actin gene (Carroll et a l ,  1986), is consistent with this suggestion. It was 
demonstrated that the structural sequence of the chicken a -s m o o th  muscle 
actin gene is interrupted by eight introns. Examination of the intron positions 
in vertebrate a -sk e le ta l  (Fornwald et a l ,  1982; Zakut et a l ,  1982; Hu et al., 
1986), a -ca rd iac  (Hamada et a l ,  1982; Chang et a l ,  1985) and B-cytoplasmic 
(Nudel et a l ,  1983; Kost et a l ,  1983; Ng et a l ,  1985) actin genes, as well as 
those found in sea urchin genes (Cooper and Crain, 1982; Foran et a l ,  1985), 
revealed that the intron positions in these latter genes represent subsets of the 
intron positions found in the chicken a -sm oo th  muscle actin gene (Carroll et 
a l ,  1986; Table 1.2). This observation suggests a common ancestral gene with 
multiple intron positions which have been partially lost during evolution. It 
was therefore concluded, at least for the case of the deuterostome actin genes, 
that intron deletion has been the dominant process influencing the placement 
of introns in modern actin genes (Zakut et a l ,  1982; Blake, 1983; Nudel et a l ,  
1984; Carroll et a l ,  1986). From this standpoint, the fact that lower organisms 
with high reproductive rates have lost more introns than higher organisms 
(Table 1.2) is rationalised in terms of a need to minimise the size of their 
genom es .
When the nucleotide sequences of different actin isoforms are compared 
in a single species, only the coding regions show a high degree of homology. 
No significant homology was detected in the 5' and 3' untranslated regions of 
genes for different actin isoforms. Moreover, the lengths of these parts of the 
genes often vary considerably, which suggests that at least part of the 
sequence heterogeneity is due to deletion and/or insertion of DNA. On the 
other hand, comparison of the genes for a single actin isoform in different
mammals shows a considerable degree of homology between their untranslated
regions. For example, the 3' untranslated regions of rat (Mayer et a l ,  1984) 
and human (Hamada et al., 1982) cardiac actin genes show a high degree of 
homology : two-thirds of the 3’ part of these regions exhibit 92.5% homology 
and the 5' part of this region shows 85% homology. Similarly, a large part of 
the 3' untranslated regions of human (Hanukoglu et a l ,  1983) and rat (Nudel 
et a l ,  1983) B-actins shows more than 85% homology. In fact, it has been 
shown that the 3' untranslated regions of actin mRNAs in birds and mammals 
are unique for each actin isoform (Cleveland et a l ,  1980; Minty et a l ,  1981; 
Ponte et a l ,  1983; Yaffe et a l ,  1985). Furthermore, the 3' untranslated regions 
of human skeletal, cardiac, B and y-actin mRNAs all hybridised to the
corresponding genes of rodents (Ponte et a l ,  1984). However, in the case of
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the chicken a - s m o o th  muscle actin gene (Carroll et al., 1986), probes 
containing the 3' untranslated region did not hybridise to any sequences in 
human DNA, suggesting greater species divergence for this isoform. The 
biological significance of the conservation of the 3 ' untranslated regions in the 
majority of the genes is unclear, although a structural or a regulatory role has 
been suggested. If they are important in such ways, however, it is difficult to 
account for the apparent non-similarities of the 3' untranslated region of the 
a-smooth muscle actin genes.
Similar patterns of isoformic specificity are also observed with the 5' 
untranslated regions. Comparison of the 5' untranslated region of the human 
(Ponte et al., 1984; Ng et al., 1985) and rat B-actin genes (Nudel et al., 1983) 
revealed 80% homology, indicating a considerable conservation of this region 
of the gene. However, comparison of the 5' untranslated region of chicken a -  
actin with chicken and rat skeletal a  -actin and B-actin genes did not reveal any 
regions with substantial homology. A small but significant homology exists in 
the promoter regions for the skeletal a-ac tins  (19 out of 20 nucleotides) and the 
promoter regions for B-actins (21 out of 25 nucleotides) in chicken and rat
(Kost et al., 1983; Ordahl and Cooper, 1983; Eldridge et al., 1985).
1.2  P s e u d o g e n e s
1 .2 .1  In t r o d u c t io n
Pseudogenes are defined as DNA sequences with significant homology to
functional genes, but possessing mutations that would prevent them expressing 
a functional product. Such mutations can, for example, cause premature 
termination of translation; the formation of polypeptides with little homology 
to the functional gene product; interference with transcriptional initiation; 
and interference with the processing of RNA transcripts. There are two types 
of pseudogenes, namely, duplicative and processed pseudogenes.
Pseudogenes of the first type, the duplicative pseudogenes, are thought to
arise from duplication and divergence of functional genes, with silencing of
one of the two copies. Therefore they are closely linked to their functional 
counterparts  and, in the case of genes encoding proteins, retain the 
intervening sequences of the functional gene. The second type, the processed 
pseudogenes, apparently  arose through incorpora tion  of mRNA reverse
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transcripts into the genome, probably at staggered breaks in the chromosome. 
Therefore they lack intervening sequences and have oligo(A) tracts at their 3' 
ends. Although processed pseudogenes may have intact coding regions, they 
can still be classed as pseudogenes by virtue of their transcriptional silence, a 
consequence of their mRNA origins.
In addition to processed pseudogenes corresponding to mRNAs, there are 
non-duplicative pseudogenes corresponding to RNA transcripts which serve 
non-coding functions. Although these are not necessarily 'processed', they are 
best considered with processed pseudogenes because of their similar origin. 
These pseudogenes include ones corresponding to small nuclear RNAs (snRNAs)
and 7SL RNA (Denison and Weiner, 1982; Ullu and Tschudi, 1984).
1 .2 .2  Duplicat ive  Pseudogenes
These pseudogenes are thought to arise by tandem duplication of
functional genes, to which they are usually linked. Thus they show the major
structural features of expressed genes, such as recognisable promoters, exons, 
introns, and RNA processing sites.
(i) The X e n o p u s  5S rRNA Pseudogene
The first gene-like sequence to be named a 'pseudogene' was that 
corresponding to the Xenopus laevis  5S rRNA gene (Jacq et al., 1977). This 
pseudogene sequence is located downstream from the functional gene for 5S
rRNA, and is part of the 700 nucleotide repeat unit that is expressed during
oogenesis. The pseudogene lacks the last 20 base pairs from the 3' end of the
functional gene (totalling 121 base pairs) and otherwise differs by 9 base
changes (Miller et al., 1978). Although RNA corresponding to this pseudogene 
is not found in vivo , a high rate of transcription (85% of that of the functional 
gene) can be achieved when the pseudogene is micro-injected into the 
X e n o p u s  oocyte. However, most of the transcripts produced do not terminate 
correctly at the 3 ' end of the gene, but are of varying greater lengths and are 
unstable. Thus the apparent absence of transcripts in vivo may reflect a
defect in the termination, rather than the initiation, of transcription (Miller
and Melton, 1981).
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( i i)  Evolutionary Behaviour of  Duplicative Pseudogenes
The a  and B-globin gene families of a variety of mammals provide typical
examples of duplicative pseudogenes at different stages of their evolutionary
decay and of the variety of processes by which the different gene clusters have
evolved. All the globin pseudogenes, with the exception of two mouse a - g l o b i n  
p seudogenes  (L eder et al., 1981), are found linked to their functional 
counterparts. This is consistent with the origin of these pseudogenes from 
duplicated genes formed within the gene clusters, which have since diverged 
and become inactive.
Once a duplicated gene becomes inactive, it should be free from all
se lec tive  constra in t  and then rap id ly  accum ulate  m utations at a rate 
character is tic  of non-coding  sequences. It is conceivable  that certain 
pseudogenes still retain some regulatory functions within their parental gene 
cluster, although so far there are no data to support this suggestion. Another 
possibility is that, a silent gene may by chance undergo a reversion mutation 
and be reactivated (Ohno, 1970). This process does occur with 'cryptic' genes in 
bacteria, which under strong selective pressure can revert to a functional state 
(Hall, 1983). Such events are, however, likely to be rare, since defects 
accumulated in pseudogenes often include deletions and insertions which are 
most unlikely to undergo reversion. Reactivation of a pseudogene can occur by 
another m echanism  term ed gene conversion , which could lead to the 
’correction' o f  a pseudogene by replacing a defective gene segment with 
functional sequences from a neighbouring gene (Jeffreys et al., 1983). Gene 
conversion involves the non-reciprocal copying of information from one gene 
to another homologous gene within a cluster, as the result o f  inter- or 
intrachrom osom al exchange (Lauer et al., 1980; Slightom et al., 1980). A 
number of instances of gene conversion have been detected among the a  and 
B-globin genes (Slightom et al., 1980; Shen et al., 1980; Leibhaber et al., 1981; 
Schon et al., 1982).
The evolutionary time spent by each pseudogene, first under selection as 
a functional gene, and then without selection as a pseudogene, has been 
estimated from the percentage of silent and replacement base changes in the 
coding sequence compared to the functional gene (Perler et al., 1980). These 
estimations have assumed that pseudogenes accumulate mutations at the same 
rate as silent changes in functional genes. However, it seems that there may be 
some selective pressure against changes, even between synonymous codons in
10
functional genes. Thus, it has been reported that the rate of nucleotide
substi tu tion  in g lob in  pseudogenes is approxim ate ly  twice the rate of 
substitutions in the third codon position in functional genes (Miyata and 
Yasunaga, 1981; Miyata and Hayashida, 1981; Li et al., 1981). A further factor 
that has to be taken into account is the gene conversion events that may mask 
the true evolutionary age of genes or pseudogenes. For example, comparison of 
the coding regions of the two human adult globins, 5 and B, suggests that they 
arose from a duplication event not more than 40 million years ago (Spritz et 
al.,  1980; Efstratiadis et al., 1980). However, various non-coding regions, the
second intervening sequence, the mRNA 3' untranslated region, and the 5' 
sequences upstream of the CAAT box , all appear to have diverged over a much 
longer period of time (Martin et al., 1983; Hardies et al., 1984). Thus the 5-
globin coding region appears to have undergone a recent conversion by the 15- 
gene, which has covered the traces of its more ancient origin. Reliable 
estimates of evolutionary divergence times can, therefore, only be derived 
from those regions of the gene that have not been subject to gene conversion.
(iii)Human a -G lob in  Pseudogenes
Besides the two active embryonic (£) and adult ( a l , a 2 )  genes, the human 
a-globin gene clusters also contains two pseudogenes, yC and y a .  Pseudogene 
vjfC, is more than 99.5% homologous in its coding region to the functional £- 
globin gene and has a single deleterious mutation, a termination codon in its
first exon; suggesting that the formation of this pseudogene is only recent
(Proudfoot et al., 1982). On the other hand, pseudogene \j/a is only 75 to 80%
homologous to the functional a-g lob in  genes and has a considerable number of 
mutations. These include base substitutions that cause missense codons that
affect translation and mRNA processing; deletions that cause frame shifts in
the coding sequence, and that alter the spacing between CAAT and TATA boxes 
in the transcription promoter region (Proudfoot and Maniatis, 1980).
Comparative studies of the sequences surrounding the \|/a pseudogene and
the two functional genes a l  and a 2 suggest that they arose by gene duplication
and subsequent unequal crossing over (Lauer et al., 1980; Proudfoot and
Maniatis, 1980). Such events still appear to be operating in contemporary
human populations, since chromosomes carrying either a single functional a -
globin gene, or an a-g lob in  gene triplication have been reported (Orkin et al.,
1979; Higgs et al., 1980; Goosens et al., 1980). Since the formation of the y a ,  a l ,
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oc2  cluster, the two functional genes have been maintained closely homologous 
by gene conversion events, while \j/a has accumulated changes to become a
pseudogene. Sequences in the intergenic regions upstream of a l  and a 2 show 
strong homology and have been implicated in gene conversion, whereas their
absence upstream of \|/a may explain why it has apparently not been a subject to 
conversion (Proudfoot and Maniatis, 1980).
( iv )  fi-GIobin Pseudogenes
Detailed DNA sequence analysis of the 8 -like pseudogenes from man and a 
number of the other primates has shown that a \|/B gene is found in all primates 
and that this gene has probably been a pseudogene for the whole of primate 
evolu tion , suggesting that the ancestral prim ate  B-globin genes cluster 
comprised a five gene set, e -y - \ j /B - 8 -B (Chang and Slightom, 1984; Harris et al.,
1984). Comparison of the yB  sequences with those of the other B-globin genes
showed that the primate \y B gene is most closely related to the e gene of goats 
(Goodman et al., 1984). Both the primate \|/B pseudogene and the embryonically 
expressed goat e gene appear to be derived from a common ancestral gene, 
named r | , that is distinct from the e, y, 8 , and B ancestral genes. The mouse and 
rabbit B-globin gene clusters lack T| -like genes and are thus derived from an e -  
y-8 -B four gene set. The goat B-genes, however, lack descendants of the y-type 
gene, and are derived from a triplicated e - t | - 8 -B set of genes. Only in primates 
have descendants of all five types of ancestral genes been retained. It is 
curious that the descendants of the ancestral 8 -type gene, mouse Bh2  and BI13
pseudogenes, rabbit \j/B2, goat \j/Bx and \j/Bz , and the minor adult 8 -globin gene of 
primates have all shown a tendency to become silent.
The evolutionary history of the primate 8 -globin gene is of particular 
interest. Comparative studies with other adult B-genes show that although its 5' 
end has been subject to a relatively recent gene conversion by the B-gene, its 
3 ' end still bears significant homology to the pseudogenes of mouse (Bh2 ) and 
rabbit (M/B2 ). It appears that the 8 -globin gene was originally a pseudogene 
and it became reactivated in the early primate lineage by a gene conversion 
with the adult B-gene (Martin et al., 1983). Although the 8 -globin gene is still 
active in man, it has become silent in the Old World monkeys and will 
presumably evolve into a pseudogene. Thus, the 8 -globin gene illustrates the 
possibility of both loss of activity and reactivation for the products of a gene 
d u p lica tio n .
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1 .2 .3  Processed Pseudogenes
P ro cessed  p seudogenes  are quite  d is t in c t  from  the dup lica tive
pseudogenes in bearing evidence of generation from RNA (Sharp, 1983). They 
are widely dispersed in the genome, and, where this has been examined, are 
g ene ra lly  on d iffe ren t  ch rom osom es from  the ir  paren ts .  P rocessed 
pseudogenes corresponding to sequences encoding proteins resemble DNA
copies of mature mRNA in some or all of  the following characteristics :
extending only from, the 5' CAP site to the site of polyadenylation; possessing a
polyA tail in the expected position following a polyadenylation/processing 
signal; lacking all introns present in the functional gene; being flanked by
direct repeat sequences (typically 11 to 15 base pairs in length) immediately 
preceding the transcriptional start and immediately following the polyA tail 
(Jeffreys and Harris, 1984). These characteristics clearly indicate that these 
pseudogenes originated from spliced polyadenylated mRNAs, DNA copies of 
which were inserted at sites in the chromosome created by a staggered
endonucleolytic break. Most of such processed pseudogenes have been inserted 
at sites at which the lack of a promoter renders transcription impossible, and 
most have accumulated mutations that would, in any case, render any 
transcripts functionless (Vanin, 1984).
(i) Structural  Characteristics
Processed pseudogenes corresponding to sequences encoding proteins
may be further divided into two types. The first type are those which are more
or less colinear with normal mRNAs, starting at the 5' mRNA CAP site and 
ending in an A-rich or oligoA stretch of 7 to 36 nucleotides, and are flanked by 
direct-repeat sequences of 9 to 25 bases. Processed pseudogenes of the second 
type, although clearly  derived from  RNA m olecules, since they lack 
intervening sequences found in parent genes and end in oligoA or A-rich 
tracts; differ significantly from the normal cellular mRNAs of their parent
genes .
A common feature of the members of the first class of processed
pseudogene is that they correspond to mRNAs expressed in undifferentiated 
tissues. The first example of this type was a human B-tubulin pseudogene 
(Wilde et al., 1982b). Other examples include pseudogenes corresponding to the
genes for the mouse cytochrome c (Limbach and Wu, 1985), cellular tumour
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antigen p53 (Benchimol et al., 1984; Zakut-Houri et al., 1983), and ribosomal 
proteins L7 (Klein and Meynhas, 1984), L I 8 (Peled-Yalif et al., 1984), L30 
(Wiedemann and Perry, 1984), and L32 (Dudov and Perry, 1984); rat a - t u b u l i n  
(Lemischka and Sharp, 1982) and cytochrome c (Scarpulla and Wu, 1983) ; and 
human m etallothionein (Karin and Richards, 1982), nonmuscle tropomyosin 
(MacLeod and Talbot, 1983), y-actin (Leube and Gallwitz, 1986), B-actin (Moos 
and Gallwitz, 1982, and 1983), dihydrofolate reductase (Chen et al., 1982; Masters 
et al.,  1983), a rg in o - s u c c in a te  s y n th e ta se  (F re y ta g  et al., 1984), 
glyceraldehyde-3-phosphate  dehydrogenase (Benham et al., 1984; Hanauer and 
Mandel, 1984), and c -ras  (McGrath et al., 1983; Miyoshi et al., 1984). There 
are, in fact, different rat cytochrome c (Scarpulla and Wu, 1983) and human B- 
tubulin (Lee et al., 1983) processed pseudogenes corresponding to mRNAs with 
3' untranslated regions of different lengths.
The examples of the second type of processed pseudogene are less 
numerous. They include: (1) a human im m unoglobulin  X light chain
pseudogene (Hollis et al., 1982), containing spliced J and C regions, but no V
region  (which is the present in the functional gene); (2) a human
im m unoglobu lin  e heavy chain pseudogene (Ueda et al., 1982; Battey et al.,
1982), comprising only the four spliced exons of the e constant region, but no 
variable region coding elements (V, D, or J regions); (3) a mouse myosin light 
chain pseudogene (Robert et al., 1984), consisting of five terminal exons
common to both myosin alkali light chains LC1 and LC3, and lacking either of 
the two com binations  of N -term inal exons norm ally  present in the 
corresponding cellular mRNAs; (4) a mouse a-g lob in , a-\|/3, which extends at 
least 350 nucleotides 5’ to the transcriptional start site (Vanin et al., 1980; 
Nishioka et al., 1980). The common feature of the processed pseudogenes of 
this class is that they correspond to mRNAs expressed only in specific 
differentiated cells.
The immunoglobulin J-C^ and Ce pseudogenes end in A-rich tracts of 
( C A x )y or (GA)X, whereas the myosin light chain pseudogene has a short oligoA
tract preceding an A-rich sequence. The pseudogenes are flanked by direct
repeat sequences with the exception of the mouse a-globin  a - \y 3  pseudogene. 
All these pseudogenes are truncated at their 5' ends relative to their parent 
genes, with the exception of the mouse a - \ j /3  pseudogene. Thus they appear to 
have arisen from transcripts that initiated anomalously in the intervening
sequence immediately upstream of those exons found in the pseudogene. The 
mouse a-\j/3 pseudogene also appears to be derived from an aberrant transcript,
14
initiated at a promoter upstream of the usual transcriptional start position.
( i i)  Small Nuclear RNA Pseudogenes
Small nuclear RNAs (snRNAs) are a family of abundant discrete RNAs 
found associa ted  with p ro te ins  in r ibonucleopro te ins  in the nuclei of
eukaryotes. A number of snRNA species have been identified (U1 to U6), and
each hybridises to 102 to 103 sequences in the mammalian genome. The 
majority of these appear to be pseudogenes by the criterion of multiple base 
substitutions (Denison et al., 1981; Hayashi, 1981; Lund and Dahlberg, 1984).
Different classes have been identified in snRNA pseudogenes according to
their  s tructural characteris tics . Members of the firs t  class of snRNA 
pseudogenes show significant homology to functional snRNA genes in their 
flanking regions, thus suggesting that they were generated by divergence of 
duplicated snRNA genes (Denison and Weiner, 1982). Members of the second 
class of more common snRNA pseudogenes were generated (see below) by the 
incorporation of reverse transcripts into the genome at either blunt or 
staggered chromosomal breaks (Van Arsdell et al., 1981). These pseudogenes 
are characterised by containing sequences corresponding to snRNA molecules 
themselves. Their homology with snRNA genes begins precisely at the 5' end 
and extends either to the 3' end of the snRNA, or else they show some degree of 
3' truncation. A number of these pseudogenes are flanked by short direct- 
repeats and contain short 3' terminal A-rich segments (Hayashi, 1981; Ohshima 
et al., 1981; Monstein et al., 1983; Nojima and Kornberg, 1983; Denison and 
Weiner, 1982). Since functional snRNA genes have a conserved 3' flanking 
sequence that is not A-rich, such pseudogenes must have been derived from 
aberran tly  po lyadeny la ted  m olecules (O hshim a et al., 1981; Manser and 
Gesteland, 1982; Watanbe-Nagasu et al., 1983).
(iii)Origins of Processed Pseudogenes
Processed pseudogenes are widespread in most individuals of a species in 
which they occur, and are transmittable as inheritable components in the 
genome. Hence they must have originally arisen in cells of the germ line. It 
follows from this that processed pseudogenes would be expected to be formed 
only from those genes that are expressed in germ line cells. Indeed, those 
processed pseudogenes that are essentially colinear with cellular mRNAs do
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seem to be derived either from 'housekeeping' genes common to all cell types
(eg.  tubulins, cytoplasmic actins) or from genes that might be preferentially 
expressed in the germ line (eg. ,  tumour antigen p53, c-ras) .
In contrast, those processed pseudogenes that appear to be derived from
aberrant transcripts originate from genes that are not normally expressed in
the germ line, since they encode products of highly differentiated somatic cells 
(ie. ,  lymphocyte immunoglobulin chains, erythrocyte a -g lo b in ,  and muscle 
myosin light chain). Presumably, the aberrant nature of the transcripts from 
which they appear to be derived is a reflection of their abnormal transcription
in the germ line.
The processed pseudogenes corresponding to human actin genes further
emphasise the point that processed pseudogenes are usually  only found 
corresponding to mRNAs that are expressed in the germ line. Processed 
pseudogenes seem to account for a large part of the genomic sequences 
hybridising to cytoplasmic 15 and y-actin cDNA probes (see section 1.1.2). In 
contrast, the a-card iac  and a -ske le ta l  muscle actins, products of differentiated 
somatic tissues, are encoded by single copy genes with no related processed 
pseudogenes (Ponte et al., 1983).
The overwhelming majority of processed pseudogenes have been found
in mammals, examples from other vertebrates and invertebrates being very
few indeed. A single calmodulin processed gene has been reported in chickens 
(Stein et al., 1983), and some at least of the histone orphons of sea urchins 
appear to be derived from reverse-transcribed mRNAs (Liebermann et al.,
1983). In addition, the F elements of D. melanogaster  appear to be dispersed by 
the integration of polyadenylated RNA transcripts, and hence the mechanism 
of their origin formally resembles that of processed pseudogenes (DiNocera et 
al., 1983). Thus, although the mechanisms responsible for the generation of 
processed pseudogenes may not be exclusive to mammals, some feature of the 
metabolism of the mammalian gametes must make them peculiarly susceptible 
to the formation of processed pseudogenes.
( iv)  Evolutionary Divergence and Possible Expression of
Processed Pseudogenes
Unlike duplicative pseudogenes, which may show as little as 75% 
homology to their parent gene, most processed pseudogenes analysed seem to 
show very high (90 to 99%) homology to the genes from which they derive.
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This suggests that they have arisen relatively recently in evolutionary history. 
For example, the myosin light chain pseudogene, which shows 99% homology to 
the functional gene, is found in Mus muscuius  but not the related species M u s  
s p r e t u s ,  which diverged less than 7 million years ago (Robert et al., 1984). 
Similarly, the human dihydrofolate reductase pseudogene, h D H F R - y 1, which 
has perfect homology to the functional gene, is only present in certain
individuals of the species and shows an imbalance in its frequency in different 
racial groups (Anagnou et al., 1984). However, as the processed pseudogenes 
studied to date have been detected and isolated using DNA hybridisation probes, 
there may have been bias towards those that are little diverged from their
parent genes, especially when the probes were used under high stringency
conditions. When genomic blots have been performed under low stringency 
conditions, genomic sequences with weaker homology to the probe have been 
detec ted  (Lee et al., 1983; Minty et al., 1983; Wilde et al., 1982a). Hence
m am m alian  genomes may in fac t conta in  whole series of processed 
pseudogenes varying quite widely in their divergence from their parental 
genes .
P ro c e s se d  p se u d o g e n e s  have  g e n e ra l ly  been  assum ed  to be 
transcriptionally inactive since the time of their formation. Consistent with
their inertness, pseudogenes may show a higher degree of DNA methylation 
than their functional counterparts (Lund and Dahlberg, 1984; Dudov and Perry,
1984). With the exception of the mouse a - \ j /3  globin pseudogene, which retains 
upstream  RNA polym erase II prom oter sequences (Vanin, 1984), other 
p rocessed  pseudogenes  analysed  have genera lly  lacked their original
transcriptional promoters. Nevertheless it is possible to envisage integration
occurring correctly downstream of a sequence that happens to correspond to 
that of a RNA polymerase II promoter. Apparent examples of this are a chicken 
processed calmodulin pseudogene (Stein et al., 1983), and the rat preproinsulin 
I gene (Lomedico et al., 1979; Soares et al., 1985).
(v)  Models for the Generation of Processed Pseudogenes
The basic mechanism for the formation of a processed pseudogene has 
been taken as the insertion of an mRNA or its cDNA copy into a staggered break 
in chromosomal DNA and subsequent repair of single stranded regions. 
Although this mechanism is widely accepted, it is difficult to define in greater 
detail the precise series of m olecular events that gave rise to these
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pseudogenes, since the only inform ation concerning their mechanism of 
origin derives from the organisation of sequences flanking them.
Any model for the formation of processed pseudogenes must answer the 
fo llow ing  questions : What is the polym erase responsible  for reverse
transcription? How is the reaction primed? Where and how do the insertions
occur in the genome? Is the inserted molecule an RNA or a cDNA (or an RNA- 
cDNA heteroduplex)?
The source of the reverse transcriptase is difficult to decide as no such
enzyme is detectable in normal cells. One possibility is that it is some secondary 
activity of a normal cellular DNA polymerase, since human DNA polymerase B
can copy synthetic RNA templates in vitro (Weissbach, 1977). A second
possibility is that it derives from an endogenous retrovirus (Bernstein et al., 
1983), a supporting argument being that invertebrates, which are not thought
to be subject to retroviral infection, generally lack processed pseudogenes. The 
weakness of this latter argument can be seen when one considers the paucity 
of chicken processed pseudogenes. A more attractive possibility is that the
reverse  transcrip tase  derives from  the enzyme encoded by endogenous 
transposable elements such as the LI family (see section 1.3.4ii).
The sites into which processed pseudogenes and other retroposons have 
integrated are frequently relatively AT-rich. Since such sequences are more 
prone to local melting of DNA strands and perhaps, therefore, to strand 
breakage, they might be expected to be a common source of sites for
pseudogene insertion. It has also been suggested that DNA topoisomerase plays
an important role in generating the transient breaks in DNA between which
the insertion may occur (Van Arsdell and Weiner, 1984).
Questions concerning the primer for reverse transcrip tion and the 
nature of the inserted molecule will be discussed together in comparing 
different models that have been proposed to account for the formation of
processed pseudogenes (Figure 1.1). The first model was proposed for snRNA
pseudogenes (Van Arsdell et al., 1981) and suggested the following sequence of 
events: (1) synthesis of a cDNA copy of the snRNA; (2) covalent linkage of the 
cDNA 3' end to a 5' overhang of a staggered chromosome break; (3) second
strand cDNA synthesis primed from the recessed 3' OH of the break; and (4)
ligation and repair of the ends of the break, creating flanking direct repeats
(Figure 1.1a). The use of the cDNA transcript in this model eliminated the need 
to propose mechanisms for decapping the snRNA and for the ligation of RNA to 
DNA, but it does not explain how the synthesis of the first cDNA strand is
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Figure 1.1 Models proposed for the form ation of processed pseudogenes
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The four models proposed to account for the formation of RNA-derived 
pseudogenes are shown. Thin wavy lines represent RNA and thick lines 
represent new DNA (cDNA and second strand or repair DNA synthesis). 
Flanking direct repeats resulting from the insertion are indicated by 
parenthesis, and topoisomerase molecules by open circles. (a) and (b) are 
'cDNA insertion' models for the generation of snRNA pseudogenes (Van 
Arsdell et al., 1981; Van Arsdell and Weiner, 1984), (c) is a primed insertion 
model for mRNA derived pseudogenes (Vanin, 1984), and (d) is a general 
retroposon insertion model (Rogers, 1985). For clarity, the second nick and 
its ligation to the RNA are shown as occurring after the first nick and cDNA 
synthesis, but they could occur concurrently.
19
primed. For some severely truncated snRNA pseudogenes, this presents no 
problem since the snRNAs from which they derive can act as a self-priming 
templates for reverse transcriptase. However, it is unsatisfactory to extend this
model to processed pseudogenes that are full-length copies of the mRNAs, as it
is necessary to invoke some exogenous T-rich primer molecule for synthesis of
the first cDNA strand.
The minimal 'cDNA insertion' model has been elaborated to involve 
topoisomerase in the formation of staggered or blunt chromosomal breaks (Van 
Arsdell et al., 1981; Van Arsdell and Weiner, 1984; Figure 1.1b). In addition, it 
was suggested that homology between the downstream direct repeat sequence 
and the incoming cDNA molecule might be instrumental in anchoring the 
cDNA relative to the staggered break (Moos and Gallwitz, 1983). This would 
account for the observation that flanking direct repeat sequences frequently 
overlap the 3' end of truncated U2 snRNA pseudogenes or the 3' oligoA or A- 
rich tails of full-length snRNA and processed pseudogenes.
This latter observation also points to a more attractive alternative model, 
which to a large extent overcomes the difficulty of 'cDNA insertion' (Figure 
1.1c). The overlap between the 3' ends of pseudogenes and their flanking direct 
repeats suggests that 3' overhangs at staggered chromosomal breaks might 
themselves act as the primers for the initial cDNA synthesis by virtue of their 
partial homology to an RNA. Thus this model (Figure 1.1c) combines the two 
steps of cDNA synthesis and cDNA insertion. Since the cDNA molecule is primed 
by a single-stranded region of the genomic DNA itself, it is necessarily already 
linked into the chromosome. Subsequent steps would involve replacement of 
the RNA to generate a double-stranded cDNA and repair and ligation of the ends 
(Vanin, 1984).
A variation of this 'primed insertion' theme has been suggested by Rogers 
(1985). In this model (Figure 1. Id), a nick in chromosomal DNA becomes tailed 
with T-rich sequences, which then act as a primer for cDNA synthesis. To 
ensure complete copying of the mRNA, the 5’ end of the inserted RNA is ligated 
to a second nick in the target DNA and repair synthesis completes the process to 
generate a DNA copy flanked by direct repeats.
Thus, several models have been proposed to account for the formation of 
processed pseudogenes. It appears that no one mechanism is likely to be 
universal, and the variety of pseudogenes structures and flanking 'tail' and 
repeat sequences probably reflects a variety of ways in which sequences 
contained in RNA may be reintroduced into the genome.
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1.3 Transposition in Eukaryotes
1 .3 .1  Transposable  Elements
The observation of an unstable phenotype in maize (McClintock, 1951) led 
to the first proposal of the existence of mobile genetic elements. Such mobile 
genetic elements are now more generally termed 'transposable elements', or 
transposons. Transposable elements were later detected in bacteria by the 
mutations they produce on moving to positions within a functional gene, and it
was bacterial transposons that were first characterised in molecular detail. All
bacterial transposable elements contain a gene coding for a transposase, which
is required for the integration of the transposon into the target DNA. Certain 
classes of bacterial transposons {eg. Tn3), also contain a second gene which 
codes for a site-specific recombinase, the resolvase (Heffron, 1983; Grindley,
1985). More recently there has been marked progress in the characterisation
of eukaryotic transposons. In eukaryotes, as well as transposons {eg. maize
elements) that undergo DNA-mediated transposition, apparently analogous to 
that in bacteria , there are several examples of transposons in which
transposition is RNA-mediated. Some examples of these eukaryotic transposable
elements will be discussed in this section.
Transposable elements are defined as stretches of DNA that are flanked by 
specific terminal DNA sequences and that have the ability to move to new DNA 
sites with little or no specificity for the latter. They are usually identified by
the effects they have on the structure or function of the genome. Thus they
can cause interruption, deletion or inversion of regions of DNA in regulatory
or coding regions of genes, and may have the ability to acquire and transpose
other genomic DNA.
1 .3 .2  Eukaryotic Transposable Elements: DNA-mediated
The first transposable  genetic  elements to be d iscussed are the 
controlling elements of Zea mays. These were detected because they can cause
unstable mutations affecting pigmentation of the aleurone layer of the maize 
kernel. McClintock (1951) coined the term 'controlling element' for elements 
of this type as they appeared to control gene expression. This occurs when a 
controlling element inserts within, or adjacent to, a gene and inhibits its 
expression. This inhibition is relieved when the controlling element is excised.
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This may occur in either somatic or germline cells and may be correlated with 
insertion  of the controlling elem ent elsewhere in the genome. Some 
controlling elements can be detected even though they do not affect gene
expression since they are sites of frequent chromosome breaks (McClintock,
1951).
Some controlling elements are termed autonomous or 'regulator elements'
because they affect the expression of adjacent genes and mediate their own 
excision and/or transposition. Others are termed non-autonomous or 'receptor
elements' because they can only transpose if  a related regulator element is
present elsewhere in the genome (Fincham and Sastry, 1974; Federoff, 1983). 
As regulators can promote their own excision and transposition as well as that
of appropriate receptor elements, the receptors are believed to be derived from
regulators by deletion.
The Activator  (Ac)  and Dissociat ion (Ds)  elements constitute one of the 
best known family of the receptor-regulator systems of maize transposable 
elements (Doring and Starlinger, 1984). D i  is a transposable element in which
the ability to move and cause chromosome breakage is dependent on the 
sim ultaneous presence of an Ac element elsewhere in the genome. In 
contrast, the Ac  elem ents are able to promote their own transposition 
(McClintock, 1951; Federoff, 1983). Several Ac  and Ds elements have been
isolated (Doring et al., 1984; Federoff et al., 1983; Sutton et al., 1984). The Ac
elements have been shown to be structurally similar or identical to each other, 
whereas the D s  elements are quite variable in length and sequence. Most of
the D s  elements are closely related to the A c  elements in structure, suggesting 
that they are derivatives of the A c  element defective in transposition (Federoff 
et al., 1983). The Ac elements exhibit two properties that are common to 
transposable elements of many organisms: they are flanked by short direct
repeats of target-site DNA (8 base pairs in this case), and possess short terminal 
inverted repeats (11 base pairs here).
Recent nucleotide sequence analysis indicates that A c is 4.6 kb in length 
and contains two open reading frames encoding polypeptides of 839 and 210 
am ino-acids, respective ly  (Pohlm an et al., 1984). These genes in the A c
element are about the size of the transposase and the resolvase of the bacterial 
transposon Tn3. The D s  element is a complementable mutant of A c ,  and it 
differs from the Ac  element by a deletion of 194 nucleotides located entirely in 
the larger open reading frame (Pohlman et al., 1984). Thus the protein which 
is inactivated by the deletion in the D s  element is probably a protein involved
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in transposition, consistent with the analogy to bacterial transposons (Federoff, 
1983). It is therefore reasonable to imagine that their mechanism of 
transposition is mediated by DNA in a similar way to that of bacterial 
transposons (Grindley and Reed, 1985).
1 .3 .3  Eukaryotic Transposable Elements : RNA-mediated
(i) Endogenous Retroviruses and Retroviral-like Elements
Retroviruses are RNA-containing animal viruses that replicate through a 
DNA intermediate incorporated into the host chromosome. Thus they have two 
alternative types of genomic nucleic acid, viral RNA and proviral DNA, both 
containing all of the genetic information of the retrovirus (Temin, 1981).
The proviral DNAs of the vertebrate retroviruses are approximately 7 kb 
in length, and are bounded by direct repeat sequences known as 'long terminal 
repeats' (LTRs) a few hundred nucleotides long (1 in Figure 1.2a). Each LTR 
includes a short inverted repeat sequence (5 to 13 base pairs in length) at its 
ends (2 in Figure 1.2a). All proviruses that have been analysed so far start with
the sequence TG and end with CA (Weiss et al., 1982). The proviral DNA is 
flanked on each side by a small number of bases (usually 5) which occur once 
at the site of insertion (3 in Figure 1.2a ) in the absence of the element (target- 
site direct-repeats).
The LTRs of proviral DNA have three components, only two of which are 
found at the non-identical ends of the viral RNA (Figure 1.2a). At the left-hand 
end of an LTR is a unique sequence from the 3' end of the viral RNA. Adjacent 
to this is a sequence which is repeated at both ends of the viral RNA and a 
unique sequence from its 5' end. These are designated U3, R, and U5, 
respectively, in Figure 1.2a. It must be stressed, however, that the proteins 
required for transposition are encoded in the DNA between the LTRs of 
retroviruses and not in the LTRs themselves. There are three well-defined
viral genes, g a g , p o l , and e n v  (Figure 1.2a), which, respectively, encode a 
virion core protein, the reverse transcriptase and an envelope glycoprotein. 
However, certain of these genes actually encode more than one protein. Thus 
the p o l  gene also encodes a ribonuclease H, which is located at its 5' end, and 
an endonuclease which is located at its 3' end (Johnson et al., 1986).
The transcription of the viral RNA from the proviral DNA is presumed to
start at the beginning of R in the left-hand LTR of the provirus and terminate
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(a) Diagram showing the relationships between sequences in retroviral
RNA and proviral DNA and between an integrated provirus and a site into
which it has inserted. Putative U5, R, U3 regions are indicated. The coding 
domains of 8 ^ 8  > are indicated on the proviral strand of DNA. The
repeats are, 1, LTR; 2, short inverted repeat; 3, direct repeat of a host sequence 
present only once at the empty site. (b) Diagram of a c o p i a -like transposable 
element, indicating the positions and orientations of the repeat sequences. The 
relationship between a full and an empty site is shown. Repeat sequences are
described as in (a) above. (Modified from Figure 1 in Finnegan, 1981).
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near the end of the right-hand LTR (Varmus, 1983). Putative promoter and
polyadenylation signals have been found at appropriate positions in all LTRs 
that have been sequenced. Synthesis of the first DNA strand is primed by a host 
tRNA, hydrogen bonded to the viral RNA by its 3' terminal 18 nucleotides. The 
sequence to which this tRNA hybridises, the primer binding site, can be found 
two base pairs to the right of the left-hand LTR. A conserved purine-rich 
sequence adjacent to the right-hand LTR is believed to be involved in priming 
synthesis of the second DNA strand.
After infection, viral RNA molecules are first reverse-transcribed in the
cytoplasm into linear double-stranded DNAs flanked by an LTR at each end.
Following migration of the DNA into the nucleus, two prominent circular 
species appear with either one LTR, or two LTRs in tandem. The former species 
may be generated by homologous recombination between the two LTRs of the
linear molecule, while the latter are apparently formed by blunt-end ligation 
of l inear molecules (Panganiban, 1985) The formation of the circular 
molecules with two tandem LTRs result in the concurrent formation of a 
retroviral att  site, which acts as a recognition site for integration into the host 
DNA (Panganiban and Temin, 1984). Therefore it is likely that only the two-LTR 
circular form serves as precursor to the provirus. Recently, reports have 
indicated that the 3' end of the p o l  gene function as an 'int' locus, a region 
encoding a retroviral endonuclease 'integrase ' (Schwartzberg et al., 1984; 
Panganiban and Temin, 1984), which specifically recognises the at t  site and 
thus mediates integration (Panganiban, 1985). Integration and resolution of 
the a t t  site results in the loss of the middle 4 base pairs of the att  site. This 
precise deletion, as well as the duplication of target DNA at the site of insertion, 
is likely to reflect staggered cleavage of both DNAs, followed by exonucleolytic 
removal of all or part of each resulting viral DNA overhang, and filling-in of 
each cellular DNA overhang by DNA synthesis (Panganiban, 1985).
Endogenous proviruses occur in the genomes of many vertebrates. The 
chrom osom al loca tions  of endogenous p rov iruses  can d iffer  between 
individuals in populations of mice and chicken (Cohen and Varmus, 1979; 
Hughes et al., 1979) and integration of both exogenous and endogenous 
proviruses can cause mutations. Proviral sequences have been found 
associated with mutations which inhibit the expression of genes affecting the 
coat colour (Jenkins et a l ,  1981) or embryonic development (Jaenisch et al.,
1983) of mice, and which activate a cellular oncogene, c - m y c ,  in chickens 
(Hayward et al., 1981; Payne et al., 1981).
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Because the endogenous retroviral sequences are carried in the germline 
they formally resemble transposable elements as well as being proviruses. 
However, there are also defective elements related to retroviral genes but 
lacking the possibility of an extracellular phase, and so can only be classified 
as transposons. These are the genes that encode the intracisternal A-particles 
(IAP), which are retrovirus-like structures observed in mouse oocytes and 
preimplantation embryos (Calarco and Szollosi, 1973; Yotsuganagi and Szollosi,
1981) and in a variety of mouse tumour cells (Kuff et al., 1972; Lueders et al., 
1977; Lueders and Kuff, 1977). Since these particles bud from the endoplasmic 
reticulum and remain within the cisternae, they are not infectious. Mouse IAPs 
contain a major protein of 73,000 daltons (Paterson et al., 1978), a reverse 
transcriptase (Wilson and Kuff, 1972), and polyadenylated RNA molecules (IAP 
RNAs) (K uff  et al., 1981; Ono et al., 1980; Pa te rson  et al., 1 97 8 ) .  
Morphologically and biochemically, IAPs have retrovirus-like features, but IAP 
RNAs have no apparent sequence homology with either type B or type C murine 
retroviral RNAs (Lueders and Kuff, 1980).
DNA sequences homologous to IAP RNAs (IAP genes) are present in 
approximately 1,000 copies per haploid genome of M. muse ulus,  and these 
genes appear to be interspersed throughout the chromosomes (Lueders and 
Kuff, 1977 and 1980; Kuff et al., 1983a). Sequences homologous to the IAP genes 
of M. musculus  are widely distributed in most rodent species and in some other 
mammals (Lueders and Kuff, 1981). The majority of DNA sequences related to 
the IAP genes can be categorised as Type I or Type II elements, the former 
being about 7 times more numerous than the latter. Type I elements are about 
7.3 kb long whereas Type II elements are about 4.8 kb long. However these 
latter appear not to be simply deletion derivatives of Type I elements (Shen-Ong 
and Cole, 1982).
Several cases of transposition of mouse IAP elements have been reported 
and these have generally involved deleted IAP genomes. In two cases, the 
immunoglobulin k  light chain gene have been inactivated by the insertion of 
an IAP element within an intron of the gene (Kohler and Shulman, 1980; 
Hawley et al., 1982; Kuff et al., 1983a). Presumably these IAP elements 
prevent expression of the k chain gene. However, in a mouse myeloma, the 
insertion of an IAP element within the cellular oncogene, c - m o s ,  has 
apparently caused its activation (Rechavi et al., 1982, Kuff et al., 1983b). In 
addition, an IAP genome has been found associated with one of the two renin 
genes of DBA/2 mice, with circumstantial evidence for gene activation in this
2 6
case (Burt et al., 1984). Recently, an IAP genome was found to be inserted
upstream of the putative TATA box of the interleukin-3 gene promoter in a
leukaemia cell line (Ymer et al., 1985). Expression studies confirmed that the
IAP genome was responsible for the constitutive expression of IL-3 in this 
leu k a e m ia .
No biological role has yet been attributed to IAP genes, other than the
rather specious one of causing mutations. However, there is evidence that the
gene for a IgE-binding factor is also a member of the Mus mus  cuius  IAP
sequence family (Moore et al ., 1986). IgE-binding factors are produced by T
lymphocytes and believed to regulate the production of IgE by B lymphocytes
(Hirashima et a l ,  1980; Ishizaka, 1984; Suemura et a l ,  1980). Analysis of the 
coding region of the IgE-binding factor indicated that it is entirely derived 
from segments of the putative IAP gag  and p o l  genes. The significance of this 
relationship is difficult to assess but the interesting possibility exists that some 
members of the mouse IAP sequence may have evolved to encode proteins with 
biological functions unrelated to retroviral replication.
( i i)  C o p i a -like Elements in Drosophila  m elanogaster
The genome of D. m e lanogas te r  contains about 30 to 50 families of 
transposable elements, together making up approximately one-half of the 
moderately repetitive DNA (5 to 10% of the total genome) in this species 
(Finnegan, 1981). The best studied families (known as the copia, 412, 297, 
m d g l , mdg3, and B104 families, after the first member of each to be studied) 
have several properties in common, although there is no detectable homology 
betw een them (Finnegan et al., 1978; Strobel et a l ,  1979; Ilyin et a l ,  1980a 
and 1980b; Scherer et a l ,  1982; Ikenaga and Saigo, 1982). They are usually 
referred to collectively as ' c o p ia - like elements'. The members of each family 
are well conserved and are located at 20 to 100 sites distributed throughout the 
genome. In general, there is only one element at each site but the number and 
location of these sites vary between strains of D. melanogaster  and between 
embryonic and tissue culture cell DNA (Ilyin et al., 1978; Potter et a l ,  1979).
C o p i a  is a 5 kb element (Finnegan et a l ,  1978) and is flanked by two 
LTRs of 276 base pairs (Levis et al., 1980). Evidence for its transposition is 
provided by mutations it causes, especially well-characterised being those 
involving the w hi te  locus. The white locus of D. melanogaster  is responsible 
for the deposition of pigment in the eye. Insertion of a c o p i a  transposable
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element into the small intron of the w h i t e  gene results in a mutant (w h i t e -
a p r i c o t )  acquiring an eye colour which is considerably lighter than the red 
colour of the wild-type (Bingham and Judd, 1981). Furthermore, the mutations 
which are caused by the insertion of copia can be reverted by excision of the 
element, although, in the case of the w h i t e - a p r i c o t  mutation, with a rather low 
frequency (Rubin et al., 1982). In situ hybridisation and Southern blotting 
experiments performed on different revertants do indicate that c o p i a  have 
been excised in these (Gehring and Paro, 1980; Goldberg et al., 1982). Recent
analysis from an isolated revertant of w h i t e - a p r i c o t  has shown that copia was 
excised in such a way that one LTR has remained at the site of insertion
(Carbonare and Gehring, 1985). The LTR has the same orientation as the 
w h i t e - a p r i c o t  mutant and also retains the 5 base pair duplication in the 
flanking DNA. This structural arrangement is consistent with the hypothesis
that c o p i a  has excised by a mechanism of intrachromosomal homologous
recom bination  between the LTRs (Carbonare and Gehring, 1985). This
mechanism of excision may also account for the occurrence of closed circular 
c o p i a  DNA molecules with one LTR only (Flavell and Ish-Horowicz, 1981),
which would represent the reciprocal crossing-over product.
C opia-Yike.  elements possess many structural similarities in sequence
organisation to that of proviruses of vertebrate retroviruses. They are of 
similar lengths to proviruses and flanked by LTR sequences a few hundred
nucleotides long (1 in Figure 1.2b). The lengths and sequences of these LTRs
are specific for each family of elements (Levis et al., 1980; Bayev et al., 1980). 
At the extreme ends of each element are short (about 10 base pairs) inverted
repeats (2 in Figure 1.2b) which, except in the m d g 3  family, occur at both ends 
of the long direct-repeats. Immediately before and after each element is a 
short direct-repeat (3 in Figure 1.2b), the length, but not the sequence, of 
which is constant for all members of a particular family. Comparison between 
particular sites in the genome from different sources, one containing and one
lacking a transposable element (the latter being referred to as an 'empty' site),
indicates that the bases of the short direct repeat occur only once at the site 
into which an elements inserts (Dunsmuir et al., 1980).
Recent sequence analysis of the c o p i a  element present at the w h i t e -
a p r i c o t  allele of the w h i t e  locus in D . m e l a n o  g a s t e r  has detected a single
open reading frame of 4,227 nucleotides (Mount and Rubin, 1985). It has the 
potentia l to encode a polyprotein with several regions of homology to 
retroviral proteins, including good homology to a region of the p o l  gene
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encoding integrase, recently shown to be distinct from reverse transcriptase 
and required for the integration of circular viral DNA to form proviruses (see 
above). However, the organisation of these coding regions within c o p i a  is 
different from their organisation in retroviruses and in the other c o p i a - l ik e  
element 17 .6 ,  but more closely resembles the Ty transposable elements of yeast 
(see below).
(iii)Ty Elements in Yeast
Ty elements are a family of approximately 30 transposable elements, 
which are dispersed throughout the genome of S a c c h a ro m y c e s  c e rev i s iae  
(Cameron et al., 1979; Roeder and Fink, 1980; Farabaugh and Fink, 1980; Gafner 
and Philippsen, 1980). They consist of a central region approximately 5.3 kb in
length, flanked by terminal direct repeats, known as 5 sequences, about 330 
base pairs long. Upon transcription, the Ty elements generate duplications of 5
base pairs in the target DNA as a consequence of integration (Farabaugh and
Fink, 1980). The 5 base-pair duplications among different Ty elements have 
been shown to be unrelated apart from being A/T rich, indicating that there is
little sequence specificity associated with transposition (Roeder and Fink, 1983).
Recent sequence analysis has detected two open reading frames in the Ty 
element, occupying the same relative positions as the g a g  and pol  coding 
sequences in retroviruses (Hauber et al., 1985). The overlap between the two 
open reading frames is 38 base pairs, and recent experiments (Mellor et al.,
1985) suggest that they are expressed as a fusion protein, possibly by a
mechanism common to retroviruses. As in the case of Rous sarcoma  virus, the 
production of this fusion protein would require translational frameshifting 
within the region of overlap between the genes (Clare and Farabaugh, 1985; 
M e l lo r  et al., 1985). Although putative transposition intermediates have not
yet been found for Ty, it was possible to decide which transposition mechanism
was used by Ty elements by following the fate of a foreign intron inserted into 
a galactose-promoted Ty element (Boeke et al., 1985). The intron (plus its 
flanking exons) was from a yeast ribosomal protein gene, and was inserted 
under the artificial control of a yeast GAL1 promoter, so that transcription
could be induced by galactose . It was found that this induced transposition and 
caused the intron to be correctly spliced out of the transposed copy. It is thus
beyond doubt that RNA is an intermediate in the transposition of Ty. The clear
implication of an RNA intermediate in Ty transposition is that yeast cells
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induced for Ty transposition contain the enzyme reverse transcriptase; and, 
consistent with this, it has been found that there is significant amino-acid
sequence homology between the Ty element and retroviral and other reverse 
transcriptases (Clare and Farabaugh, 1985; Hauber et al., 1985; Warmington et  
al., 1985; Mount and Rubin, 1985).
1.3.4 R e tro p o so n s
The name 'retroposon' was coined to describe certain dispersed sequences 
in the mammalian genome that shown common features which suggest that 
they are generated  from  RNA intermediates by a common mechanism
involving reverse transcription (Rogers, 1983). These differ from retroviruses 
and retrotransposable elements in that they lack LTRs and, in most cases,
appear to lack the ability to code the machinery of their own transposition. 
Processed pseudogenes fall into this category (see section 1.2.3), as do the
i n t e r s p e r s e d  n u c l e a r  elements described below. The interspersed nuclear 
elements are subdivided into the short interspersed nuclear elements (SINES), 
several hundred base pairs in length, and the long interspersed nuclear
elements (LINES), some thousands of base pairs in length.
(i) Short Interspersed Nuclear Elements
The SINES are typified by the Alu family found in the primate genome, 
so called because most of its members contain Alul restriction sites (Houck et
al., 1979). Each A l u -repeat is about 300 base pairs in length and there are 3 to 
5 X 105 copies, constituting 3 to 6% of the human genome (Schmid and Jelinek, 
1982). The structure of Alu  contains a head to tail tandem arrangement of two 
related sequences about 130 base pairs long, each terminated by an A-rich tail
(Figure 1.3). The 3' tandem repeat contains an additional, internal, segment of 
31 base pairs which is usually absent from the 5' repeat (Duncan et  al., 1981). 
In primates and rodents, all the genomic Alu-Uke  sequences carry variable A- 
rich 3’ tails and are flanked by direct repeats (Bell et  al., 1980; Krayev et  al., 
1980), except where there is clear evidence of deletion.
Recent studies have revealed highly-significant (about 80%) sequence 
homology between the longer unit of the A l u  consensus sequence and the 5
and 3’ portions of the 7SL RNA. The 7SL RNA is an abundant cytoplasmic RNA, 
300 base pairs in length, and forms part of the signal recognition particle
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F|g ure— ^  Structura l  features of hum an 7SL RNA and the
consensus semience of human and ro d e n t  A l u  DNA
Human 7SL RNA 
5'
Human Alu  DNA 
5
Rodent 71/u DNA
ftV.V :::::•!#>>
T T (A)n
100bp
The structural relationship of human 7SL RNA to the consensus 
structures of human and rodent A lu  DNA is shown. Homologous regions are 
indicated by identical shading. [(A)n ] is the A-rich segment at the 3’ end of two 
related tandem repeats of a head to tail dimer in human Alu DNA. (I) is the 
insert from the right monomer which is absent in the left monomer. A 
segment of 155 base pairs from the centre of the 7SL RNA sequence is absent 
from the human A l u -repeat unit. Arrows above the mouse A lu  DNA indicate 
the position of the 32 base pair tandem duplication.
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(Walter and Blobel, 1980). As shown in Figure 1.3, the central 155 base pairs of 
the 7SL RNA primary sequence is not represented in the A l u -repeat (Ullu and
Tschudi, 1984). Although it has been suggested that the A l u  sequences may 
have originated from something equivalent to processed pseudogenes of 7SL 
RNA (Gundelfinger et al., 1983), it is important to emphasise that the processed 
pseudogenes of 7SL RNA that have been described contain the central portion 
lacking from A l u  and are of the 3' truncated variety, assumed to have been
generated by self-priming facilitated by a suitable 3' secondary structure (Ullu 
and Weiner, 1984).
Most A/w-elements are capable of being transcribed by RNA polymerase 
III and thus are likely to terminate at oligo(dT) stretches in flanking 3' DNA 
( J a g a d e e s w a r a n  et al., 1981). Transcripts would thus have the potential to 
hybridise to the corresponding A-rich region, which could act as a priming site 
for reverse transcription, leading to a cDNA copy that could be reintegrated 
into the genome (see section 1.2.3v). Transposed A l u  sequences still retain 
their RNA polymerase III internal promoters and thus have the potential for
further transposition. However, the accumulation of mutations may inactivate 
the promoters of some A l u  sequences and render them incapable of further 
t ra n s p o s i t io n .
'A/u-equivalent ' families have been identified in the genomes of many 
rodents, for example in mouse (Krayev et al., 1980), rat (Lemischka and Sharp,
1982) and Chinese hamster (Haynes et al., 1981). Comparison of the A l u -  
equivalent sequences in human and rodent shows that the A / w - e q u iv a le n t  
sequences in rodents is derived from just one of the 130 base pair units found in 
A l u  (Figure 1.3), but contains a tandem repeat formed by duplication of an 
internal 32 base pair sequence (Kalb et al., 1983). This internal 32 base pair 
insert is, however, different from the 31 base pair insert of the human A lu -  
repeat. D isregarding these insert regions, the human and rodent A l u -
equivalent DNA sequences show a homology of approximately 80%.
(i i) Long Interspersed Nuclear Elements
The LINEs are typified by the LI family, which is believed to be the only 
major family of this type in the primate and rodent genome. Human LI
sequences (designated LIHs) have been shown to be homologous to the LI
family of mouse (designated LIMd), and a wide variety of other mammals
(Singer et al., 1983; Martin et al., 1984), suggesting that LI is ancient and has
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been conserved throughout the mammalian genome (Katzer et a l ,  1985; 
Witney and Furano, 1984). There are 104 to 105 copies of these elements, and 
they constitute 2 to 3 % of the mammalian genome (Singer, 1982). Most 
members of the LINE families are less than the full length of 6 to 7 kb. 
Different segments of LIH s and LIM d elements were cloned independently as 
separate sequences by digestion with particular restriction enzymes, and were 
originally thought to represent different repeated DNA families. These were 
referred to as the Hindlll (Manuelidis, 1982) and Kpnl (Grimaldi et al., 1984) 
families of primates, and the BamHI (Soriano et a l ,  1983), MIF-I (Brown and 
Piechaczyk, 1981), Bam-5 (Fanning, 1982), BstNI (Cheng and Schildkraut, 1980) 
and R -fam ilies  (Gebhard et al., 1982) of rodents. These separate repeat 
sequences were later shown to be colinear (Fanning, 1983; Bennett and Hastie,
1984).
Transposed copies of the LI family are heterogeneous in length. Smaller 
versions generally have the peculiarity that they lack varying amounts of the 
5' end of the full-length version, but contain the same 3' sequences terminated 
by an A-rich segment of variable length (Lerman et al, 1983; Grimaldi et al,
1984; D iG iovanni et al, 1983). This, coupled with the observation that 
individual LI elements are surrounded by small (less than 15 base pair) direct- 
repeats , suggests that individual LI elements are generated from RNA 
intermediates of different lengths and inserted at staggered breaks dispersed 
throughout the genome (Voliva et al, 1984; Grimaldi et al, 1984; Wilson and 
Storb, 1983).
Recently, several full-length LIM d elements have been isolated, and have
been found to contain multiple copies of a 208 base-pair tandemly repeating
region at the 5' end (Loeb et a l ,  1986). The two examples described each
contain 4 2/3 and 1 2 /3  copies of this tandem repeat, the truncated 2/3 copy
being the most 5' member in both cases. The full-length LIM d member has two 
large overlapping open reading frames of lengths 1,137 and 3,900 base pairs
(Loeb et a l ,  1986). The ratio of amino-acid replacement to amino-acid silent 
(R/S) site differences between the 3,900 base-pair open reading frame and a
composite consensus primate LI sequence was determined and indicated that 
this portion of LI is evolving under pressure to conserve protein function. It is 
not yet known whether this gene encodes a protein required for transposition 
of L I ,  but the predicted product from the 3,900 base-pair open reading frame 
bears some similarity to reverse transcriptase (Loeb et al, 1986). Such an
encoded reverse transcriptase activity would be consistent with the previous
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proposal that LI is a mobile genetic element which moves via an mRNA 
intermediate, and would provide at least a partial explanation of the abundance 
of LI elements.
1.4  Objectives of the Project
The work described in this thesis is concerned with the structure of four 
actin-like genes previously isolated from a bacteriophage lambda library of 
mouse genomic DNA. These clones were chosen for study because electron 
m icroscopic  heteroduplex analysis (performed by Dr. H. Delius, EMBL, 
Heidelberg) had shown them to be interrupted - each at a different position - 
by single regions of DNA not contained in the reference cDNA-like clone. (This 
was actually a y-actin processed pseudogene, ?imA19, the nucleotide sequence of 
which has been determined by Leader et al, (1985), or a similar clone, ^mA81, 
with a y-actin pseudogene in the opposite orientation). The interpretation of 
these heteroduplexes in terms of the structures of the actin-like genes in 
/UnA36, XmA82, A,mA118 and A,mA119 is shown in Figure 1.4.
The objective of this project was to determine the nature of these 
interruptions. Had they been found to be introns in functional actin genes, 
then attention would have focused on characterising these genes. In fact, they 
were found not to be introns, suggesting the interesting possibility that they 
might be mobile elements inserted into pseudogenes ; and the main objective 
became that of determining the nature of these inserted sequences.
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S T L  f t f  c » n i ;i i n i n, '  „ , , . . . . . .
XmA36 x AmA81
>.mA118 x XmA81
;• : :
XmA119 x XmA19
E l e c t r o n  m i c r o g r a p h s  o f  h e t e r o d u p l e x e s  b e tw e e n  r e c o m b i n a n t  l ambda  
D N A s  c o n t a i n i n g  m o u s e  ac t in - l ik e  sequ enc es  are shown.  (a) Heterodup lex  
be tween  >miA81 and ^ m A 3 6  DNA. (b) Heteroduplex between A.mA81 and X m A 118  
DNA.  (c) Heteroduplex  between XmA19 and A,mA119 DNA. 1 he double-st randed 
left and r igh t  a rms  of  the lambda  are labe lled 'L' and ’R \  respect ive ly.  The 
h o m o l o g o u s  a c t i n  s e q u e n c e s  f o r m  d u p l e x e s  in the inse r t  re g io n s ,  only  
in te r r u p te d  by on e  de l e t io n / in se r t i on  loop,  which  is marked  by a star in the 
e l e c t r o n  m i c r o g r a p h s .
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MATERIALS AND METHODS
Common chemicals were AnalaR grade supplied by BDH Chemicals, Poole,
Dorset, or Fisons Scientific, Loughborough, Leics. Exceptions to this are noted
in the text.
Suppliers of speciality reagents :
A m e rs h a m  - Amersham International, Amersham, Buckinghamshire
B o e h r in g e r  - BCL, Lewes, East Sussex
BRL - Bethesda Research Labs., Paisley, Scotland
Difco - Difco Labs., Detroit, USA
Sigm a - Sigma Chemical Company, Poole, Dorset
2 .1  Media and Antibiotics
2 .1 .1  Liquid Media
All media and solutions used in the handling of nucleic acids were
sterilized by autoclaving for 15 min at 15 p.s.i..
L - B r o t h  (per litre) : 10g Bactotryptone (Difco 0123-01)
5g Yeast Extract (Difco 0127-01)
5g NaCl
Adjusted to pH 7.2 with NaOH
M9 M edium  (per litre) : 6g Na2HPC>4
3g KH2P04
0.5g NaCl
lg NH4C1
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2YT M ed ium  (per litre) : 16g Bactotryptone (Difco 0123-01)
lOg Yeast Extract (Difco 0127-01)
5g NaCl
10X Hogness Medium : 6.3g
(per litre) 0.45g
0.09g
0.9g
1.8g
44.0g
T E  B uffer  : lOmM
ImM
L a m b d a  D ilu en t  : lOmM
lOmM
ImM
P h a g e  B u ffe r  (per litre) : 3g
8.77g
5g
lml
0.1ml
lml
2.1.2 Media Containing
L - A g a r  (per litre) : 1 litre
15g
M inim al A gar (per litre): 100ml
Hg
lml
lml
*lml
*5ml
k 2h p o 4
Na citrate 
MgS04.7H20  
(NH4)2S 0 4
k h 2p o 4
g ly c e ro l
Tris-HCl,pH8.
EDTA
Tris-HCl,pH7.5 
MgS04 
EDTA
k h 2p o 4
Na2HP04.2H20  
NaCl
1M MgS04 
1M CaCl2 
1% gelatin
Agar
L-Broth (pH7.2)
Agar (Difco 0140-01)
10X M9 Medium 
Agar (Difco 0140-01)
1M MgS04 
0.1M CaCl2
1M Thiamine-HCl(VitB 1, Sigma) 
40% glucose
B B L - A g a r  (per litre) : 10g BBL Tripticase (BBL 11921)
5g NaCl
10g Agar (Difco 0140-01)
Phenol Red added to 0.02g/l
BB L-Top L ay e r  A gar : 10g BBL Tripticase (BBL 11921)
(per litre) 5g NaCl
6.5g Agarose (BBL)
*10ml 1M MgS04
Phenol Red added to 0.02g/l
H - A g a r  (per litre) : 10g Bactotryptone (Difco 0123-01)
8g NaCl
12g Agar (Difco 0140-01)
H -Top  A g a r  (per litre) : 10g Bactotryptone (Difco 0123-01)
8g NaCl
8g Agar (Difco 0140-01)
H a m m e r s m i th  S ta b s : 9 g Nutrient Broth (Difco 0003-02)
(per litre) 7-5g Agar (Difco 0140-01)
5g NaCl
*10ml lOmg/ml Thymine
Adjusted to pH 7.2 with NaOH
*Sterilized separately as a concentrated solution.
2 .1 .3  A n t ib io t ic s
T hese were obtained from Sigma and used at the following 
c o n c e n t r a t io n s .
A m p ic i l l in  : A stock solution was made up of lOmg/ml of the sodium salt
of ampicillin in water. It was sterilized by filtration and stored in aliquots at -20
OC . The working concentration was 30|ig/ml .
T e t r a c y c l i n e  : A stock solution was made up of 5mg/ml of tetracycline
hydrochloride in ethanol/ water (50% v/v). It was sterilized by filtration and
stored in aliquots at -20 o C. The working concentration was 20|±g/ml.
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2.2 Maintenance of Bacteria and Plasmids
2.2.1 Bacterial Strains
The bacterial strains used in this work were all derivatives of E.coli K12. 
They are listed in Table 2.1 along with the markers carried on the strains, and 
the source of the strain.
2 .2 .2  Storage of Bacteria
Most bacteria could be kept for at least one month in the coldroom on 
tightly wrapped L- agar plates. Similarly overnight cultures could be kept for a 
few weeks in the coldroom.
Long term storage of bacteria  of one year was m aintained in 
Hammersmith stabs (see section 2.1.2). A single colony was inoculated into the 
stab and stored at room temperature.
Any bacterial strains of significance, such as strains carrying foreign
DNA as plasmids, were in addition kept as frozen stock culture in Hogness 
modified freezing medium (see section 2.1.1). To 2.5ml of an exponentially 
growing culture, 0.1 volume 10X Hogness medium was added, mixed, shock 
frozen in liquid nitrogen and stored at -70 °C. These bacteria remain viable for 
several years.
2 .2 .3  Storage of Plasmid and Phage DNA
Native plasmid and phage DNA were stored in TE buffer (see section
2.1.1) in a tight fitting capped Eppendorf tube. Plasmid DNA was stored at -20 °C
and lambda DNA stored at 4 °C . DNA stored in this way remains stable for
several years, and could be used to re-transform bacterial host cells should the
need arise.
2.3  Preparation of Plasmid DNA
Two major differences between E.coli  DNA and plasmid DNA are exploited
in the method to isolate pure plasmid DNA. The E .co li  chromosome is much 
larger than the DNA of commonly used plasmids. The bulk of E .c o l i  DNA 
extracted from cells is obtained as broken, linear molecules, whereas plasmid
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XaM s— IxL  E . q q H—strains described in this study
E . c o l i  Strain Genotype Reference
DH1 F", rec Al, end Al, gyr A96, thi, 
hsdR17, Sup E44, rel Al, X~
Low, 1968; Meselson 
and Yuan, 1968.
HB101 F-, hsd S20 (rg-> m g-) ,  rec A13, 
ara-14, pro A2, lac Yl, gal K2, rps 
L20 (Smr),xyl-5, mtl-1, Sup E44,
Bolivar and Backman, 
1979.
JM103 Alac pro, thi, str A, Sup E, end A, 
sbc B 15,hsd R4, F'tra D36, pro AB, 
lac IQ, ZAM15
Messing et al 1981.
JM105 thi, rps L, end A, sbc B15, hsp R4, 
A(lac-pro AB), [F, tra D36, pro AB, 
lac iqZAM15]
Yanisch-Perron et al., 
1985.
JM109 rec Al, end Al, gyr A96, thi, hsd R17 
Sup E44, rel Al, A,-,A(Iac-pro AB),
[F-, tra D36, pro AB, lac I9ZAM15]
Yanisch-Perron et al., 
1985.
Q358 hsd R^-, hsd Mfc", Sup F, 0  8Or, rec A+ Karn et al., 1980.
W8850 F~, gal-, strR, TlR, A,R Allet et al., 1973.
Y1090 Alac U169, pro H+,Alon, ara D139, 
stra A, Sup F, trp C22:TnlO(pMC9)
Young and Davis, 
1980.
4 0
DNA is generally extracted in a covalently closed-circular form. All methods
devised here were based on three basic steps. Growth of bacteria and 
amplification of the plasmids, harvesting and lysis of the bacteria and lastly 
purification of plasmid DNA.
2 .3 .1  Large Scale Preparation of Plasmid DNA 
(Birnboim and DoIy,1979)
Growth of  Bacteria and Amplification of  the Plasmid
An overnight culture was prepared from a single colony of transformed 
bacteria in L-broth supplemented with ampicillin (30|ig/ml). The main culture 
was set up by inoculating 2 X 5ml of overnight culture into 2 X 800ml of L-broth. 
The bacteria were shaken at 37 °C  until late log phase was reached (A6qo = 0-8). 
Chloramphenicol (25mg/ml in 50% ethanol) was added to a final concentration 
of 165jxg/ml and incubation continued a further 16 to 20 hr.
Harvesting and Lysis of Bacteria
Bacteria were harvested by centrifugation at 5000 rpm for lOmin at 4 °C , 
and resuspended in 9.5ml of a solution containing 50mM glucose, lOmM EDTA, 
25mM Tris-HCl (pH 8.0) and 0.5ml lysozyme (Sigma grade I : 40mg/ml in the
same solution). After 30 min on ice, 20 ml of a solution of 0.2M NaOH, 1% sodium
dodecyl sulphate was added , and the mixture left for a further 5 min on ice.
Finally, 15ml of 3M sodium acetate (pH 4.8) was added and the mixture left for
lhr  on ice. The high molecular weight DNA and bacterial debris were removed 
by centrifugation at 30,000 rpm for 30 min in a Beckman Ti60 rotor at 4 °C .  
Total nucleic acid was precipitated from the resultant supernatant by the 
addition of 0.6 volume of isopropanol and left standing for 10 min at room 
temperature. DNA was precipitated by centrifugation at 8000 rpm for 15 min at 
room temperature.
Purification of Plasmid DNA
Plasmid DNA behaves differently from E.coli DNA when the two are
centrifuged to equilibrium in caesium chloride (CsCl) gradients containing the
intercalating dye, ethidium bromide. Covalently closed circular plasmid DNA 
binds less ethidium bromide than linear E.coli DNA and therefore bands at a
higher density in CsCl gradients.
The DNA was dissolved in 30ml TE (see section 2.1.1), 28.9g of CsCl and
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1.8ml of ethidium bromide (lOmg/ml) were added, and the solution clarified by 
centrifugation in a Beckman ’Table-top’ centrifuge at 2000 rpm for 30 min.
Having avoided the surface scum and the precipitated material, the solution was 
then carefully transferred to sealable tubes and centrifuged at 50,000 rpm for 
16hr at 20 °C in the VTi50 rotor of a Beckman ultracentrifuge.
The DNA was visualised under UV (long wave) illumination, where two 
bands were usually seen. The upper band consisted of linear bacterial DNA and 
nicked plasmid DNA, while the lower band consisted of closed-circular DNA 
The plasmid DNA was collected after piercing the tube with a 21g needle just 
below the band. A second CsCl centrifugation was usually performed using 
sealable tubes, and centrifugation at 65,000 rpm overnight in the VTi65 rotor.
Plasmid DNA was isolated as described above.
Ethidium bromide was removed by repeated extraction with an equal 
volume of isoamyl alcohol (3 methyl, 1-butanol : Koch Light). The DNA solution 
was diluted with four volumes of TE and precipitated with 2.5 X the total volume 
of ethanol. DNA was sedimented by centrifugation at 10,000 rpm for lOmin at 
40C , re-precipitated, washed with 70% ethanol, and briefly dried under vacuum. 
The DNA was redissolved in 100p.l TE.
The concentration of DNA was determined by measuring the A2 6 O using 
the assumption that a 50|ig/ml solution of DNA has an A2 6 O of 1>0 when
measured in a spectrophotometer cell with a 1.0cm light-path. It was then
adjusted to lmg/ml by addition of TE. A sample of 0.5p.g was subjected to
electrophoresis  on a 1% agarose mini-gel to check the quality of the
p r e p a r a t i o n .
2 .3 .2  Small Scale Preparation Plasmid DNA
(i) Mini-preparation of Plasmid DNA
For small scale plasmid preparations, a modification of the procedure
described by Holmes and Quigley (1981) was followed. A bacterial colony
containing plasmid was streaked thoroughly onto an antibiotic plate, and
allowed to grow overnight.
Bacterial cells were carefully scraped off the plate and resuspended in
lml of a solution of : 8% glucose; 50mM Tris-HCl.pH 8.0; 50mM EDTA; 5% Triton X- 
100 in a 1.5ml plastic Eppendorf tube, and lOfil lysozyme (20mg/ml in water) 
was added. The tube was transferred to a 95 °C  block for 7 min, and centrifuged
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for 15 min. 0.6ml portion of the supernatant was transferred to a fresh tube, 2p.l 
of boiled RNase (lmg/ml) was added and incubated for 15 min at 37 OC, then ljil 
of diethylpyrocarbonate was added and incubated for a further 10 min at 65 OC. 
The plasmid DNA was collected by addition of 0.24 ml 5M ammonium acetate and 
0.54ml isopropanol, and precipitated by centrifugation. After washing the DNA 
with 0.3M ammonium acetate/70% isopropanol, it was briefly dried under 
vacuum and resuspended in 50p.l TE. A sample of 5p.l (1.0|ig) was sufficient for a 
single restriction digest.
( i i)  Midi-preparation of Plasmid DNA
This small scale method for plasmid preparation was modified from 
Birnboim and Doly (1979). Half antibiotic plates with transformed bacteria were 
prepared as above, and the scraped cells were inoculated into 100ml L-broth 
and grown to confluence. Bacteria were harvested by centrifugation in the 
'Table-top' centrifuge for 5 min, then resuspended in lml of a solution 
containing 50mM glucose, lOmM EDTA, 25mM Tris-HCl (pH 8.0) in a 15ml Falcon 
tube containing 10p.l of lysozyme (50mg/ml). After standing for 15 min on ice, 
3ml of a solution of 0.2M NaOH, 1% sodium dodecyl sulphate was added. The 
mixture was left standing on ice for 15 min, followed by addition of 2.3ml of 3M 
sodium acetate (pH 4.8) and left to stand on ice for a further 10 min. The cellular 
DNA and debris were precipitated by centrifugation (10,000 rpm for 15 min at 4 
OC), the plasmid DNA was precipitated from the supernatant with 0.6 volume of 
isopropanol. After standing for 15 min on ice, the DNA was recovered by 
centrifugation in the 'Table-top' centrifuge for 10 min, washed with 70% 
ethanol, and briefly dried under vacuum, the DNA was redissolved in 0.9ml 2.5M 
sodium  acetate, centrifuged to remove debris, and the supernatant re ­
precipitated  with 5 4 0 jjl 1 isopropanol. After centrifugation and drying under 
vacuum, the DNA pellet was redissolved in lOOjxl TE.
The plasmid DNA was usually contaminated with tRNA, which could either 
be removed by passing the sample through a column of Biogel P-60 (see section 
2.9.2), or by CsCl gradient centrifugation at 65,000 rpm (see section 2.3.1).
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2 .4 Preparation of Bacteriophage Lambda and its DNA
2.4.1 Preparation of Bacteriophage from Lytic Infection
A single colony of the bacterial host E.coli Q358 (Table 2.1), susceptible to 
infection with X 1059, was inoculated into an overnight culture of L-broth 
containing lOmM MgSC>4 . A suitable dilution of X1059 giving 10 to 100 plaques, 
was absorbed onto 200p.l Mg treated cells containing lOmM MgSC>4 , mixed with 
3ml of BBL-top agar, poured onto a BBL-plate and inoculated overnight.
A single plaque was removed and added to 200jnl of a freshly saturated 
overnight culture of bacterial host and left standing at room temperature for 20 
min. The culture was then transferred to a fresh flask with 20ml L-broth 
containing 5mM MgSC>4 . The flasks were shaken at 37 °C  until lysis occurred 
(between 4 to 6 hr), when lml of chloroform was then added. After 5 min of 
shaking, the upper layer was sedimented by centrifugation in a 'Table-top' 
centrifuge for 2 0  min and the supernatant was transferred to a fresh tube 
which could be stored at 0 °C . The supernatant was titred and found to be 
approximately 1 0 * 0  pfu/ml.
Two 500ml batches of L-broth containing 5mM MgSC>4 were inoculated 
with 2 X 3.5ml of saturated overnight bacterial culture. The culture was grown 
until the A5 3 0  value reached 0.3 and then a total of 5 X 1010 pfu of phage 
A,1059 added. The infected culture was shaken until lysis occurred (usually about 
3.5 hr) and then 5.0ml of chloroform was added to each flask and shaking 
continued a further 5 min.
The lysed cultures were decanted, sedimented by centrifugation at 4,000 
rpm for 20 min, and pancreatic DNase and RNase (Sigma) were added to a final 
concentration of 10|ig/ml. After 30 min incubation, solid NaCl was added to 2%, 
solid polyethylene glycol (Serva) was added to 8 %, and the culture was left 
standing overnight at 4 °C to precipitate the phage particles.
The phage was sedimented by centrifugation at 6,000 rpm for 30 min and 
carefully resuspended in 20ml of lambda diluent. Solid CsCl (0.71g/ml) was 
added, giving a final density of 1.5g/ml. After a clarifying centrifugation in 
thg 'Table-top' centrifuge for 30 min, the solution was transferred into sealable 
tubes and centrifugation was performed at 50,000 rpm and 25 »C overnight 
using a VTi50 rotor of a Beckman ultracentrifuge.
The white phage band was removed (see section 2.3.1) and a second CsCl 
centrifugation was performed at 65,000 rpm and 25 oC overnight. The phage
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suspension was extracted and then dialysed against four changes of 500ml 
buffer (lOmM Tris-HCl, pH 7.5; ImM EDTA; lOmM MgS0 4 ) where the CsCl was 
removed. DNA was extracted with phenol/chloroform twice (see section 2.5.1), 
and precipitated with ethanol (see section 2.5.2). DNA was sedimented by 
centrifugation at 1 0 ,0 0 0  rpm for 10 min, briefly dried under vacuum, and 
resuspended in 400pl TE. Boiled pancreatic RNase A (Boehringer, grade I) was 
added to 10p.g/ml and left standing at room temperature for 30 min. The phage 
DNA was stored at 0 °C.
2 .4 .2  Preparation of Bacteriophage from Lysogenic Strain
An overnight 30 ° C  culture of the E.coli strain W8850 (Table 2.1), 
lysogenic for X0 1 5 5 7 8 7  was prepared. The overnight culture (4 X 10ml) was 
inoculated into 4 X 200ml of L-broth containing lOmM MgSC>4 . The cultures were 
shaken at 30 °C until the A5 3 0  reached 0.7, and the lysogen was induced by 
incubation at 42 ° C  for 30 min. The induced culture was shaken a further 90 
min at 37 °C. The cells were harvested by centrifugation at 6,000 rpm for 15 min 
and resuspended in 4ml of supernatant fluid. Chloroform (0.3ml) was added and 
then shaking was continued at room temperature until the solution became 
very viscous. DNase (Boehringer, grade II) was added to 5|xg/ml and incubated 
at 37 °C  for 5 min to reduce the viscosity.
The volume was adjusted to 20ml with lambda diluent and 14.2g of CsCl was 
added to give a density of 1.5g/ml. Subsequent procedures continued as 
described in the standard phage preparation (see section 2.4.1).
2 .5  Extraction and Precipitation of DNA
DNA was routinely  purified free of enzyme by extraction with
phenol/ch lo roform  or with phenol/ether, fo llowed by p rec ip ita tion  with 
e th a n o l .
2 .5 .1  Phenol/Chloroform Extraction
Phenol was redistilled before use, saturated with TE and stored at -20 OC.
Extraction with phenol/chloroform was performed as follows: an approximately
equal volume of phenol was added to the DNA sample to be extracted, mixed;
centrifuged for 1 min; the upper aqueous layer transferred to a fresh tube and
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the extraction with phenol was repeated; 500jil chloroform was added and 
mixed; centrifuged for 10s; the aqueous layer transferred to a fresh tube and 
the extraction with chloroform repeated.
2 .5 .2  Phenol/Ether Extraction
E xtrac tion  with phenol/ether were performed as above with ether 
saturated with water replacing the chloroform. In this case, the ether was 
removed as the upper phase after extraction.
2 .5 .3  Ethanol Precipitation
The ethanol was of the absolute alcohol 100 grade (James Burrough) and
stored at -20 °C. To the solution of DNA 0.1 volume of 3M sodium acetate (pH 5.2) 
and 2.5 volumes of cold ethanol was added and mixed; placed at -20 °C overnight 
or -70 °C for 15 min; centrifuged for 10 min at 0 OC; the precipitate washed with 
70% ethanol and dried under vacuum for 5 min. The DNA was usually stored in 
TE at -20 oc.
2.6  Digestion with Specific Restriction Endonucleases
Restriction enzymes were obtained from the following:
Anglian Biotechnology Ltd. : Unit 8 , Hawkins Rd, Colchester, Essex C 02 8JX 
Boehringer : The Boehringer Corporation (London) Ltd.,Lewes, E. Sussex 
BRL : Bethesda Research Labs., PO Box 35, Trident House, Renfrew Rd., Paisley 
PA3 4EF
NBL : NBL Enzymes Ltd., South Nelson International Estate, Cramlington,
Northumberland, NE23 9HL 
New England Biolabs : CP Labs. Ltd. (UK distr.), Bishop Stortford, Herts 
Pharmacia Ltd : Pharmacia House, Midsummer Boulevard, Central Milton 
Keynes, Bucks MK9 3HP
2 .6 .1  Reaction Buffers
Restriction digests were generally set up using one of three convenient 
buffers and at the temperature specified by the manufacturer.
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The composition of the restriction enzyme buffers are shown below:
B u f fe r NaCl Tris-HCl MgS04 D ith io th re i to l
low 0 lOmM, pH7.4 lOmM ImM
m edium 50mM lOmM, pH7.4 lOmM ImM
high lOOmM 50mM, pH7.4 lOmM 0
Buffers were usually stored as a 10 X concentrated stock at -20 o c .
2 .6 .2  Restriction Digestions
Restriction digestions were routinely carried out in 1.5ml Eppendorf 
tubes in the presence of the appropriate reaction buffer. One unit of enzyme 
activity is defined as the amount of enzyme required to digest lg g  of DNA to 
completion in 1 hr. However a several fold excess of enzyme per digest was 
usually added to ensure complete digestion.
A typical reaction mixture contained l p g  of DNA and 10 units of 
restriction enzyme in a final volume of 25 |il  of the appropriate restriction 
enzyme buffer. The mixture was incubated for 1 to 2 hr and the extent of 
digestion was monitored by electrophoresis of a small aliquot in a 1% agarose 
mini-gel (see section 2.7.2).
In multiple digestions where different buffers were required, the 
digestion which required the lowest ionic strength was carried out first, then 
the ionic conditions adjusted, the second enzyme added and the incubation 
c o n t in u e d .
2 .6 .3  Restriction Mapping
This was carried out mainly by logical interpretation of the results of a 
combination of single and double digestions. Sequential digests of fragments 
recovered from agarose gels (see section 2.7.3) were very useful.
2 .7  Separation of DNA Fragments by Agarose Gel
E lec tro p h o res is
Electrophoresis through agarose gels was the standard procedure used to 
separate, identify, and purify DNA fragments.
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2 .7 .1  Preparation of Agarose Gels
(a) E le c tr o p h o r e s i s  Buffers
Loening's phosphate buffer (Loening, 1967) contains : 36mM Tris-HCl; 
30mM NaH 2 PC>4 ; ImM EDTA; 0.5|ig/ml ethidium bromide; should be pH 7 .7  
without further adjustment.
Acetate buffer contains : 40mM Tris-HCl; 5mM sodium acetate; ImM EDTA; 
0.5|xg/ml ethidium bromide; adjusted to pH 7.4 with acetic acid.
TBE buffer contains : lOOmM Tris-HCl; lOOmM boric acid; ImM EDTA; 
0 .5 |ig /m l ethidium bromide; should be pH 8.3 without further adjustment.
These buffers were prepared as a 20 X (10 X for TBE) concentrated stock
solution and stored at room temperature.
( b )  Load in g  Buffers
These were 1:1 ratios of glycerol and 0.025% bromophenol blue in the
appropriate  electrophoresis buffer.
( c )  A garose  So lutions
The required concentration of agarose (Sigma, type II) was made up in
electrophoresis buffer. The mixture was dissolved by heating and could be
stored at room temperature.
(d) E le c tr o p h o r e s i s  Condit ions
Size Range Gel Concentration Recommended Voltage
1 0 - 1 0 0 kb 0.5% 40V
0.8-15kb 0.7% 40V
0.4-8kb 1.0 % 60V
0.1-3kb 2 .0 % 80V
1% agarose gels were routinely used for plasmid DNA, while 0.5% was best
for restriction digests of lambda DNA, and 0.7% was used to handle genomic
DNA.
(e) H o r iz o n ta l  Gel E le c t ro p h o re s is  A p p a ra tu s
The dimensions of the mini-agarose gel were 12 X 12cm, and this was
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submerged in a 18 X 12cm mini-gel tank. This was either used as an analytical 
gel or a preparative gel, depending on the percentage of agarose and the 
capacity of the comb size.
The dimensions of the large agarose gel accompanying the large 
horizontal gel tank (Pharmacia GNA-200) were 2 2  X 22cm, and this was 
generally used in the analysis of genomic DNA.
2 .7 .2  Electrophoresis in Agarose Gels
The DNA sample was mixed with 3p.l (or 0.3 volume) of loading buffer and 
applied  to the sample well. Electrophoresis was carried out until the
bromophenol blue had travelled the desired distance, dependent upon the size 
of the specific sample.
On completion of electrophoresis, the gel was removed and examined on a 
UV transilluminator (UV Products, Bishops Stortford, Herts) and photographed 
(if  desired) using a Polaroid camera (Cu-5 Hand camera) with type 665 
posit ive/negative  film.
The sizes of the restriction fragments were determined by comparing 
with DNA marker fragments of known size subjected to electrophoresis
alongside the unknown fragments.
The distances between the well and the positions where the DNA 
fragments of known sizes had travelled were measured and plotted on semi-log 
graph paper as distance travelled (mm) against log size of DNA (kb). Similarly,
the distance travelled by DNA fragments of unknown sizes were then measured,
and their sizes were determined from the standard curve.
2 .7 .3  Recovery of DNA from Agarose Gels
(i) E lec tro e lu t io n
This method is after McDonnell et al (1977) and involves electroelution of
the DNA band in a dialysis bag.
The DNA band of interest was excised from the agarose gel (prepared and 
electrophoresed in acetate buffer) with a small scalpel, and placed into a piece 
of dialysis tubing (9mm in width). A minimal volume of acetate buffer was 
added (200p.l) and the bag was sealed with clips at both ends. The bag was 
immersed in a shallow layer of acetate buffer on the platform of the gel tank,
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and electrophoresis was performed at 60V for 1 hr. The solution was removed
(and reta ined) and a further 2 0 0 | i l  of acetate buffer was added and
electrophoresis was continued for 15 min. The polarity of the current was 
reversed for 2 min, and then the solution was collected. The pooled DNA solution 
was centrifuged to remove agarose, then precipitated with ethanol. The DNA
isolated was suitable for the nick-translation reaction.
( i i)  Recovery of DNA from Low Melting Agarose
Low melting agarose (BRL) gels were prepared exactly as agarose gels
(see section 2.7.1), except that they were poured and electrophoresis conducted
in the cold room.
The DNA band of interest was excised and transferred to an Eppendorf 
tube. Two volumes of TE were added, and the sample was placed in a 65 °C  
heating block to melt the agarose. The sample was mixed, extracted twice with
phenol/chloroform  and precipitated with ethanol.
2 .8  Separation of DNA Fragments by Polyacrylamide  
Gel Electrophoresis
Electrophoresis through polyacrylamide gels was another method used to 
separate, identify and purify DNA fragments. The method was routinely used to 
isolate 32p_iabelled DNA fragments for sequencing by the method of Maxam and 
Gilbert, and to resolve DNA fragments of similar size where agarose gel
electrophoresis was inadequate.
2 .8 .1  Preparation of Acrylamide Gels
( a )  E le c tr o p h o r e s i s  Buffer
This was TBE buffer (see section 2.7.1).
( b )  Acry lamide  Loading Buffer
This was a 1:1 ratio of glycerol and 0.05% Xylene Cyanol, 0.05% 
bromophenol blue in TBE buffer.
( c )  Acrylamide Stock (20%)
This was a mixture of 19% v/v acrylamide (BRL, ultra pure grade) and 1%
50
N,N-methylene bisacrylamide (BRL) dissolved in distilled water, filtered, and 
stored in the dark at 4 oc .
( d )  E le c tr o p h o r e s i s  C ondit ions
Size Range Gel Concentrations
lOO-lOOOkb
80-600kb
60-400kb
4%
8 %
6 %
40-200kb 12%
Acrylamide gels (4%) were routinely used for the isolation of labelled
fragments. A typical acrylamide gel mixture contained 4% acrylamide, 10%
glycerol and 0.04% ammonium persulphate in a final volume 50 ml in TBE
b u f f e r .
( e )  Vertical Gel Apparatus
The vertical gel apparatus (BRL model V161) was assembled with 1.5mm
spacers. TEMED (NNN'N'-tetramethylethylenediamine; 40p.l) was added to 5ml of 
the gel mixture, and poured down the gel plates to form the plug. TEMED (30|il) 
was then added to the remaining gel mixture and the main gel was poured.
2 .8 .2  Electrophoresis in Acrylamide Gels
The gel was subjected to pre-electrophoresis for 30 min at 150V. The DNA 
sample was mixed with the loading dye (0.3 volume) and applied to the gel.
Electrophoresis was continued for 2 to 3 hr at 200V, until the required
resolution was obtained. The gel was then stained in a solution of ethidium
bromide for 15 min, and photographed on a UV illuminator (see section 2.7.2).
2 .8 .3  Recovery of DNA from Polyacrylamide Gels
Having stained and photographed a gel, the desired band was cut out and 
placed in a lml automatic pipette tip (Eppendorf), previously sealed at the 
narrow end and plugged with glass wool. The gel piece was ground with a glass 
rod, then 600p,l of elution buffer (500mM ammonium acetate; lOmM
51
M g(ace ta te)2 ; ImM EDTA; 0.1% SDS) was added. The top of the tip was sealed with 
Nescofilm, placed in a siliconised 15ml Corex tube, and incubated overnight at 
37 oc.
The DNA of interest was eluted by cutting the end of the tip and allowing 
the elution buffer to drain into the Corex tube. The tip was further rinsed with 
4 X 200p.l portions of elution buffer. The pooled eluate was precipitated with 
ethanol, and the DNA sedimented by centrifugation at 10,000 rpm for 30 min at - 
10OC. The DNA was then suspended in 400|il of 0.3M sodium acetate, centrifuged 
to remove any acrylamide debris and the supernatant transferred to a fresh 
E ppendo rf  tube. The supernatant was then re-precipita ted  with ethanol, 
centrifuged to sediment the DNA, and briefly dried under vacuum.
2 .9  Southern Blotting, Radiolabelling and Hybridisation 
of DNA
2 .9 .1  DNA Transfer to Nitrocellulose (Southern Blotting)
This method is based on that of Southern (1975). After electrophoresis the 
agarose gel was placed in 250ml of denaturing solution (1.5M NaCl; 0.5M NaOH) 
and left to soak for 30 min. The gel was then placed in 500ml of neutralising 
solution (1.5M NaCl; 0.5M Tris-HCl, pH 7.6) for a further 30 min.
The arrangement of the blotting components were as follows: 500ml of 20 
X SSC (SSC = 0.15M NaCl; 15mM Na citrate, pH 7.3) was added to the buffer 
reservoirs; two strips of Whatman 3MM paper were connected over the solid 
support into both reservoirs to form the wicks; the gel was inverted and placed 
onto the bridge (ideally the same width); nitrocellulose filter (Schleicher and 
Schuell, BA85; cut to size) was carefully placed onto the gel after previously 
wetting in 2 X SSC; four sheets of 3MM paper were further placed on top; a stack 
of absorbent pads (cut to size and 6cm in thickness) was then placed on top; and 
finally the whole system was compressed using a glass plate and a 1.5kg weight. 
Transfer of DNA was allowed to proceed for up to 16 hr at room temperature.
After blotting, the nitrocellulose filter was removed, washed in 2 X SSC to 
remove any adhering agarose and allowed to dry at room temperature on 3MM 
paper. This was then baked in a vacuum oven for 2 hr at 80 °C.
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2 . 9 .2  Radiolabelling DNA Fragments
(i) Nick-translation of DNA
This method is according to Rigby et al. (1977). It was applied to insert
DNA derived from agarose separation gels (see section 2.7.3).
The labelling reaction was assembled in the following order on ice: probe 
DNA (0.3 to l.Opg); 50pCi oc32p_(ii\[TP (lmCi/100p.l, Amersham); 50jiM of each of 
the remaining dNTPs; DNasel (10-7mg/ml); and 5 units of DNA polymerase I
(Boehringer) in a total volume of 18p.l in medium salt restriction enzyme 
buffer. The reaction was allowed to proceed for 4 hr at 15 OC, after which time 
lOOjil of NE (50mM NaCl; 0.5mM EDTA, pH7.0) was added. The labelled DNA 
fragment was purified by applying the mixture to a column of Biogel P-60
(Biorad) in a blue lml Eppendorf tip (equilibrated with NE). After the solution 
had adsorbed the column was eluted with 9 X 100(il of NE, each fraction being 
collected separately.
The 3 2 p in each fraction was estimated from its Cherenkov radioactivity 
in the channel of a scintillation spectrometer. The values obtained are
approximately 30% of those by scintillation counting in the 3 2 p  channel. The 
first peak of radiation fractions were pooled.
The nick-translated DNA was stored at -20 °C. The specific activity of DNA
labelled by this method was between 5 X 10? and 10& cpm per jig of DNA.
( i i)  Oligo-nucleotide labelling of DNA
A modified method for labelling DNA fragments without purifying the 
DNA from agarose was developed by Feinberg and Vogelstein (1984) and used in 
the later phases of this work. This modified technique is even more efficient 
than nick-translation, eliminates the loss of DNA and time involved in 
recovering the DNA fragments from agarose gels and can be used with very
small amounts of template DNA.
Plasmid DNA was cleaved with an appropriate restriction enzyme and the 
fragments were electrophoretically separated in a single lane of a 1% low 
melting point agarose gel in acetate electrophoresis buffer (see section 2.7.1). 
The desired band was excised cleanly and placed into an Eppendorf tube. Water
(2 X volume) was added and the tube was placed in a boiling water bath for 10
min to dissolve the gel and denature the DNA. It was stored at -20 °C .
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Preparatory to subsequent labellings, the gel was reboiled for 7 min and 
maintained in a 37 OC block for at least 30 min until initiating the labelling 
re a c t io n .
The labelling reaction was carried out at room temperature by addition of 
the following reagents in the order stated: 2 0 % of oligo-nucleotide labelling 
buffer (see below); 20pg of bovine serum albumin ; 10 to 30ng of insert DNA;
20pCi of a 3 2 P-dNTP (Amersham lmCi/lOOpl); 5 units of large fragment of E.coli
DNA polymerase I (BRL) in a final volume of 50|xl. The reaction was left 
standing overnight at room temperature, after which time 50pl of a solution of: 
20mM NaCl; 20mM Tris-HCl, pH7.5; 2mM EDTA; 0.25% SDS; and lpM  dNTP was 
added to stop the reaction. Purification of labelled DNA was by chromatography 
through a small column of Biogel P-60 as described previously (see section 
2.9.2i).
O ligo-nucleotide labelling buffer was made up from the following 
components: 0.018% 2-mercaptoethanol and 50mM each of the remaining cold 
dNTPs in a final volume of lml in a solution of 1.25M Tris-HCl (pH 8.0) and 
0.125M  M gCl2 ; 2M Hepes (pH 6 .6 ); and a solution of hexadeoxyribonucleotide 
(Pharmacia) in TE at 90 OD units/ml, mixed in a ratio of 2:5:3 and stored at -20 °C.
The specific activity of the DNA labelled by this method was between 10& 
and 5 X 109 cpm per pg of DNA.
2 .9 .3  Hybridisation of Blotted DNA
The following hybridisation and working conditions were used for the
detection of blotted nucleic acid sequences with DNA probes. The relatively low 
s t r in g en c y  gave optim al hybrid isa t ion  signals, but the non-spec ific  
background was nevertheless low.
The blotted nitrocellulose filter was pre-wetted in 5 X SSPE (SSPE= 0.18M
NaCl; lOmM Na2 H 2 P 0 4 ; lOmM NaOH; ImM EDTA; adjusted to pH 7.2) and placed
into a polythene bag. The bag was then sealed and prehybridised for 2 hr at 
42 0 C  with 10ml of hybridising solution containing : 5 X SSPE; 10 X Denhardt's 
solution (Denhardt's = 0.02% Ficoll; 0.02% Polyvinyl-pyrolidine; 0.02% BSA; 
filtered and stored at -20 oQ ; 0.1% SDS; and 50% deionised formamide.
The appropriate DNA probe was denatured by adding 0.1 volume of 1M
NaOH for 10 min, then neutralised by adding 0.1 volume of 1M Tris-HCl (pH 7.6)
and 0.1 volume of 1M HC1.
After pre-hybridisation the filter was then hybridised overnight at 42 o C
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with the hybridising solution (approximately lm l/cm 2 0f  filter ) and denatured 
probe. The hybridised filter was washed in 2 X SSC, 0.1% SDS for 5 X 10 min at 
room temperature, followed by 0.1 X SSC, 0.1%SDS at 420C for 2 X 30 min. After 
washing the filter, the filter was air dried, wrapped with cling film, and 
exposed to Kodak-X-Omat H film using an intensifying screen (Cronex-lighting) 
and left overnight at -70 °C.
The DNA fragments that were complementary to the sequence of the DNA
probe were identified by the autoradiograph.
2 . 1 0  Subcloning into pUC Plasmid Vectors
DNA fragments of interest and of suitable size (usually less than 4kb) 
from mouse genomic lambda clones were derived and used to construct
subclones. The plasmid vector pUC18 (Yanisch-Perron, Vierra and Messing, 
1985), Figure 2.1, was used in the construction of the subclones in this project, 
the DNA to be cloned being inserted into one of the unique restriction sites in 
the polylinker of this vector.
2 . 1 0 . 1  Preparation of Insert and Plasmid Vector DNA
Plasmid vector pUC18 DNA (5 to lOpg) and the cloned lambda DNA (2p.g) 
were separately digested with the appropriate enzyme(s), and agarose gel
electrophoresis was performed to check the completeness of the digest. Both 
vector and insert DNA were purified by extraction with phenol/ether, and then 
precipitated with ethanol. After lyophilisation, the insert DNA was redissolved 
in TE at 0.2p.g/|il, while the vector DNA was kept as a lyophilised precipitate.
2 . 1 0 . 2  Alkaline Phosphatase Treatment of Vector DNA
Any undigested circular molecules of vector DNA would subsequently
transform with a high efficiency to give a high background of blue colonies. 
This was reduced by complete digestion of vector DNA or purification of the 
linear form by agarose gel electrophoresis. If the vector DNA had been 
linearised by digestion with a single enzyme, then subsequent ligation and
transformation would result in a high background of blue colonies due to
religation of the vector. This could be reduced by removing the 5' phosphates 
with alkaline phosphatase.
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The plasmid vector pUC18 (Yanisch-Perron e ta l . ,  1985), used in the 
construction of the subclones in this project. This is a double-stranded circular 
DNA molecule, 2686 base pairs in length. It carries a 54 base pair multiple 
c lo n in g  s ite  (p o ly l in k e r )  that con ta ins  s ites  fo r  13 d iffe ren t  
hexanucleotide-specific  restriction enzymes. The overall map shows the 
restriction sites of those enzymes that were used in this project. The 
polylinker is shown below the map. The map also shows the positions of the 
ampicillin resistance gene and the lac gene fragment.
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The restricted vector DNA precipitate was redissolved in 20|il of 50mM
Tris-HCl (pH 9.5), ImM spermidine, O.lmM EDTA and 1 unit of alkaline 
phosphatase (Calf intestinal, Boehringer grade I ) was added. After incubation
at 37 OC for 30 min, the incubation volume was increased to lOOjil with TE and 
then extracted with phenol/ether and precipitated with ethanol. The DNA was
redissolved in TE at 0.3jig/jil.
2 . 1 0 . 3  Ligation of DNA Fragments
For high efficiency cloning, it was essential to have the correct molar 
ratios of clonable ends of vector and insert. Suitable molar ratios of total
clonable ends of vector and insert were 1:1 and 3:1. Linearised pUC vector is 
approximately 2.5kb, so there would be 2 X clonable ends for 2.5p.g. Lambda is 
approxim ately  50kb, thus if an enzyme cuts at n sites, generating n+1 
fragments, n-1 of these would have clonable ends. Thus there are 2 X(n-l) 
clonable ends per 50p.g lambda DNA, or 2 X(n-1)0.05 clonable ends per 2.5p.g 
lambda DNA, and 2 clonable ends per 2.5p.g pUC DNA. Hence 1:1 weight ratio = 1:
0 .05(n-l) vector : insert molar end ratio, and 3:1 weight ratio = 3 : 0.05(n-l) 
vector : insert molar end ratio.
The ligation reaction was assembled in the following order on ice: insert 
DNA(a suitable amount); cut phosphatased vector DNA (0.3p.g); 0.5mM ATP ;1 
unit of T4 DNA ligase (BRL) in a final volume of 30p.l ligase buffer which 
contains 40mM Tris-HCl (pH 7.6), ImM MgCl2 , and ImM dithiothreitol.
The ligation mixture was incubated overnight at 15 °C. Control ligations 
of digested vector, and vector treated with alkaline phosphatase were carried 
out.
2 . 1 0 .4  Transformation of E.coli  by Plasmid DNA
(i) Preparation of Cells Competent for Transformation
The bacterial strains used to make 'competent' cells were E.coli JM103 and 
JM109.
An overnight culture of the bacterial host cells (2.5ml) was inoculated 
into 500ml L-broth. It was shaken at 37 o c  and allowed to grow until an A6 0 o of 
0.2 was reached. The cells were harvested by centrifugation at 5,000 rpm for 15 
min at 4 o c ,  the supernatant removed and the cells resuspended in 0.5 volume
5 7
(250ml) of cold lOOmM CaCl2 . After allowing to stand on ice for 20 min, the cell 
suspension was re-centrifuged at 6 ,0 0 0  rpm for 10 min at 4  o c ,  and the cells 
were gently resuspended in 0.01 volume (5ml) of cold lOOmM CaCl2 . Sterile 
glycerol was added to a final concentration of 10% (v/v). The cells were
aliquoted in lml portions, frozen in liquid nitrogen and stored at -70 OC.
( i i)  Transformation of E .co l i  by Plasmid DNA
An aliquot of frozen competent JM109 cells were allowed to thaw slowly 
on ice for 30 min. Then 0.1 and 0.5 volumes of both 1:1 and 3:1 ligation mixes of 
vector and insert, plus the two controls, were used to transform 100 | i l  aliquots 
of competent cells. The transformation reaction mixture was allowed to stand
on ice for 30 min, maintained for 2 min at 37 °C , and plated directly onto
ampicillin/X-gal/IPTG plates. The plates were prepared 5 min before use, 0.5%
IPTG (isopropyl-thiogalactoside) in sterile water, 0.5% X-gal (5-bromo-4-
chloro-3-indolyl-B-D-galactoside) in dimethyl formamide was spreaded over the 
surface of the ampicillin L-plates.
The plates were left at room temperature until all the liquid had been
adsorbed, then they were inverted and incubated overnight at 37 °C .
S e lf- re l iga t ing  and und igested  vector give blue colonies, while 
recombinants containing the insert DNA normally give white colonies in 8 to 
10  hr.
2 . 1 0 . 5  Selection of Recombinant Clones
The pUC plasmids have been constructed as cloning vectors using B-
galactosidase activity as the basis of selection. The vector has a fragment of the 
E.coli lac operon containing the regulatory region and the coding information 
for the first 146 amino-acids of the B-galactosidase (Z) gene. The amino-
terminal peptide is able to complement the product of a defective B-
galactosidase gene present on the F' episome in the host cell. A polylinker
DNA fragment containing several unique restriction sites for cloning have 
been inserted, in phase, into the amino-terminal portion of the B-galactosidase 
gene. This insertion does not affect the complementation. However, insertion
of additional DNA into the 'polylinker' region generally  destroys the
c o m p le m e n ta t io n .
The complementation produces active B-galactosidase which gives rise to
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a blue colour when the transformed cells are grown in the presence of the 
inducer IPTG and the chromogenic substrate X-gal. However, when DNA is 
cloned into the polylinker region, the B-galactosidase is inactive and the 
colonies appear white. False positive white colonies occur at low frequency, 
probably due to incorrect self-ligation of the vector.
2 . 1 0 . 6  Identification of Recombinant Subclones
Bacteria containing the recombinant plasmid were identified by picking 
white colonies, and isolating their DNA (see section 2.3.2 i). The recombinant 
DNA was screened by limited restriction analysis and hybridisation to the 
blotted DNA with a 2.P-labelled. probe (see section 2.9). An example is described 
below .
An Xbal fragment of 2.5 kb from the genomic clone >.mA119, containing 
the actin-like DNA, was subcloned into the Xbal site of plasmid vector pUC18 
(Figure 2.1).
The DNA of ^m A l 19 (2p.g), and pUC18 (5|ig) were digested with Xbal (see 
section 2.10.1). The restricted vector DNA was then treated with alkaline 
phosphatase (see section 2.10.2). The Xbal fragments from A,mA119 were ligated 
into the restricted pUC18 (see section 2.10.3), and then used to transform 
'competent' JM109 cells (see section 2.10.4),
The e ff ic iency  of  transform ation  was approxim ately  3 X 1C)4 
transformants per p.g of genomic DNA. A total of 144 white colonies were
in itia lly  picked and plated onto master ampicillin plates. Small scale 
preparation of DNA were made for 12 of these colonies (see section 2.3.2).
The DNA was subjected to electrophoresis through a 1% agarose gel to 
check the quality of the preparation, and to select suitable subclones which
might contain the recombinant plasmid. A number of the chosen subclone
DNAs ( lf tg )  were digested with suitable restriction enzymes, and then subjected
to electrophoresis as shown in Figure 2.2a. The restricted DNA was then 
transferred to nitrocellulose filters by the Southern blotting method (see 
section 2.9.1).
Subclones designated A33 and A610 can be seen to contain a similar 2.5kb 
Xbal fragment (Figure 2.2a) which could correspond to that in kmA119. This 
was confirmed by the fact that they hybridised to a 3 2p_iabelled  Pstl-PvuII 
fragm ent from clone pm Cl (see sections 2.9.2 and 2.9.3, Figure 2.3b), 
corresponding to cDNA specific for amino-acids 1 to 231 of cardiac muscle actin
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A n u m b e r  o f  s u b c l o n e s  d e r iv e d  f rom s u b c lo n in g  the 2.5 kb Xbal 
fragment f r o m  the  g e n o m i c  c lone  XmA119  (F igure  3.6; sec t ion  3.2.2) ,  were 
sub je c te d  to re s t r ic t io n  d iges t ion,  and hybr id i sed  to a P - l a b e l l e d  P s t l - P v u l l  
f r agme nt  o f  act in  c D N A  clone  p m C l  (Figure 2.3). (a) shows the eletrophoretic
pa t te rn  o f  the  su b c l o n e s  g ive n  the pre l imina ry  des ig na t ions  A33, A610,  B4 
and A17 d i g e s t e d  wi th  EcoRI ,  Bgl l l  and BamHI,  and Xbal .  ( ) s ows e 
autoradiograph o f  the  hy b r id i s a t i o n .
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The partial restriction maps of the actin clones used in this project are 
listed, (a), pmS3, a mouse skeletal muscle actin cDNA clone (Leader etal., 1986a).
(b), pm Cl, a mouse cardiac muscle actin cDNA clone (Leader etal., 1986b). (c),
A,mA19, a mouse y-actin pseudogene (Leader etal., 1985). The vectors are 
excluded from the diagrams. The coding region of actin is indicated by solid 
blocks, and the 3' untranslated region is indicated by open blocks. The 
fragment of insert used as a probe is indicated by parenthesis.
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L
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(Figure 2.2b).
Further restriction analysis of the subclones A33 and A610 was carried
out to characterise them in more detail, and to determine the orientation of the
cloned fragment relative to the vector in the two subclones. The subclone A33 
produced a 1.9kb fragment when digested with EcoRI (for which there is one 
site in the polylinker of the vector), while the subclone A610 produced a 0.6kb 
fragment (Figure 2.2a). This is consistent with the two subclones representing 
both orientations of a 2.5kb Xbal insert possessing a single asymmetrically 
positioned EcoRI site.
Purified DNA from the subclones A33 and A610 was prepared (see section
2.3.1) in order to allow for further analysis including sequence determination.
2 . 1 1  Preparation of Fragments for Sequencing by the 
Method of Maxam-Gilbert
2 . 1 1 . 1  Polynucleotide Kinase End-labelling of DNA
DNA for end-labelling must be free of low molecular weight RNA. This 
was removed where necessary using a Biogel A-15 (Biorad) column.
(i) Phosphatase Treatment
The terminal 5' phosphate of DNA was removed by treatment with 
alkaline phosphatase (Calf intestinal, Boehringer grade I).
The DNA sample (5 to lOpg) with 1 to 50 pmol of 5’ protruding ends was 
made up to lOOpl with TE. Alkaline phosphatase (1 unit) was added, mixed well, 
and incubated for 75 min at 37 °C. After incubation the mixture was extracted 
with phenol, and the phenol layer was re-extracted with lOOpl TE. The aqueous 
phases were pooled and precipitated with 100p.l of 0.3M Na acetate and 300pl of 
ethanol, washed with 70% ethanol, and briefly dried under vacuum.
(ii) Polynucleotide Kinase Labelling
This method is specific for labelling 5’ protruding ends. The reaction was
assembled by adding the following to the dried DNA (1 to 50 pmol ends):
d i th io th re i to l ;  60pC i Y3 2 P - a TP  ( A m ersham , 1 m C i / 1 OOpl); and 5 units of 
polynucleotide kinase (PL Biochemicals ) in a final volume of l l p l  kinase
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buffer (50mM Tris-HCl, pH8.0; lOmM MgCl2 ). The mixture was incubated at 37°C 
for 30 min. After incubation, 40p.l of 2.5M ammonium acetate was added and 
prec ip ita ted  with 160p.l of ethanol. The DNA was then re-precipitated with 
100(xl of 0.3M sodium acetate and 300jxl of ethanol, washed with 70% ethanol, and 
briefly dried under vacuum.
2 . 1 1 . 2  Klenow End-labelling of DNA
The removal of tRNA from the DNA preparation, or the elimination of the 
5' phosphate from DNA were not required for this method, which involves the 
3’ to 51 'filling-in' reaction of the Klenow large fragment of the restricted DNA.
This method could only be used for labelling 5' protruding ends. The 
radioactive a ^ p - d N T P  with high specific activity (Amersham, lmCi/lOOp.1) 
must be complementary to one of the nucleotides in the restricted 'sticky end1. 
It was routine to add all three of the remaining cold nucleotides to the reaction. 
However, it was sometimes possible to label a single end of a fragment with 
different 5' sticky ends specifically by judicious choice of hot and cold 
nucleotides to fill in.
The reaction was assembled by the addition of the following to the dried 
DNA (5 to lOjig) : 50p.Ci a32p-dA T P (Amersham, lmCi/lOOjil); 4|iM of each of the 
remaining three cold dNTPs; and 2 units Klenow fragment (Boehringer) in a 
final volume of 25jLL 1 in 1.5 X medium restriction enzyme buffer (see section
2.6.1). The mixture was incubated for 30 min at room temperature. After 
incubation, 90 |il  of 2.5M ammonium acetate was added and precipitated with 
3 6 0 jll1 of ethanol. The DNA was then re-precipitated with lOOjxl of 0.3M sodium 
acetate and 300p.l of ethanol, washed with 70% ethanol, and briefly dried under 
vacu u m .
2 . 1 1 . 3  Secondary Digestion and Separation of 
Labelled Ends
Chemical sequencing could only be performed on a fragment of DNA 
labelled at one end. therefore DNA fragments labelled at both ends were cleaved
and the fragments separated.
A restriction enzyme was chosen that would cleave the DNA fragment 
asymm etrically , and preferably into two. The restricted fragments were 
separa ted  by polyacrylam ide gel electrophoresis, usually employing 4%
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acrylam ide (see sections 2.8.1 and 2.8.2). The gel was stained and the DNA
fragments were eluted as described previously (see section 2.8.3). If the amount 
of DNA was too small to be seen by staining with ethidium bromide, then the gel 
was subjected to autoradiography for 15 min at room temperature.
The rad ioactiv ity  of the dried DNA was estim ated by m easuring its 
Cherenkov radiation. The minimum activity required to proceed to the next 
stage was 2 X 1()4 cpm.
2 . 1 2  Sequencing DNA by the Chemical Method of
Maxam and Gilbert
This method of sequencing involves base modification and strand scission 
by chemical means. A detailed description is given by Maxam and Gilbert (1977 
and 1980).
2 . 1 2 . 1  Reagents and Solutions
Dimethlysulphate - DMS (Aldrich Chemical Co., Dorset)
Hydrazine - HZ (Kodak Ltd.) : stored at -70 °C.
Piperidine - (Koch Light Labs., Bucks.) : stored at 4 OC.
Pyridine form ate : 4% v/v formic acid was adjusted to pH2.0 with 
pyridine (BDH,AnalaR).
DMS Buffer : 50mM Na cacodylate; lOmM M gC^; O.lmM EDTA; adjusted to
pH8.0 and stored at 4 °C .
DMS Stop : 1.5M Na acetate, pH7.0; 1M B-mercaptoethanol (Koch Light);
100pg/ml yeast tRNA; stored at -20 °C.
HZ Stop : 0.3M Na acetate; O.lmM EDTA; 50pg/ml yeast tRNA; stored at 4 oc .
2.12.2 Modification Reactions and Strand Scission
The four reactions used for full sequence determination were specific for 
guanine (G), guanine and adenine (G+A), cytosine and thymine (C+T), and 
cytosine (C). Chain cleavage was achieved using 1M piperidine. The precise 
procedure followed for each of the four reactions was as follows.
The dried labelled DNA (lp g )  was dissolved in 11 p i of water and 4pg of 
calf thymus carrier DNA was added. The mixture was aliquoted equally into four 
siliconised Eppendorf tubes labelled G, A(+G), T(+C) and C. Each tube then
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received different components : 98p.l DMS buffer into tube G; llp.1 water into
tube A(+G); 6p.l water into tube T(+C); 8p.l water saturated with NaCl into tube C.
P yrid ine form ate (2.5p.l) was added to tube A(+G), and the mixture was 
incubated for 70 min at 30 °C . The reaction was stopped by freezing the mixture
at -70 °C  for 5 min followed by drying under vacuum. The sample was washed
with 10p.l water, frozen and dried as before.
D im eth y l su lp h a te  (0 .5 |x l) was added to tube G, and the mixture was 
incubated for 5 min at 20 OC. The reaction was stopped by the addition of 24jxl 
DMS Stop, 400jll1 cold ethanol and then left at -70 °C  for 15 min.
H ydrazine (15jil) was added to tubes T(+C) and C, mixed and incubated at
2 0 °C  for 8 and 10 min respectively. The reactions were stopped by the addition
of 60jo.l HZ Stop, 250jil cold ethanol and then left at -70 °C  for 15 min.
A fter precipitation, tubes G, T(+C) and C were centrifuged for 5 min and 
the supernatant was discarded. The DNA was re-precipitated in 60fil 0.3M
sodium acetate and 200jil cold ethanol, and then briefly dried under vacuum.
To all four tubes G, A(+G), T(+C) and C, lOOjil of 1M piperidine was added,
and the mixtures were heated at 90 o c  for 30 min. After a brief centrifugation
(5s), the samples were frozen at -70 °C  and dried under vacuum for 2 to 3 hr. 
The residual piperidine was removed by washing twice with 20p.l water followed 
by drying under vacuum (2 hr). The Cherenkov radiation of each tube was 
m easu red .
2 . 1 2 .3  DNA Sequencing Gels
DNA fragments differing in length by only one nucleotide were separated
by electrophoresis on 6% polyacrylamide urea denaturing gels (40cm X 20cm X
0.4mm) according to Sanger and Coulson (1978).
A typical gel mixture contained 6% acrylamide, 7M urea and 0.01%
ammonium persulphate in a final volume of 100ml in TBE buffer.
T h e  ge l  p l a te s  were  s i l i co nise d  before  use wi th  R ep e lc o te  (BDH) and 
a s s e m b l e d  wi th  0.4 m m  spacers .  TEMED ( N N N 'N ’- te t r am ethyl e thy lene dia mi ne ;  
4 0 jll 1), was  added  to the gel mixture  before pouring,  a comb (14 X 7mm) was 
inserted  , and the gel was a llowed to set at room temperature.
The gel was subjected to pre-electrophoresis at 25 to 30mA for 1 to 2 hr 
(LKB 2103 power supply, LKB Instruments Ltd., Surrey). During this time, the 
samples were dissolved in the appropriate volume of sequencing loading dye 
(99% de ion ised  form am ide; 0.05% xylene cyanol) to give 10,000 cpm
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(Cherenkov) per p i.
W hen the gels were ready, the samples were boiled for 2 min, chilled on 
ice, and 1.5pl of each was loaded on the first set of wells. The length of the run
was chosen so as to be appropriate for the total length of the DNA fragment.
For DNA fragm ents betw een 200 base pairs and 1.2 kb in length, three 
consecutive loadings were usually made. The first dye front was allowed to
travel down the gel for approximately 20cm before the second loading was 
made, and this allowed to travel 15cm before the third loading was made. 
E lectrophoresis was stopped when the dye front from the third loading had 
travelled about 13cm. The samples had to be reboiled before each loading, and 
l ( i l  of each was used for the second and third loading. Xylene cyanol migrates 
with a m obility equivalent to a DNA fragment of 60 base pairs on a 6%
acrylam ide gel.
2 . 1 2 . 4  A u t o r a d io g r a p h y
After electrophoresis, one of the glass plate was removed and the exposed 
gel was covered with clingfilm . Autoradiography was performed at -70 °C  
using Kodak X-Omat H film  and an intensifying screen (Cronex Lighting Plus, 
Dupont, Huntingdon). An overnight exposure was required for 10,000 cpm 
(Cherenkov) per loading, the exposure time was increased accordingly if less 
than 10,000 cpm were used.
Follow ing autoradiography, it was possible to read between 150 to 200 
nucleotides from one gel. Figure 2.4a shows an example of an autoradiograph 
of a sequencing gel.
2 .1 3  Cloning into M13 and Preparation of  
Single-stranded Template
The aim of cloning into bacteriophage M13 (mpl8 and m pl9; Figure 2.5) 
was to take fragments of double-stranded DNA, and using M13 RF (replicative 
form) DNA as a vector, produce from the resulting virus, pure single-stranded 
DNA tem plate suitable for the Sanger "Dideoxy Sequencing" method (Sanger, 
1981; Messing, 1983). All the protocols for cloning were supplied in the form of 
"M13 Cloning and Sequencing Handbook" (Amersham International) and these
were strictly adhered to.
The paired vectors M13 m pl8 and M13 mP19 (Yanisch-Perron er al„ 1985;
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(a,  T h e  s u bc l one  119XB from clone B ^ n . "m ™ ™
with Styl ,  5 ’ K l e - n o w  end label led ,  and seconj?ar^  the  StyI s i t e , a l lowing 
and  G i l b e r t  s e q u e n c i n g  w a s  pe r for m' ed  p . 3 9 . The  resul t ing
d e t e r m i n a t i o n  o f  s e q u e n c e  n u m  er 1 , according to the complete
au to rad io gr ap h  is s h o w n .  Nucleo ti  es are f the subclone 36KK in
sequence in F igure  3.10.  (b) An EcoRI  ^ a g m e m  Jro ^  ^  ^  ^  ^
clone XmA3 6 (F ig ure  4 .8)  was  clone s  e r  "D id eo x y "  seq uen c in g  was
s i n g l e - s t r a n d e d  t e m p l a t e s  p r e p a r e -  sen Uence number 10 in Figure 4.9.
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Qal 6682
Mstll 6508
Bglll 6935
Multiple 
cloning sites 
6231-6282
Ahall 6001 
Avail 5914 
Aval 5825 
Dralll 5716
Bgll 6431 
Pvul 6405
Ball 5080
XmnI 357
2000 —
Clal 2527 
XmnI 2646
6230
Multiple cloning sites in M l3 mpl8:
6289
EcoRI S s t I  Kpnl
A cc I 
H in c I I
BamHI X bal S a i l  P s t l  SphI H in d l l l
GAATTCGAGCTCGGTACCCGGGGATCCTCTAGAGTCGACCTGCAGGCATGCAAGCTTGGC
Smal TaqI
Xmal
T h e  ba c te r iopha ge  vectors  M l 3 m p l 8  and M13 m p l 9  (Yan isch -Pe r ron  e t  
a l . ,  1 9 85) ,  u s e d  f o r  the  n u c l e o t i d e  s e q u e n c e  d e t e r m i n a t i o n  by S a n g e r  
" D i d e o x y - S e q u e n c i n g "  method .  This  are s in g le - s t ra n d ed  c i r cu l a r  molecu les ,  
7253  b a s e s  in length,  and d i f fe r  only  in the or i en t a t io n  o f  the 54 base
p o l y l i n k e r  t h a t  t h e y  c a r r y .  T h e  p o l y l i n k e r  i n c l u d e s  10 d i s c r e t e  
he x a n u c l e o t i d e  recogni t ion  sites for  13 dif ferent  enzymes.  The  map shows a 
n u m b e r  o f  rest r ic t ion  sites of  enzymes  that cleave  the molecule  once or twice.  
The  m u l t ip le  c lon ing  sites in the orientat ion presen t  in M l 3 m p l 8  are shown 
b e lo w  the  map.  In M13 m p l 9  the same sites are presen t  in the oppos i te
or ien ta t ion .  The  map also shows the posit ions of  the lac gene f ragment and  the
or ig ins  o f  plus  and minus  st rand replicat ion.
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Figure 2.5) were used in this project, and their double-stranded replicative 
form was a gift from Dr Ken Duncan.
2 . 1 3 . 1  Preparation of Insert and Vector DNA
Insert DNA ( lp g )  and M l3 vector DNA (2pg) were digested with the 
a p p ro p ria te  enzym e(s) and the ex ten t o f d igestion  checked  by gel 
electrophoresis. After digestion, the insert and vector DNA were purified by 
ex trac tio n  w ith phenol/ch loroform  and precip ita ted  with ethanol. The 
restricted insert DNA was resuspended in TE to 20ng/jil.
If  the vector had been linearised by digestion with a single enzyme, 5'
phosphates would have to be removed by alkaline phosphatase to reduce the 
high background of the plaques due to religation of the vector.
The restricted vector DNA was redissolved in a final volume of 40 |il in a
solution of lOmM Tris-HCl (pH9.2), O.lmM EDTA and 1 unit of alkaline
phosphatase (calf intestinal, Boehringer grade I) was added. After incubation 
at 45 °C  for 30 min, 1 unit of alkaline phosphatase was further added and re­
incubated at 45 °C  for 30 min. The vector DNA was then purified by extraction
with phenol/ether, precipitated with ethanol, and redissolved in TE to 10ng/p.l.
2 . 1 3 . 2  Ligation of RF DNA to Insert DNA
Ligation mixes for ligation of RF DNA to insert DNA were assembled on ice 
as follows : Insert DNA (lOOng); vector DNA (20ng);lmM ATP; 5mM dithiotheitol; 
and 1 unit of T4 DNA ligase (BRL) in a final volume of 10p.l in ligase reaction 
buffer (50mM Tris-HCl,pH7.4; lOmM MgCl2 ). The ligation mixture was incubated 
at 14 o c  for 4 to 12hr.
2 . 1 3 . 3  Transformation of E.coli  and Plating Out
Com petent cells were prepared from E.coli JM109 strain as in section 
2.10.4. Alternatively, frozen competent cells were used routinely. 10ml of 2 X
TY was also inoculated with a drop of overnight culture to provide
exponentially growing cells for plating.
To 300|il of competent cells, 5pl of DNA ligation mix was added, mixed, and
left on ice for 40 min. The cells were then maintained at 42 o C for 3 min and
returned to ice. During this time the following were added to 3ml of molten H-
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top agar (kept at 42 OC) in sterile culture tubes : 0.03% IPTG in water; 0.03% X- 
gal in dimethyl formamide; 0.06% fresh JM109 cells. After mixing, the molten 
agar mix was added to the transformation mix, and directly spreaded onto a pre­
warmed H-plate (see section 2.1.2). The plate was allowed to set, and incubated 
at 37 oC  overnight.
T ransform ed cells showed up as a colourless plaque on a lawn of
uninfected cells, while self-religating vectors showed up as blue plaques.
2 . 1 3 . 4  Preparation of Single-Stranded Template
A single white plaque was inoculated using a sterile Eppendorf tip into 1.5
ml 2 X TY containing 0.01 volume of an overnight E.coli JM109 culture.
This culture was shaken for 5 hr at 37 °C , and the cells sedimented by
centrifugation, while the supernatant was transferred to a fresh tube and re­
centrifuged. The second supernatant (1.0ml) was added to 200jil of a solution of 
20% polyethylene glycol 6,000 and 2.5M NaCl, mixed, and left standing at room 
tem perature for 15 min. The viral DNA was then sedimented by centrifugation, 
and the remaining supernatant was removed by a drawn out pasteur pipette in
order to rem ove all traces of polyethylene glycol. The viral DNA was 
red isso lved  in 100p.l TE, purified by extraction with phenol/chloroform , 
precip ita ted  with ethanol, washed with 1ml of cold ethanol, dried at room 
tem perature, redissolved in 30p.l TE and stored at -20 °C .
A sam ple (3 .0 p l)  of the viral DNA tem plate was subjected to 
electrophoresis on a 1% agarose gel to check the condition of the template, and 
to determ ine whether the DNA insert was incorporated into the vector.
2 .1 4  Sequencing by the Sanger Chain Termination Method
Sequencing was carried out using the protocols supplied by Amserham in
the form  of "M13 Cloning and Sequencing Handbook" as in the previous
cloning  section.
2 . 1 4 . 1  Working Solutions
All nucleotide stocks and working solutions were stored at -20 oC.
Deoxy NTP w orking  solutions : 10mM stocks supplied were
diluted to 0.5mM working solutions. 0.5mM dATP was not required when
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sequencing with a  35S-dATP.
Deoxy NTP mixes (AO, Co, Go, TO)
Ao Co Go j o
O.SmM dCTP 20p.l lp l 20jiil 20jil
0.5mM dGTP 20jil 20pl ljLll 20p.l
0.5mM dTTP 20JJ.1 20 ill 20 jll1 lp.1
TE, pH8.0 20pl 20 nl 20jxl 20pl
D ideoxy N TP w ork ing  so lu tions lOmM stocks supplied were
diluted to O.lmM ddATP, O.lmM ddCTP, 0.3mM ddGTP, and 0.5mM ddTTP. These 
concentrations were altered for the sequencing reaction if the need required.
Deoxy N T P/D ideoxy NTP mixes : An equal volume of dNTP was 
added to the corresponding ddNTP working solution.
2 . 1 4 . 2  Annealing Primer to Template
The prim er used was a 17mer universal prim er with the sequence 
5'd[GTAAAACGACGGCCAGT] 3'. The first stage of the sequencing reaction was to 
anneal the primer to the single-stranded template. The following reaction was 
assem bled : Single-stranded tem plate DNA (5p.l of preparation); and ljig  of
prim er (A m ersham , lp.g/fi.1) in a final volume of lOjil in Klenow reaction 
buffer (lOmM Tris-HCl, pH8.5; 5mM MgCl2 ). The mixture was incubated at 60 °C 
for 1 to 2 hr.
2 . 1 4 . 3  Sequencing Reactions
To the annealed primer/template mixture, 15p.Ci a35S -dA T P  (Amersham 
lm C i/ lO O f il )  and 1 unit of Klenow fragment (Boehringer) were added and 
mixed. The mixture (2.5p.l) was placed into each of the four tubes marked A, C, G, 
and T in a microcentrifuge rotor. The relevant dNTP/ddNTP mix (2pl) was placed 
inside the rim of each tube and a brief spin mixed the contents. After 20 min, 
2jxl of chase mixture (0.5mM of all four dNTPs) was placed into each tube, mixed, 
and allowed to stand for a further 15min. The chase reaction was stopped by the 
addition of 4 p l of formamide dye (0.03% xylene cyanol; 0.03% bromophenol 
blue; and 20mM EDTA in deionised formamide).
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2 . 1 4 . 4  DNA Sequencing Gels
Polyacrylam ide urea denaturing gels (6%) were prepared as in section 
2.13.3, using a 32 X 2.5mm comb. The samples were boiled for 3 min, then loaded 
imm ediately onto the gel. Electrophoresis was performed at 25mA and 40W until 
the bromophenol blue reaches the bottom of the gel (approximately 2 hr).
Follow ing autoradiography, it was possible to read between 180 to 220 
nucleo tides from  one loading (Figure 2.4b). Two separate loadings were 
necessary to maximise the length of the sequence that could be read: the first
loading was subjected to electrophoresis for 3 to 4 hr; and the second loading
for 2 hr. A total of 280 to 330 nucleotides could be read from two loadings. Buffer 
gradient gels were sometimes used to give up to 280 nucleotides with increased
resolution in the lower section of the gel.
2 . 1 4 . 5  A u to r a d io g r a p h y
A fter electrophoresis, the gel was fixed after removing the notch plate 
by soaking in a 2 litre bath of 10% v/v acetic acid and 10% methanol for 30 min 
to remove the urea. The gel was drained for a few min, transferred onto a sheet 
of W hatman 3MM paper, and dried under vacuum on a gel drier (Biorad, model 
1125; California) for 30 min at 80 °C .
After drying, the gel was exposed directly onto Kodak X-Omat H film 
overnight at room temperature. A longer exposure was sometimes subsequently 
r e q u ire d .
2 . 1 5  Isolation of High Molecular-weight DNA and
Genomic Southern Transfer
High molecular-weight genomic DNA was extracted from mouse liver and 
subsequently  purified according to Blattner et al. (1978). Southern blotting 
was used to identify sequences of interest within digests of the genomic DNA.
2 . 1 5 . 1  Isolation of High Molecular-weight DNA from
Mouse Liver
Six  mice  were  s tarved  overn ight  to reduce  the g ly co ge n  conten t  o f  thei r
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livers. The mice were killed and their livers quickly removed and frozen in 
liquid nitrogen. The frozen liver was ground to a fine powder and then added to 
100ml of pre-prepared medium as follows. To 0.5M EDTA pH 8.0, 0.5% N-lauroyl 
sarcosine (Sigm a), and proteinase K (100|ig/m l) were added and the solution 
heated for 30 min at 55 OC.
The mixture was incubated for 2 hr at 55 °C  in a rotory stirring water
bath (200 rpm). After incubation, the DNA was extracted with phenol three 
times, then dialysed overnight against 4 X 500ml of : 0.05M Tris-HCl, pH 8.0; 
0 .01M EDTA; and 0 .01M NaCl at 4 °C. The solution was removed from the dialysis 
bag and CsCl was added to 1.273 volume, giving a final density of 1.7g/ml. After 
m ixing carefully, the solution was clarified by centrifugation in a ’Table-top’ 
centrifuge for 15 min, transferred to a sealable tube and centrifuged at 50,000
rpm for 16 to 20 hr at 20 °C  in a VTi50 rotor (Beckman).
The DNA was extracted by piercing with a large bore needle (21 gauge) 
near the bottom  of the tube and collecting all fractions. The fractions
containing DNA were detected by their high viscosity. These were pooled and
dialysed overnight against 4 X 500ml of : 0.01M Tris-HCl, pH 7.0; 0.01M NaCl; ImM
EDTA at 4 °C. The dialysed DNA was stored at 4 °C.
2 . 1 5 . 2  Genomic Southern Transfer
G enom ic DNA (lO jig) was digested with the appropriate restriction 
enzym e(s), and loaded into a single lane of a 0.7% agarose gel in a large
horizon tal tank (Pharm acia GNA-200) with acetate e lectrophoresis buffer. 
E lectrophoresis was perform ed at 30V overnight. A fter electrophoresis the 
agarose  gel was denatured , transferred  to a n itrocellu lose  f ilte r  and 
immobolised (see section 2.9.1). The appropriate 32p-iabelled DNA probes (see 
section 2.9.2) were then hybridised to the genomic DNA attached to the filter 
(see section 2.9.3). The specific radioactivity of the probes were usually at least 
1 0 8  cpm/p.g, and were added to the hybridisation buffer at approximately 10^ 
cpm/ml. The filters were continued to hybridise for 48 hr at 42 °C .
A fter hybridisation, the filters were washed as in section 2.9.3, and
au to rad iog raphy  was perform ed to locate the position  of any bands 
com plem entary to the radioactive probe.
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Screening a Bacteriophage Genomic Lambda Library
The genomic lambda library was screened with various 32p_iabelled DNA 
probes to identify  the number of plaques that contain the com plem entary 
sequence. The plaques were picked and purified for further experiments.
2 . 1 6 . 1  Preparation of Filter Replicas
The library of EMBL 3 was titred (see section 2.4.1), then a dilution of the
phages were plated out to give approximately 1,000 plaques on each of six BBL-
plates with BBL-top layer agarose containing lOmM MgSC>4 . A fresh overnight 
culture (L-broth supplemented with lOmM MgSC>4 and 4% maltose; 200|il) of the 
bacterial host E.coli Y1090 (susceptible to the EMBL 3 library) was used for the 
phage in fec tion .
A fter incubating the plates at 37 °C  overnight, they were cooled at 4 o c
for 1 hr. N itrocellulose filters (Schleicher and Schuell, 9cm diam eter) were
placed grid-side down onto the agarose surface, and the plates were returned to 
4 °C fo r 20 min. After carefully marking the plate and filter on various 
asym m etric positions, the filters were removed and transferred through a 
series of solutions : 0.2M NaOH, 1.5M NaCl for 20s to 5 min; 0.2M Tris-HCl (pH 7.6), 
1.5M NaCl for 1 min; 2 X SET (SET = 0.15M NaCl; 30mM Tris-HCl, pH 8.0; ImM EDTA) 
until ready for the next stage. The filters were allowed to dry on Whatman 3MM 
paper for 1 hr at room temperature.
The complete procedure was repeated to obtain the required number of 
filters per plate. The nitrocellulose filters were baked for 2 hr at 80 °C  in a
vacuum  oven.
2 . 1 6 . 2  Hybridisation of Replica Filters
The replica filters were pre-wet in 4 X SET and then soaked for 1 hr at 65
OC in 10 ml per filter of : 4 SET; 10 Denhardt's solution (see section 2.9.3); and
0.1% SDS.
The filters were pre-hybridised by shaking at 100 rpm for 3 hr at 65 o c  in 
a buffer containing : 4 X SET; 10 X Denhardt's solution; 0.1% SDS; 0.1% sodium 
pyrophosphate; 50jig/ml sonicated salmon sperm DNA; 50p.g/ml each of poly rA, 
rl, rU, and rC. Each set of filters was stacked together in a 1 litre wide-neck 
plastic bottle with approximately 1 ml of buffer per filter.
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The appropriate 32p_iabeu ed DNA probes were prepared (see section 
2.9.2) and denatured (see section 2.9.3), then added to the filters. The probes 
prepared usually have a specific radioactivity of at least lO ^cpm /gg , and were 
added to the hybridisation buffer at approximately 1.5 X 106  cpm/ml. The filters 
were continued to hybridise overnight at 65 o c .
A fter hybridisation, the probe/hybridisation solution was poured off and 
subsequent washes were performed as follows : 4 X SET, 0.1% SDS, 0.1% sodium 
pyrophosphate for 2 X 20 min at 65 o c ; 2 X SET, 0.1% SDS for 4 X 15 min at 45 o c ; 
0.2 X SET, 0.1% SDS for 15 min at 45 °C ; 3mM Tris-HCl (unbuffered) for 1 hr at 
room  tem perature .
The filters were then allowed to dry on Whatman 3MM paper for 30 min. 
A utoradiography was performed to identify the clones in the genomic library 
that contained the complementary sequence of the DNA probes.
2 . 1 6 . 3  Plaque Purification
The p laques g iving the positive signal on au toradiography were
identified and their positions marked on the photograph film. After lining the 
film to its respective plate, the area of plaques that coincided with the positions
were picked using the wide end of a pasteur pipette, and inoculated into 1ml of
phage buffer (see section 2.1.1) in a glass tube. The glass tubes were left to 
stand at room temperature for 1 hr, then a drop of chloroform was added to kill 
off the bacteria. The phage was stored at 4 o c  until further use.
Dilutions of the phage solution were plated to obtain 100 to 300 plaques on 
BBL-plates (see section 2.16.1). The plates were re-hybridised as before, and the 
positives identified. This procedure was repeated until a low density plate
containing more than 50% positive plaques were obtained, then a well isolated 
plaque was picked and used.
2 .1 7  Computer Programs for the Analysis of DNA Sequences
The following programs were used in the compilation, manipulation and 
analysis of DNA sequences. A number of programs devised by Staden (1978),
were run on a Digital PDP 11-34 computer, with a multi-user facility in the 
Biochemistry Department, University of Glasgow. Other programs of the UWGCG 
(University o f W isconsin Genetics Computer Group) package (Devereux et al., 
1984) were run on the EMBL (European Molecular Biology Laboratory) VAX
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11/785 and VAX 8600 computers. This package contains program s for the 
analysis and investigation of DNA sequences and comparison of sequences with 
those in the EMBL database (EMBL, Heidelberg, W. Germany).
2 . 1 7 . 1  Staden Programs
SEQEDT :this program was used to create and edit a file for DNA sequences. 
SEQLST : lists the sequence file created by SEQEDT in the Staden format. 
TRN TRP: translates nucleotide sequences into peptide sequences in any 
desired reading frame using the three-letter amino-acid code.
SEARCH: searches sequences for restriction sites and strings of sequences 
of no more than 20 bases.
SEQFTT : searches sequence for similarities with a string of sequence less 
than 200 bases, and can also be used for percentage complementation.
SQRVCM: generates a sequence complementary to the sequence in question. 
CUTSET : compares given sequence file with restriction enzyme file and 
lists all known restriction sites within the sequence.
2.17.2 Other Programs
These two programs were devised by Dr. P. Taylor (Department of Virology, 
University of Glasgow), and were run on the Digital PDP 11-34 computer.
PALIGN : compares two sequence files with a maximum of 2048 characters. 
This program uses the blocks that satisfy the minimum number of matches to 
obtain the best alignment and then align the remaining to the best. However, it 
has lim itations and sometimes misses the match.
CINTHOM: creates a homology matrix plot between two sequence files .
2 .1 7 . 3  UWGCG Programs
FIND : searches through sequence(s) for short sequence patterns. It is 
able to look through large data sets for any sequence patterns specified, 
recognise patterns with some symbols mismatched but not with gaps, and 
searches both strands of the sequence if necessary. Patterns may not be more
than 41 characters long.
BESTFIT: finds the best region of similarity between two sequences, and
inserts gaps to obtain the optimal alignment. The sequences can be o f very
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d ifferen t lengths but the program  cannot evaluate a surface o f com parison 
larger than 106  base squared, with input sequences not m ore than 30,000 
sym bols long.
GAP . produces an optim al alignm ent betw een two sequences by
inserting gaps in either one as necessary. It considers all possible alignments 
and gnp positions, and creates the alignment with the largest num ber of 
matched bases and the fewest gaps.
REPEAT . finds repeats in sequences. It allows one to choose a minimum 
repeat window, stringency, a search range and then finds all the repeats with 
these param eters.
STEM LOOP: finds stems (inverted-repeats) in nucleic acid sequences. It 
allows one to choose a minimum stem length, maximum loop size and minimum 
bonds per stem. The stems found can be sorted by position, size (stem length), or 
quality (number of bonds).
FOLD : finds an 'optimal' secondary structure for an RNA molecule with
m inim um  free energy.
Since the programs WORDSEARCH with SEGMENTS were used extensively 
throughout this project, they will be described in more detail.
WORDSEARCH tries to find places where one sequence is similar to any set 
of other sequences. The search finds diagonals in each comparison that have 
the largest number of common words. A word is any short sequence (n-mer) 
where n is preset to a constant, like 6 or 7, and it can be created from an
alphabet consisting of the four letters G, A, T, and C. A diagonal is a path across 
a surface of comparison where X minus Y for every point is a constant. A series 
of dots along a diagonal represent a segment of sim ilarity between two
sequences. WORDSEARCH makes and sorts the scores of all the diagonals in the
comparison, and shows a list of the N best diagonals, where N is pre-selected to
be some finite number, like 25 or 100. WORDSEARCH is able to compare both 
strands of the query sequence to any set of sequences, and shows the specified
number of best diagonals and the number of words on each of these diagonals.
The best segments of similarity on or near the diagonals can be viewed with the
program SEGMENTS.
T he  st rategy used by W O R D SE A R C H /S EG M EN TS is to use word compari son,  to
identify "regions of possible similarity" between a query sequence and some 
sets of sequences, and then to use optimal alignment to display the best segment 
of similarity in each segment. SEGMENTS uses a symbol comparison table, a gap
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weight, and a gap length weight to find the best region of similarity between
two sequences.
SEGMENTS uses symbol comparison values of 1.00 for each nucleotide match 
and -0.60 for every mismatch, to construct a path matrix that represents the 
entire surface of the comparison in a score at every position for the best 
possible alignment path to that point. Random alignments should have a path- 
value that averages about zero. The gap w eight and gap leng th  w eight are 
user-variab le  penalties for the creation of a gap and for the num ber of
nucleotides over which the gap extends, respectively. The best region has the 
h ighest q u a l i t y ,  where for each alignment, the q u a l i ty  is equal to the sum of 
m atches, minus 0.6 times the sum of mismatches, minus the gap weight times 
the sum of gaps, minus the gap length weight times total length of all the gaps.
Hence :
Quality = 1.0 x matches - 0.60 x mismatches - (gap weight x gap number)
- (gap length weight x total length of gaps)
The output of the program includes an area extending beyond the highest
scoring region of a particular diagonal. In addition to the quality, which 
rela tes only to this highest scoring region, an im portant indicator of the 
com parison is the ra tio . This is in effect the quality over the total length of 
the diagonal in the output.
Hence :
Ratio = Quality______
Length of diagonal
An example of one of the output files in SEGMENTS that was used to 
display segments in the output file for WORDSEARCH is given in Figure 4.2.
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ANALYSIS OF ACTIN PSEUDOGENES
The first part o f this work was focused on the actin-like DNA of genomic 
clones A,mA82, A,mA119 and A.mA118, in order to establish whether they were 
functional genes or pseudogenes (the actin-like DNA of A,mA36 was analysed by 
others as part of a different project in the same laboratory). Restriction 
analysis o f these genomic clones was carried out in order to provide a basis for 
subc lon ing  and sequencing, and to determ ine w hether they represen ted  
d ifferen t genom ic regions.
3 .1  Restriction Analysis of the Genomic Clones
The objective of the restriction mapping was limited in the first instance 
to locating restriction sites near the actin-like region of the three genomic 
clones A.mA82, ^mA118 and ^mA119.
The approach adopted was as follows. Single restriction digestion was 
perform ed on the genom ic clones with suitable restriction enzymes that 
cleaved the DNA relatively  infrequently. The fragm ents produced were 
hybridised to a 32p_iabelled actin DNA probe (Pstl fragment from cDNA clone 
pmS3, containing most of the mouse skeletal muscle actin coding region, and 
100 base pairs of the 3' non-coding region; Figure 2.3a) and fragments which 
contain all or part of the actin-like region were identified. The position of the 
actin -like  regions had previously been determined by electron m icroscopic 
heteroduplex analysis (Figure 1.4; H. Delius, EMBL, Heidelberg), is shown in 
Figure 3.1. By combining this latter information with the above hybridisation
results, a partial restriction map was constructed for the three genomic clones
(Figure 3.2). Although this was incomplete it nevertheless provided an 
adequate basis for devising a subcloning strategy (see section 3.2)
W hen the partial restriction maps of XmA119 and XmAS2  were compared
(F igure 3.2), it was observed that both clones contained some common
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Partial restriction maps are shown for the mouse DNA inserts of genomic 
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positions of the actin-like gene, and the vertical lines indicate the approximate 
positions of restric tion  sites. The restriction sites H ind lll and Xbal are 
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left-hand (20kb) arms of the lambda vector.
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restriction  sites (eg.  SstI, EcoRI) at similar positions with respect to the actin- 
like region. This, together with the similar size and position of their insertions 
suggested that clones ?tmA119 and XmAS2  possibly contained overlapping 
regions of DNA, but in opposite orientations (Figure 3.3). Different digestion
patterns were observed when XmA119 and ^m A82 were digested with Bglll, 
Xbal, EcoRI, and SstI. However, when the two clones were double digested with
B glll and Xbal, 1.4 kb fragments of identical mobility containing actin-like DNA
were identified when the digest was blotted with a 32p_iabelled actin DNA probe 
(Figure 3.4a). In the sequenced uninterrupted y a c tin  pseudogene, A,mA19 
(Leader et a l ,  1985), there is a Bglll site at amino-acid 84 and a Xbal site at 
amino-acid 374 , 0.9 kb away. Thus, when the 0.5 kb extra DNA is allowed for, it 
is evident that the 1.4 kb Bglll-Xbal fragment from clones XmA119 and >.mA82 
could have been generated from cleavage at sites corresponding to those in
tanA19. In addition when the two clones were double digested with Bglll and
SstI, 2.8 kb and 1.0 kb fragments of identical mobility containing actin-like DNA 
were identified (Figure 3.4b). This together with the results of other digestions 
(Figure 3.3), implied that the two clones >,mA119 and A.mA82 did indeed originate 
from the same genomic region. Therefore one only of these clones was taken
for further analysis, A,mA119 being chosen on the basis that it contained more 
flanking DNA 5' to the actin-like region.
3 .2  Subcloning Strategy
3 .2 .1  Subcloning of the Genomic Clone A,mA118
On the basis of the partial restriction map of XmA118 in Figure 3.2, it was 
decided that the 2.6 kb Xbal fragment was likely to contain the actin coding DNA 
and was of a suitable size for subcloning. An Xbal subclone, was constructed 
(see section 2.10.6), and was designated 118Y1-1. Restriction analysis and
hybridisation to the actin probe confirmed that it contained the desired 2.6 kb
f ra g m e n t .
Restriction analysis was carried out on the subclone 118Y1-1 and a more 
detailed restriction map was constructed as shown in Figure 3.5. In order to 
assist the sequencing, further subclones from the original parent subclone 
118Y 1-1 were derived from the two internal Pstl sites. A total of three 
subclones were constructed using : a 0.7 kb Pstl-Xbal fragment , a 1.1 kb Xba
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indicate the approximate positions of restriction sites. The derived subclones 
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PstI fragm ent , and a 0.9 kb Pstl-PstI fragment of 118Y1-1, and were designated 
118P1, 118P2, and 118P3 respectively (Figure 3.5).
3 . 2 .2  Subcloning of the Genomic Clone A,mA119
Three prim ary subclones were derived from ^m A 119 to encompass both 
coding and non-coding regions of the actin-like gene.
A subclone was derived from the 2.5 kb Xbal fragment of XmA119 (Figure 
3.2; and section 2.10.6), and was designated 119X1-1. Restriction analysis and
hybridisation to the actin probe confirmed that it contained the desired 2.5 kb
f ra g m e n t .
A further two subclones which hybridised to a y-actin  3' non-coding
probe (a 32p_ iabelled Xbal-PstI fragment from a subclone of XmA19: Figure
2.3c) were derived from a 2.8 kb SstI fragment and a 3.1 kb Xbal fragment of 
XmA119, and were designated 119SS and 119X2-1, respectively (Figure 3.6).
More detailed restriction analysis was performed on the subclone 119X1-1, 
allowing a further subcloning strategy to be devised (Figure 3.6). A total of 
four subclones were constructed using : a 1.0 kb Xbal-Bglll fragment; a 1.5 kb 
Bglll-X bal fragment ; a 1.9 kb Xbal-EcoRI fragment ; and a 0.6 kb EcoRI-Xbal 
fragm ent of 119X1-1, and were designated 119XB, 119BX, 119XR and 119RX,
re s p e c tiv e ly .
3 .3  Sequencing
3 .3 .1  Sequencing of the Genomic Clone A,mA118
The sequencing strategy was based on the detailed partial restriction map
of X.mAl 18 and its derived subclones (Figure 3.5). Sequencing was performed
by the chemical method of Maxam and Gilbert (see sections 2.11 and 2.12). The 
PstI and Xbal sites define the limits of the region sequenced, which included
the coding portion of the actin-like region and the interrupted sequence (see
section 4.1), as summarised in Figure 3.7. Sequencing of the actin region of
clone A,mAl 18 was as follows. Sequencing from the PstI, TaqI, and Bglll sites
(sequences number 1, 2, 31, and 32) allowed the region from Ile^ to L e u  140 to be
sequenced, while sequencing from the T th l l l l ,  EcoRI, Kpnl (Asp718), and Xbal
sites (sequences number 11 to 23) allowed the completion of sequencing from
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The strategy for the determ ination of the nucleotide sequence in the 
region from the PstI site at the 5' end of the actin-like DNA to the 3’ Xbal site in 
X m A llS  is shown. Sequencing of the coding and non-coding strands with 
respect to the actin pseudogene are indicated by arrows below and above the 
broken line, respectively. Fragments are numbered sequentially for ease of 
reference. The arrows represent the portion o f sequence read from a
particu lar restric tion  site.
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L e u  140 to Phe374.
The complete sequence was built up from a large number of overlapping 
fragments. Each part of the sequence was determined at least once, and 94% of
the sequence was determined from both strands.
C om pilation o f the total sequence data gives the com plete nucleotide
sequence determ ined in the genomic clone A,mA118, as shown in Figure 3.8. 
Both strands of the nucleotide sequence are shown, together with a number of
res tric tion  sites which were useful in the determ ination of the sequence. 
Com parison of this nucleotide sequence with other known sequences is made in
subsequent sections.
3 .3 .2  Sequencing of the Genomic Clone ^ m A 1 1 9
The sequencing strategy was based on the detailed partial restriction map 
ofA.mA119 and its derived subclones (Figure 3.6). Sequencing was performed 
by the chemical method of Maxam and Gilbert (see sections 2.11 and 2.12). The 
region sequenced was from approximately 260 nucleotides 5' of the B glll site to
the Xbal site. This included the coding portion of the actin-like region and the 
in te rru p ted  sequence (see section  4.2), as sum m arised in F igure 3.9. 
Sequencing of the actin region of clone A,mA119 was as follows. Sequencing
from the Bglll and Hinfl sites (sequences number 1, 2, and 19 to 21) allowed the
region from M etl to T h r l 6 0  to be sequenced, while sequencing from the SstI 
and Xbal sites (sequences number 8 to 12) allowed the region from P h e 2 6 5  to
P he374  to be sequenced. In order to identify further restriction sites suitable 
for sequencing, a 0.9 kb Bglll-SstI fragment was isolated from subclone 119BX
(see section 2.7.3), and subjected to extensive restriction analysis. The eventual
id en tif ica tio n  of the res tric tio n  sites XhoII and Styl enabled fu rther
sequencing from these sites (sequences number 3 to 5, and 16 to 18) and 
allowed the completion of sequencing from the region T h r l 6 0  to P he 26 5 0f the 
actin region.
A total of approximately 250 nucleotides were determined 3' to the stop 
codon at the Xbal site, although only 10 bases of the region 5 to actin-like DNA 
were covered. The complete sequence was built up from a large number of 
overlapping fragm ents. Each part of the sequence was determined at least 
once, and 97% of the sequence was determined from both strands.
C om pilation o f the total sequence data gives the complete nucleotide 
sequence determined in the genomic clone A.mA119, as shown in Figure 3.10.
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FigWre — Sequence of in terrupted actin pseudogene
determined— in the genomic clone 1 m A 11 ft
E,s_t I_
1 CTGCAGGCTA CACTGCGCTT CTTGCCGCTG CTCCATCGCC AATCAATCGC AATAGCCGCA 60 
GACGTCCGAT GTGACGCGAA GAACGGCGAC GAGGTAGCGG TTAGTTAGCG TTATCGGCGT
61 CTAGTCATTG ACAATGGCTC CGGCACGTCA ATGACAACGC CCTCAGGGCC ATGTTCCCTT 12 0
GATCAGTAAC TGTTACCGAG GCCGTGCAGT TACTGTTGCG GGAGTCCCGG TACAAGGGAA
121 CCATCATAGG GCGCCCCCGA CACCAGGGTG TCTTGGTGGG CATTGGCCAG AAGGACTCCT 180
GGTAGTATCC CGCGGGGGCT GTGGTCCCAC AGAACCACCC GTAACCGGTC TTCCTGAGGA
TaqI
181 ACGTGGGTGA TGAGGCCCAG AGCAAGAGGG GTATCCTGGC CCTGAAGTAC CCTGTCGAGC 240
TGCACCCACT ACTCCGGGTC TCGTTCTCCC CATAGGACCG GGACTTCATG GGACAGCTCG
B g l l l
2 41 ATGGCATTGT CACCAACTGG GACGACATGG AGAAGATCTG GCACCACACC TTCTACAATG 30 0
TACCGTAACA GTGGTTGACC CTGCTGTACC TCTTCTAGAC CGTGGTGTGG AAGATGTTAC
301 AGCTGCGTGT GGCCCCTGAG GAGCACCCGG TGCTACTGAC CGAGGCCCCC CTGAACCCCA 360
TCGACGCACA CCGGGGACTC CTCGTGGGCC ACGATGACTG GCTCCGGGGG GACTTGGGGT
361 AAGCTAACAG AGAGAAGATG ACGCAGATAA TGTTTGAACC CTTCAATACC CCAGCCTTGT 420
TTCGATTGTC TCTCTTCTAC TGCGTCTATT ACAAACTTGG GAAGTTATGG GGTCGGAACA
D r a l l
421 ACGTCACCAT TCAGGTTGGTG C1JTGGTCACG GACTGGGGCT CTGTGGGCCC TCTTCGGTCT 480
TGCAGTGGTA AGTCCACCAC GAACCAGTGC CTGACCCCGA GACACCCGGG AGAAGCCAGA
H in f l
481 GCGGAATCAG AGTCTCAGAC AGATGGGCAT AGAGTGGGCG AGTGACAAAC AGACGTGACA 540
CGCCTTAGTC TCAGAGTCTG TCTACCCGTA TCTCACCCGC TCACTGTTTG TCTGCACTGT
541 AGAGAACGTG TTGAATCTGA GTGTAATTTA TCAAATCCAG CATCAAACTT TTTATACAGA 600
TCTCTTGCAC AACTTAGACT CACATTAAAT AGTTTAGGTC GTAGTTTGAA AAATATGTCT
601 ATAACAAGAA ACCAGGCGAA CACATCCGCT AAGTTACAGT GACACAAAAC AAAAGGAATG 660
TATTGTTCTT TGGTCCGCTT GTGTAGGCGA TTCAATGTCA CTGTGTTTTG TTTTCCTTAC
661 CATACATCAA AAGATGGCGG GGACCAAGCT CATTACCACT AGAAGGAACA GGTGTAATGC 720
GTATGTAGTT TTCTACCGCC CCTGGTTCGA GTAATGGTGA TCTTCCTTGT CCACATTACG
721 TAGTCTATTG TTAAACCCAC CACCAAGGGG TTCTTAGTAA ATGCCTGATT ATGCTGTTCC 780
ATCAGATAAC AATTTGGGTG GTGGTTCCCC AAGAATCATT TACGGACTAA TACGACAAGG
781 TTTGGGCCTA GTGAAGAAAC CTGTCCAAGG GGGATTCCCT AACTCTTTCA TGGTTACCCC 840
AAACCCGGAT CACTTCTTTG GACAGGTTCC CCCTAAGGGA TTGAGAAAGT ACCAATGGGG
P s tI ..
841 ACCTATTTGC TAGGCCATTG TGTCCTAAGG CTACTGTCCT AAATAATCAC TCTGCAGACT 900
TGGATAAACG ATCCGGTAAC ACAGGATTCC GATGACAGGA TTTATTAGTG AGACGTCTGA
901 AGCCCTGAGC TATTCTAGCT CCGTTCGGAG CACTGGGTGC TCCTCAGGGG CCACACACAC 960
TCGGGACTCG ATAAGATCGA GGCAAGCCTC GTGACCCACG AGGAGTCCCC GGTGTGTGTG
EcoRI
961 GCTTCTCTAC TAGAAGTAAA TTTGAATGTT ACTGAATAGG TAACCTTCTC ACTGAATTCC 1020
CGAAGAGATG ATCTTCATTT aaacttacaa TGACTTATCC ATTGGAAGAG TGACTTAAGG
1021 CACTAAATTC CAAGCTCCTC GGCGTCGAGG ATTTTCTAGG ACATTGCAAC ACTGGCGAAG 1080
GTGATTTAAG GTTCGAGGAG CCGCAGCTCC TAAAAGATCC TGTAACGTTG TGACCGCTTC
continued overleaf. . . .
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1081 GCTTAGCTAT GTCAAGCAAT CAAATCTTAA AGGCACTTAT AATAAAACAA TACTGAAAGA 1080
CGAATCGATA CAGTTCGTTA GTTTAGAATT TCCGTGAATA TTATTTTGTT ATGACTTTCT
BamHI Ao.r.T
1141 GAGCACGTGG ATCCATACAC CAAACTAACA CGGGAAAAGG GTTTGAGTAT ACGGGCTATG 1200
CTCGTGCACC TAGGTATGTG GTTTGATTGT GCCCTTTTCC CAAACTCATA TGCCCGATAC
1201 GGAATGCCAA GGTTCCAGGA GGCATAGTTT CCTTGAAACT CATTGCCTCG TGAGTGTTTC 12 60
CCTTACGGTT CCAAGGTCCT CCGTATCAAA GGAACTTTGA GTAACGGAGC ACTCACAAAG
12 61 CAGGCCTCTT GGCCAGTCAA GCAGACTTCA CCGGAGTGGG CGTAGGAI55T GCTjCTCCTTG. 132 0 
GTCCGGAGAA CCGGTCAGTT CGTCTGAAGT GGCCTCACCC GCATCCTlCCA CGaIgAGGAAC
T t h l l lT
1321 TATGTATCTG GGCGCACCAC TGGCATTGTC ATGGACTCTG GTGACGGGGT CACACACACA 138 0 
ATACATAGAC CCGCGTGGTG ACCGTAACAG TACCTGAGAC CACTGCCCCA GTGTGTGTGT
1381 GTGGCCATCT ATGACAGCTA CACCCTTCCT CACGCCATCT TGTGTCTGGA CTTGGTTGGC 1440
CACCGGTAGA TACTGTCGAT GTGGGAAGGA GTGCGGTAGA ACACAGACCT GAACCAACCG
EcoRI
1441 TAGGACCTGA CAGAGTACCT CATGAATTCC TTGACTGAAC GGGGCTACAG CTTTACCACC 1500
ATCCTGGACT GTCTCATGGA GTACTTAAGG AACTGACTTG CCCCGATGTC GAAATGGTGG
1501 ACTGCTGAGA GGGAAATTGT GACAAGGAGA AGCTGTGCTA TGTTGCCCTG GATTTTGAGC 1550  
TGACGACTCT CCCTTTAACA CTGTTCCTCT TCGACACGAT ACAACGGGAC CTAAAACTCG
1561 AAGAAAAGGC TACTGCTGCA TCATCTTCCT 
TTCTTTTCCG ATGACGACGT AGTAGAAGGA
1621 GGCAGGTGAT CACCATTGGC AATGAGCGGT 
CCGTCCACTA GTGGTAACCG TTACTCGCCA
1681 CCTTCCTGGG CATGGAATCC TGTGGCATCT 
GGAAGGACCC GTACCTTAGG ACACCGTAGA
17 41 GTGATGTGGA TATCTGCAAA GACCTGTATG 
CACTACACCT ATAGACGTTT CTGGACATAC
CCTTGGAGAA GAGTTACCAG CTGCCCGATG 1620  
GGAACCTCTT CTCAATGGTC GACGGGCTAC
TCCGGTGTCC GGAGGCACTC TTCCAGCATT 1680  
AGGCCACAGG CCTCCGTGAG AAGGTCGTAA
ACGAGACCAC CTTCAACTCC ATCATGAAGT 17 40 
TGCTCTGGTG GAAGTTGAGG TAGTACTTCA
Kpnl
CCAATACAGT GCTGTCCGGT GGTACCACCA 1800  
GGTTATGTCA AGACAGGCCA CCATGGTGGT
1801 TGTACCCAGG CATTGCTGAC AGGATGTAGA 
ACATGGGTCC GTAACGACTG TCCTACATCT
18 61 TGAAGATTAA GATCATTGCT CCCCCTGAGC 
ACTTCTAATT CTAGTAACGA GGGGGACTCG
1921 TCCTACCTCA CTGTCCACCT TCCAGCAGAT 
AGGATGGAGT GACAGGTGGA AGGTCGTCTA
Xbal
1981 GGGCCCATCG TCCACCGCAA ATGCTTCTAG 
CCCGGGTAGC AGGTGGCGTT TACGAAGATC
AGGAGATCAC AGCCCTAGCA CCCAGCACAA 18 60 
TCCTCTAGTG TCGGGATCGT GGGTCGTGTT
GCAAGTACTC AGTCTGGACC TGCGGCTCCA 1920 
CGTTCATGAG TCAGACCTGG ACGCCGAGGT
GTGGATCAGC AAGCAGGAGT ATGATGAGTC 198 0 
CACCTAGTCG TTCGTCCTCA TACTACTCAG
A 2011  
T
Both strands of the nucleotide sequence of the interrupted actin pseudogene in 
genomic clone ^mA118 are shown, the PstI and Xbal sites (Figure 3.7) defining the 
limits o f  the region sequenced. Restriction sites are underlined above the 
appropriate nucleotides. The boxed sequences are direct repeats flanking the 
inserted sequence.
F l8ure— ^  SLgqagncine— strategy— £ai— t — ac t in - i ik*  region ana  
interrupted—DNA of the genomic clone Vm A }  }  Q
1 9 0 0 n t
■1QOb|
The strategy for the determination of the nucleotide sequence in the 
region from the PstI site at the 5' of the Bglll site of the actin-like region to the 
3' Xbal site in ^mA119 is shown. Sequencing of the coding and non-coding 
strands with respect to the actin pseudogene are indicated by arrows below 
and above the broken line, respectively. Fragments are numbered 
sequentially for ease of reference. The arrows represent the portion of 
sequence read from a particular restriction site.
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F>gUll£— 3 i l0  NllClgOtidg— Sfqwepgg— a£ interrupted actin nseudogene and
flflnkipg—nggiQns— determined in the genomic clone X.mA119
1 CGTCGCAATG GAAGAAGAAA TCGCCACACT CGTCATTGTC AATGGCTCCG GCATGTGCAA 
GCAGCGTTAC CTTCTTCTTT AGCGGTGTGA GCAGTAACAG TTACCGAGGC CGTACACGTT
61 AGCTGGCTTT GCTGGAGACG ACGCCCCCAG GGCCGTGTTC CCTTCCATCG TAGGGTGCCC 
TCGACCGAAA CGACCTCTGC TGCGGGGGTC CCGGCACAAG GGAAGGTAGC ATCCCACGGG
121 CCGACACCAG GACGTCATGG TGGGCATGGG CCAGAAAGAC TCGTATGTGG GTGACAAGGC 
GGCTGTGGTC CTGCAGTACC ACCCGTACCC GGTCTTTCTG AGCATACACC CACTGTTCCG
181 CCAGAGCAAG AGGGGTATCC TGACCCTGAA GTACCCTATC GAACACGGCA TTGTCACCAA 
GGTCTCGTTC TCCCCATAGG ACTGGGACTT CATGGGATAG CTTGTGCCGT AACAGTGGTT
B a l l  I
241 CTGGGATGAC ATGGAGAAGA TCTGGCACCA CACCTTCTAC AATGAGCTGC GTGTGACCCC 
GACCCTACTG TACCTCTTCT AGACCGTGGT GTGGAAGATG TTACTCGACG CACACTGGGG
301 TGAGGAGCAC CCGGTGCTTC TGACCGAGGC CCCCCTGAAC CCCAAAGCTA ACAGAGAGAA 
ACTCCTCGTG GGCCACGAAG ACTGGCTCCG GGGGGACTTG GGGTTTCGAT TGTCTCTCTT
361 GATGACGCAG ATAATGTTTG AAACCTTCAA TACCCCAGCC ATGTACGTGG CCATTCAGGC 
CTACTGCGTC TATTACAAAC TTTGGAAGTT ATGGGGTCGG TACATGCACC GGTAAGTCCG
H in f I
421 GGTGCTGTCC TTGTATGCAT CTGGGTGCAC CACTGGCATT GTCATGGACT CTGGTGACGG 
CCACGACAGG AACATACGTA GACCCACGTG GTGACCGTAA CAGTACCTGA GACCACTGCC
481 GGTCACACAC ACAGTGCCCA TCTATGAGGG CTACGCCCTT CCCCATGCCG TCTTGCGTCT 
CCAGTGTGTG TGTCACGGGT AGATACTCCC GATGCGGGAA GGGGTACGGC AGAACGCAGA
XhoII
541 GGACCTGGCT GGTCGGGTCC TGACAGACTA CCTCATGAAG ATCCTGACTG AACGGGGCTA 
CCTGGACCGA CCAGCCCAGG ACTGTCTGAT GGAGTACTTC TAGGACTGAC TTGCCCCGAT
601 CAGCTTTACC ACCACTGCTA AGAGGGAAAT TGTTCGAGAC ATAAAGGAGA AGCTGTGCTA 
GTCGAAATGG TGGTGACGAT TCTCCCTTTA ACAAGCTCTG TATTTCCTCT TCGACACGAT
S t y l
6 61 TGTTGCCCTG TATTTTGAGC AAGAAATGGC TACTGCTACA TCATCTTCCT CCTTGGAGAA 
ACAACGGGAC ATAAAACTCG TTCTTTACCG ATGACGATGT AGTAGAAGGA GGAACCTCTT
721 GAGTTACGAG CTGCCCGATG GGCAGGTTAT CACCATCGGC AATGAGCGGT TCCGGTGTCC 
CTCAATGCTC GACGGGCTAC CCGTCCAATA GTGGTAGCCG TTACTCGCCA AGGCCACAGG
781 AGAGGCACTC TTCCAGACTT dCllCJTGAAA GAAAGTGAAA TTTCAAGACC TGTAAGTCAT 
TCTCCGTGAG AAGGTCTGAA GGAAGACTTT CTTTCACTTT AAAGTTCTGG ACATTCAGTA
841 ATAAAGTACT CAGAAATTGC TGGCTGTTTG TGAGCCTAGA GGCGCCTGGG GCGAGAAAAG 
TATTTCATGA GTCTTTAACG ACCGACAAAC ACTCGGATCT CCGCGGACCC CGCTCTTTTC
901 AGAAAAACAA ACCTGGGTAT GCCTCGTAGT TAAAACATTC CTGGGAACAT CTTGACCATA 
TCTTTTTGTT TGGACCCATA CGGAGCATCA ATTTTGTAAG GACCCTTGTA GAACTGGTAT
H in f I
9 61 AGATAAAGGG GACTGTGAAG ACATAGCAGG GCTATCTGAA CTGAGTCAAC AACTCACAGA 
TCTATTTCCC CTGACACTTC TGTATCGTCC CGATAGACTT GACTCAGTTG TTGAGTGTCT
continued overleaf.
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continued.
1021 ACTCTGACAC CCTGCACGTA CATGTAATTT TTCTGTTAAT GTTTGAATAA GCCAATAGTG 1080
TGAGACTGTG GGACGTGCAT GTACATTAAA AAGACAATTA CAAACTTATT CGGTTATCAC
EcoRI
1081 TGTCGCTATG CTGAATTCCA CACCCCTAAG CCCCTTACCC CATAAAACCC CCTAACTTTC 1140
ACAGCGATAC GACTTAAGGT GTGGGGATTC GGGGAATGGG GTATTTTGGG GGATTGAAAG
S s t I
1141 GAGCCTCGTG GCCGGCCATC CGTTATCTCC TGTGTGGGAT ACATGTCGGT CTGGAGCTCC 1200
CTCGGAGCAC CGGCCGGTAG GCAATAGAGG ACACACCCTA TGTACAGCCA GACCTCGAGG
1201 GTAATTAAAC GTCCTCATGT AATTACAGCA AGATGGGTCC TCGTGTTTCT TTGGGTGCTC 1260
1261
CATTAATTTG CAGGAGTACA TTAATGTCGT TCTACCCAGG AGCACAAAGA AACCCACGAG
TCACACTCCT GAGACTAGAG TGGGGGTCCC CAAAAGGGGT CTTACACTTC CTGGGCATGG 1320
AGTGTGAGGA CTCTGATCTC ACCCCCAGGG GTTTTCCCCA GAATGTGAAG GACCCGTACC
1321 AGTCCTGTGG TATCCACGAG ATCACCTTCA ACTCCATCAT GAAGTGTGAT GTGGATATCC 1380
TCAGGACACC ATAGGTGCTC TAGTGGAAGT TGAGGTAGTA CTTCACACTA CACCTATAGG
1381 GCAAAGACCT GTATGCCAAT ACAGTGCTGT CTGGTGGTAC CCACCATGTA CCCAGGCATT 1440
CGTTTCTGGA CATACGGTTA TGTCACGACA GACCACCATG GGTGGTACAT GGGTCCGTAA
1441 GCTGACAGGA TGAAGAAGGA GATCACAACC CTAGCACCCA GCACAACGAA GATTAAGATC 1500
CGACTGTCCT ACTTCTTCCT CTAGTGTTGG GATCGTGGGT CGTGTTGCTT CTAATTCTAG
1501 ATTGCTCCCC CTGAGCGCAA GTACTCAGTC TGGTTCTGTG GCTCCATTCT GGCCTCACTG 1560
TAACGAGGGG GACTCGCGTT CATGAGTCAG ACCAAGACAC CGAGGTAAGA CCGGAGTGAC
1561 TCCACCTTCC AGCAGATGTG GATCAGCAAG CAGGAGTATG ATGAGTTGGG CCCCTCTATC 1620
AGGTGGAAGG TCGTCTACAC CTAGTCGTTC GTCCTCATAC TACTCAACCC GGGGAGATAG
X bal
1621 ATCCACATCA AATGCTTCTA GATGGACCGT GGCAGGTGCC AAGCATCTGC TGCATGAGCC 1680
TAGGTGTAGT TTACGAAGAT CTACCTGGCA CCGTCCACGG TTCGTAGACG ACGTACTCGG
1681 GATATTGAAG TATTGATTTG CCCTGGCAAA TGTACACACC TCATGCTAGC CTCATGAAAC 1740
CTATAACTTC ATAACTAAAC GGGACCGTTT ACATGTGTGG AGTACGATCG GAGTACTTTG
1741 TGGAATAAGT CCCCCCCCCC TTTCCTTTTT ATTTTTTATT CACTTAACAT CCCAGACACA 1800
ACCTTATTCA GGGGGGGGGG AAAGGAAAAA TAAAAAATAA GTGAATTGTA GGGTCTGTGT
1801 GCCCCCGCCC CTTTTCAGAG TTCCTCCTTT ACAAGTTCCT TCCACCATTC CCTTTTCTCT 1860
CGGGGGCGGG GAAAAGTCTC AAGGAGGAAA TGTTCAAGGA AGGTGGTAAG GGAAAAGAGA
1861 TTGTCTCTTA GAAATGGGAC CCGTTTGTGT ACCACTTACC 1900
AACAGAGAAT CTTTACCCTG GGCAAACACA TGGTGAATGG
Both strands of the nucleotide sequence of interrupted actin pseudogene 
and flanking region determined in the genomic clone A.mA119 are shown. The 
Bglll and Xbal sites, near the limits of the region sequenced are those of Figure 
3.9. Other restriction sites are underlined above the appropriate nucleotides. 
The boxed sequences are direct repeats flanking the inserted sequence.
Both strands of the nucleotide sequence are shown, together with a number of 
restric tion  sites which were useful in the determination of the sequence. 
C om parison  o f  this nucleotide sequence with other known sequences is 
discussed in subsequent sections.
3 .4  Analysis of Actin-like Amino-acid Sequences
3 .4 .1  The Actin-like Sequence in Clone XmA118
The portion of the nucleotide sequence of clone kmA118 corresponding to 
the actin-like gene is shown in Figure 3.11. This was related to the coding
sequence of an actin-like gene over an area from amino-acid 5 to a stop codon 
following amino-acid 374. Examination of the predicted amino-acid sequence 
shows that ^mA118 most closely resembles a gene for a cytoplasmic isoform of 
actin (Vandekerckhove and Weber, 1979a). Of the 22 residues unique to 
cytoplasmic actins, all are found in the predicted sequence in clone 7,mA118 
(represented by the underlined residues in Figure 3.11), except for two amino- 
acid residues at positions 16 and 17, and the latter position is part of a deletion.
There are four amino-acids at the N-terminal end of the sequence which 
differentiate  the cytoplasmic actin B and y isoforms (Vandekerckhove and 
Weber, 1979a). These are amino-acid position 2 (B = Asp, y = Glu), position 3 (B = 
Asp, y = Glu), position 4 (B = Asp, y = Glu), and position 10 (B = Val, y = lie). 
However, the actin-like sequence in clone A,mA118 only starts from the lie at 
codon position 5, therefore only the amino-acid at position 10 could be used to
identify the isoform. As this corresponds to lie (bold in Figure 3.11), the
predicted  amino-acid sequence resembles that of the y, rather than the B
isoform .
The actin-like gene of A,mA118 bears some of the hallmarks of a processed 
pseudogene. There are 33 differences in the predicted amino-acid sequence to
that of y-actin (represented by residues in bold italics in Figure 3.11), 
including stop codons rather than Arg and Gin, at positions 183 and 313 
respectively. In addition, there are four deletions of nucleotides, these being at 
codon positions 16 to 24, 209 to 213, 345 to 347, and 365 to 368. Furthermore, the
actin-like  sequence is not interrupted by the introns anticipated for a
mammalian actin. Although it is not yet known whether the coding gene for y-
actin has introns, the genes for the four mammalian actin isoforms so far
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Figure— 2*11 Nucleotide—sequence—and am ino-acid translation of the
V-actm— nseudogene in genomic clone A m A 1 1 8
l i e  A la
1 CTGCAGGCTACACTGCGCTTCTTGCCGCTGCTCCATCGCCAATCAATCGCA ATA GCC
a® i s  24
A la  Leu V a l l i e  Asp Asn G ly S er G ly Thr Asp Asn  A la
58 GCA CTA GTC ATT
3®
GAC AAT GGC TCC GGC ACG TCAAT GAC AAC
40
GCC
Leu Arg A la Met Phe Pro S er l i e H e G ly Arg Pro Arg H is G in
102 CTC AGG GCC ATG TTC CCT TCC ATC ATA
s@
GGG CGC CCC CGA CAC CAG
G ly V a l Leu V al G ly l i e  G ly Gin Lys Asp S er Tyr V al G ly  Asp
147 GGT GTC TTG GTG
@@
GGC ATT GGC CAG AAG GAC TCC TAC GTG GGT
7®
GAT
G lu A la Gin S er Lys Arg G ly l i e Leu A la Leu Lys Tyr Pro Val
192 GAG GCC CAG AGC AAG AGG GGT ATC CTG
© @
GCC CTG AAG TAC CCT GTC
G lu H is G ly H e V al Thr Asn Trp Asp Asp Met Glu Lys l i e Trp
237 GAG CAT GGC ATT
§@
GTC ACC AAC TGG GAC GAC ATG GAG AAG ATC
1@@
TGG
H is H is Thr Phe Tyr Asn Glu Leu Arg V al A la Pro Glu Glu H is
282 CAC CAC ACC TTC TAC AAT GAG CTG CGT
11®
GTG GCC CCT GAG GAG CAC
P ro V al Leu Leu Thr Glu A la Pro Leu Asn Pro Lys A la Asn Arg
327 CCG GTG CTA CTG
IS®
ACC GAG GCC CCC CTG AAC CCC AAA GCT AAC
13®
AGA
G lu Lys Met Thr Gin l i e Met Phe Glu Pro Phe Asn Thr Pro A la
372 GAG AAG ATG ACG CAG ATA ATG TTT GAA
14®
CCC TTC AAT ACC CCA GCC
Leu Tyr V al Thr l i e Gin Val V al Leu Ser Leu Tyr V al S er G ly
417 TTG TAC GTC ACC
IS®
ATT CAG GTIG GTG
442
OTIC TCC 
! It 1313
TTG TAT GTA TCT
If®
GGG
Arg Thr Thr G ly l i e V al Met Asp Ser G ly Asp G ly V al Thr H is
1333 CGC ACC ACT GGC ATT GTC ATG GAC TCT
17®
GGT GAC GGG GTC ACA CAC
Thr V al A la l i e Tyr Asp S e r Tyr Thr Leu Pro H is A la l i e Leu
1378 ACA GTG GCC ATC
IS®
TAT GAC AGC TAC ACC CTT CCT CAC GCC ATC
IS®
TTG
C ys Leu Asp Leu Val G ly End Asp Leu Thr Glu Tyr Leu Met Asn
1423 TGT CTG GAC TTG GTT GGC TAG GAC CTG
s@@
ACA GAG TAC CTC ATG AAT
S e r Leu Thr Glu Arg G ly Tyr Ser Phe Thr Thr 1Thr A la Glu Arg
1468 TCC TTG ACT GAA CGG GGC TAC AGC TTT ACC ACC ACT GCT GAG AGG
continued overleaf
57 
101  
146  
191 
236  
281  
32 6 
371 
416 
1332
1377
1422
1467
1512
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continued.
G lu l i e  V a l Lys Glu Lys Leu Cys Tyr V al A la  Leu Asp Phe
1513  GAA ATT GTG AC AAG GAG AAG CTG TGC TAT GTT GCC CTG GAT TTT 1556
G lu  S in  G lu L ys  A la  Thr A la  A la  S er  S er  S er  S er  Leu G lu Lys
1557 GAG CAA GAA AAG GCT ACT GCT GCA TCA TCT TCC TCC TTG GAG AAG 1601
240
S e r  Tyr Gin  Leu Pro Asp G ly Gin V al l i e  Thr l i e  G ly Asn Glu
1602 AGT TAC CAG CTG CCC GAT GGG CAG GTG ATC ACC ATT GGC AAT GAG 164 6
§?g@
A rg Phe A rg Cys Pro Glu Ala. Leu Phe Gin H is  S er  Phe Lau G ly
1647 CGG TTC CGG TGT CCG GAG GCA CTC TTC CAG CAT TCC TTC CTG GGC 1691
§7®
Met G lu S er  Cys G ly l i e  T yr  Glu Thr Thr Phe Asn S er  l i e  Met
1692 ATG GAA TCC TGT GGC ATC TAC GAG ACC ACC TTC AAC TCC ATC ATG 1736
2§@
L ys Cys Asp V a l Asp l i e  Cys Lys Asp Leu Tyr A la  Asn Thr V a l
1737 AAG TGT GAT GTG GAT ATC TGC AAA GAC CTG TAT GCC AAT ACA GTG 1781
Leu S e r  G ly  G ly  Thr Thr Met Tyr Pro G ly l i e  A la  Asp Arg Met 
1782 CTG TCC GGT GGT ACC ACC ATG TAC CCA GGC ATT GCT GAC AGG ATG 182 6
End  Lys G lu l i e  Thr A la  Leu A la Pro S er  Thr Met Lys l i e  Lys
1827 TAG AAG GAG ATC ACA GCC CTA GCA CCC AGC ACA ATG AAG ATT AAG 1871
33© 3«®
l i e  l i e  A la  Pro Pro Glu Arg Lys Tyr S er  V al Trp Thr Cys G ly
1872 ATC ATT GCT CCC CCT GAG CGC AAG TAC TCA GTC TGG ACC TGC GGC 1916
3€S 317 3S@
S e r  l i e  Leu S er  Leu S er  Thr Phe Gin Gin Met Trp l i e  S er
1917 TCC ATC CTA CC TCA CTG TCC ACC TTC CAG CAG ATG TGG ATC AGC 19 60
3®@ 3 iS  3i® 37®
Lys G in G lu Tyr Asp Glu G ly H e  V al H is Arg Lys Cys
19 61 AAG CAG GAG TAT GAT GAG TCG GGC CC ATC GTC CAC CGC AAA TGC 2 00 4
Phe End 
2005  TTC TAG A 2011
The figure shows the complete y-like actin coding sequence from clone
XmAl 18. Numbering of amino-acids is as in Vandekerckhove and Weber
(1979a). .
U n d e r l in e  = residues specific for cytoplasmic actins.
Bold = residues specific for cytoplasmic y-actin.
B o l d  i t a l i c s  = difference from amino-acid sequence of mouse y-actin.
The arrow between nucleotides 442 and 1313 indicates the position of the 
inserted sequence. The boxed sequences are direct repeats flanking the
inserted  sequence.
characterised all have introns at amino-acid positions 41, 267 and 327 (as well as 
at other positions specific for different isoforms).
Although it is possible, in principle, that the inserted sequence in
A,m A 118 might be an intron (discussed in section 5.2.3i), the lack of any other
introns, including those that have been conserved in mammalian actins, is
consistent with XmA118 being a pseudogene.
Most processed pseudogenes contain DNA copies of the whole of the
mRNA, including the 5' untranslated region. However, ^mA118 only contains 
actin-like sequence from amino-acid 5 (Figure 3.12). Another y - a c t in - l ik e  
pseudogene, A.mA19, is truncated at position 7 (Leader et a l ,  1985). This was 
shown by a preceding sequence (target-site direct repeat) that was repeated 
after the poly A tail. In the case of A,mA118 the 3' untranslated region has not
yet been sequenced, so that it is unclear whether the pseudogene arose from a 
truncated transcript, or from a full-length transcript, the 5' portion of which 
was subsequently deleted.
3 .4 .2  The Actin-like Sequence in Clone /UnA119
The portion of the nucleotide sequence of clone kmA119 corresponding to 
the actin-like gene is shown in Figure 3.13. This resembled the coding
sequence of an actin-like gene from an initiating Met codon to a termination 
codon after amino-acid position 375. Examination of the predicted amino-acid 
sequence shows that XmA119 also most closely resembles the gene for a 
cytoplasmic isoform of actin (Vandekerckhove and Weber, 1979a). Of the 22 
residues unique to cytoplasmic actins, all of them corresponded to those of the 
predicted sequence in clone XmA119 (represented by the underlined residues in
Figure 3.13), except for Leu at amino-acid position 364.
Of the four amino-acids at the N-terminal end of the sequence which
distinguish the B and j  isoforms of cytoplasmic actin (Vandekerckhove and
Weber, 1979a), all of these (Glu^, Glu3, GluA and IlelO) in the predicted amino-
acid sequence of clone XmA119 correspond to those of the y-isoform (indicated 
by residues in bold in Figure 3.13). Thus the sequence of the actin-like gene in 
XmA119 resembles that of the y, rather than the B isoform.
The actin-like gene of ?imA119 also has characteristics of a processed 
pseudogene. It differs in predicted amino-acid sequence from the y-actin at 21 
positions (indicated by residues in bold italics in Figure 3.13). The predicted
amino-acid sequence does not have the potential to encode a full actin-like
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JFigure— 3.12 Comparison of nucleotides encoding the N-terminal
geia.ucn.ces— o f—ac tin g — m lh — corresponding reg io n  in  c lo n e  X m  A 1 1 ft
I S  10
MetAspAspAspIleAlaAlaLeuValVa1 
B-actin: ............. ATGGAYGAYGAYATNGCNGCNCTNGTNGTN
I I I I II I I I I I I I I I I I I I 
tanA118: CCGCTGCTCCATCGCCAATCAATCGCAATAGCCGCACTAGTCATT 69
I I I I I I I I I I I I I I I I I I I I I
y-actin : ..............AT GG ARG ARG ARATNGCN G CN CTN G TN ATN
MetGluGluGluIleAlaAlaLeuVallie 
1 i  10
The nucleotide sequences that could encode the known amino-acid 
sequences of the N-terminal positions of mouse B- and y-cytoplasmic actins are 
aligned to the corresponding region of the processed actin pseudogene in 
A,mAl 18, numbered as in Figure 3.8. R = purine, Y = pyrimidine and N = 
unspecified nucleotide. Vertical lines between nucleotides indicate identity.
9 6
F ig u r e
1
47
92
137
182
227
272
317
362
407
452
497
542
587
632
2*12. Nucleotldfr—sequence—and— am ino-arid translation of
lhe_.„ Y - a c t i n — BSfudoaene in genomic clone A. mA1T9
1
Met G lu G lu
CGTCGCA ATG GAA GAA
S e r  G ly  Met Cys Lys 
TCC GGC ATG TGC AAA 
3®
A la  V a l Phe Pro S er  
GCC GTG TTC CCT TCC
Met V a l G ly  Met G ly  
ATG GTG GGC ATG GGC 
f>©
G in S e r  Lys Arg G ly  
CAG AGC AAG AGG GGT
G ly  l i e  V a l Thr Asn 
GGC ATT GTC ACC AAC 
S@
Thr Phe Tyr Asn Glu 
ACC TTC TAC AAT GAG
Leu Leu Thr Glu A la  
CTT CTG ACC GAG GCC 
12®
Met Thr G in l i e  Met 
ATG ACG CAG ATA ATG
V a l A la  l i e  Gin A la  
GTG GCC ATT CAG GCG
IS®
Thr G ly  H e  V al Met 
ACT GGC ATT GTC ATG
P ro l i e  Tyr Glu G ly  
CCC ATC TAT GAG GGC 
1 ®®
Asp Leu A la  G ly Arg 
GAC CTG GCT GGT CGG
Thr G lu Arg G ly  Tyr 
ACT GAA CGG GGC TAC 
2 1 ®
V a l Arg Asp H e  Lys 
GTT CGA GAC ATA AAG
G lu l i e  A la  Thr Leu 
GAA ATC GCC ACA CTC 
2®
A la G ly Phe A la  G ly  
GCT GGC TTT GCT GGA
l i e  V al G ly Cys Pro  
ATC GTA GGG TGC CCC 
S©
Gin Lys Asp S er  Tyr 
CAG AAA GAC TCG TAT
l i e  Leu Thr Leu Lys 
ATC CTG ACC CTG AAG 
S@
Trp Asp Asp Met Glu 
TGG GAT GAC ATG GAG
Leu Arg V al Thr Pro 
CTG CGT GTG ACC CCT
11®
Pro Leu Asn Pro Lys 
CCC CTG AAC CCC AAA
Phe Glu Thr Phe Asn 
TTT GAA ACC TTC AAT 
11®
V al Leu S er Leu Tyr 
GTG CTG TCC TTG TAT
Asp S er  G ly Asp G ly  
GAC TCT GGT GAC GGG
17®
Tyr A la Leu Pro H is  
TAC GCC CTT CCC CAT
Val Leu Thr Asp Tyr 
GTC CTG ACA GAC TAC
2®®
S er Phe Thr Thr Thr 
AGC TTT ACC ACC ACT
Glu Lys Leu Cys Tyr 
GAG AAG CTG TGC TAT
1®
V al l i e  Val Asn G ly
GTC ATT GTC AAT GGC
Asp Asp A la  Pro Arg  
GAC GAC GCC CCC AGG 
40
Arg H is Gin A sp  V a l 
CGA CAC CAG GAC GTC
V al G ly  Asp L ys  A la  
GTG GGT GAC AAG GCC 
7®
Tyr Pro l i e  Glu H is  
TAC CCT ATC GAA CAC
Lys l i e  Trp H is H is  
AAG ATC TGG CAC CAC
1@@
Glu Glu H is Pro V al 
GAG GAG CAC CCG GTG
A la Asn Arg Glu Lys 
GCT AAC AGA GAG AAG
13©
Thr Pro A la  Met Tyr 
ACC CCA GCC ATG TAC
A la S er G ly Cys  Thr 
GCA TCT GGG TGC ACC 
IS®
V al Thr H is Thr V al 
GTC ACA CAC ACA GTG
A la Val Leu Arg Leu 
GCC GTC TTG CGT CTG 
IS®
Leu Met Lys l i e  Leu 
CTC ATG AAG ATC CTG
A la L ys  Arg Glu l i e  
GCT AAG AGG GAA ATT
2 2 ®
V al A la  Leu T yr  Phe 
GTT GCC CTG TAT TTT
continued overleaf
46
91
136
181
226
271
316
361
406
451
496
541
586
631
676
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continued..
S3® S 3 ie
677
G lu G in G lu Met A la Thr A la Thr S er S er S er S er Leu Glu Lys
GAG CAA GAA
Si®
ATG GCT ACT GCT ACA TCA TCT TCC TCC TTG
S5@
GAG AAG
S e r Tyr G lu Leu Pro Asp G ly Gin V al l i e Thr l i e G ly  Asn Glu
722 AGT TAC GAG CTG CCC GAT GGG CAG
Si®
GTT ATC ACC ATC GGC 
2 S3
AAT GAG
A rg Phe Arg Cys Pro Glu A la Leu Phe Gin Thr S er Phe Leu G ly
767 CGG TTC CGG TGT CCA GAG GCA CTC TTC CAG ACT TOC TTQ CTG GGC
805 ft 1310
S7® s®@
Met G lu S er CY? G ly l i e H is Glu H e Thr Phe Asn S er l i e Met
1317 ATG GAG TCC TGT GGT ATC CAC GAG
IS®
ATC ACC TTC AAC TCC ATC ATG
L ys Cys Asp V al Asp l i e Arg Lys Asp Leu Tyr A la Asn Thr V al
1362 AAG TGT GAT
3@@
GTG GAT
3@S
ATC CGC
3@3
AAA GAC CTG TAT GCC AAT ACA
31®
GTG
Leu S er G ly G ly Thr Thr Met Tyr Pro G ly l i e A la Asp Arg
1407 CTG TCT GGT GGT ACC C ACC ATG TAC
3S@
CCA GGC ATT GCT GAC AGG
Met L ys Lys Glu l i e Thr Thr Leu A la Pro S er Thr Thr Lys l i e
1450 ATG AAG AAG GAG
33®
ATC ACA ACC CTA GCA CCC AGC ACA ACG AAG
3i®
ATT
Lys H e l i e A la Pro Pro Glu Arg Lys Tyr S er V al Trp Phe Cys
1495 AAG ATC ATT GCT CCC CCT GAG CGC AAG
3S@
TAC TCA GTC TGG TTC TGT
G ly S er l i e Leu A la S er Leu Ser Thr Phe Gin Gin Met Trp H e
1540 GGC TCC ATT CTG
3i@
GCC TCA CTG TCC ACC TTC CAG CAG ATG TGG
37®
ATC
S er Lys Gin Glu Tyr Asp Glu Leu G ly Pro S er l i e l i e H is l i e
1585 AGC AAG CAG GAG TAT GAT GAG TTG GGC CCC TCT ATC ATC CAC ATC
3 7 «
L y s  C y s  P h e  E n d
1 6 3 0  A A A  TGC TTC TAG ATGGACCGTGGCAGGTGCCAAGCATCTGCTGCATGAGCCGATA 1 6 8 4  
1 6 8 5  TTGAAGTATTGATTTGCCCTGGCAAATGTACACACCTCATGCTAGCCTCATGAAACTGG 1 7  4 3
1 7  4 4  AATAAG TCCCCCCCCCCTTTCCTTTTTATTTTTTATTCACTTAACATCCCAGACACAGC 1 8 0 2  
1 8 0 3  CCCCGCCCCTTTTCAGAGTTCCTCCTTTACAAGTTCCTTCCACCATTCCCTTTTCTCTT 1 8  6 1
1 8  6 2  TGTCTCTTAGAAATGGGACCCGTTTGTGTACCACTTACC 1 9 0 0
The figure shows the complete y-like actin coding sequence from clone
7.mAl 19. Numbering of amino-acids is as in Vandekerckhove and Weber (1979a).
U n d e r l in e  = residues specific for cytoplasmic actins.
Bold = residues specific for cytoplasmic y-actin.
B o ld  i t a l i c s  = difference from amino-acid sequence of mouse y-actin.
The arrow between nucleotides 805 and 1310 indicates the position of the
inserted sequence. The boxed sequences are direct repeats flanking the inserted
se q u e n c e .
protein as it is interrupted by an out-of-phase nucleotide between amino-acid 
positions 302 and 303. Furthermore, the actin-like sequence is not interrupted
by the in trons that are conserved in known mammalian actin isoforms 
(discussed in section 3.4.1, above), although there is a sequence interrupting it,
the nature of which is discussed in Chapter 5.
The 3' untranslated region of A,mA119 also resembles that of mouse y-actin,
both the previously published y-actin pseudogene ?imA19 (Leader et al., 1985), 
and the as yet unpublished partial mouse y-actin cDNA sequence (Peter and 
Leader, personal communication). However, unlike X,mA19, this relatedness 
only extends to nucleotide 1751, afterwhich the sequences diverge (Figure 
3.14).
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F igu re  .3 ,1 4  Compari son  o f  y-actin 3 ' untranslat,.,! sen ..en«-«  with  
clone X mA119
cDNA: 
XmAl19: 
XmA19: 
cDNA: 
XmAl19: 
XmA19: 
cDNA 
XmA119: 
XmA19: 
cDNA: 
XmAll9: 
tanA19:
End
TAgiatggactga- gcaggtgccaggcatctgctgcatgagctgatattga 
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I | | I | | | | | [ | 
TAGATGGACCGTGGCAGGTGCCAAGCATCTGCCGCATGAGCTGATATTGA 
I I I I I I I I I I I II I I I I I I I I I I I I I II I I II I I I I I I I I I 
&TGGAC-TGAGCAGGTGCCAGGCATCTGCTGCATGAGCTGATATTGATAG
AGTATCAATTTGCCCTGGCAAATGTACACACCTCATGCTAGCCTCATGAA 
I I I I I I I I I I II I I I I I I I I I II I I I I I II I I I II I I II I I I I I II II 
AGTATTGATTTGCCCTGGCAAATGTACACACCTCATGCTAGCCTCATGAA 
I I I I I I I I I I I I I I I I I I I II I I I I I I I I I I I I I I I I I I I I I I I I I I I 
AGTATCGATTTGCCCTGGCAAATGTATACACCTCATGCTAGCCTCATGAA
ACTGGAATAAGCCTTTGAAAAGAAATTTAGTCCTTGAAGCTTGTATCTGA
I I I I I I I I I I I I I I I I
ACTGGAATAAGTCCCCCCCCCCTTTCCTTTTTATTTTTTATTCACTTAAC
I I I I I I I II I II I I I I I II I
ACTGGAATAAGCCTTTGAAAAGAAATTT-GTCCTTGAAGCTTGTATCTGA
TATCAGCACTGGATCGTAGAACTTGTTGCTGATTTTTGACCTTGTATTCA
I I I I  I I I I I I I I  I I I
ATCCCAGACACAGCCCCCGCCCCTTTTCAGAGTTCCTCCTTTACAAGTTC
I II I I I I I I I I I  I M
TATCAGCACTGGATCGTAGAACTTGTTGCTGATTTTTGACCTTGTATTCA
1035
1688
1400
1085
1738
1450
1135
1788
1499
1185
1838
1549
The region of the y-actin pseudogene in ^m A 119 corresponding to the 
3 'untranslated sequence of the mRNA is compared with the corresponding 
regions in mouse y-actin cDNA (Peter and Leader, personal communication),
and clone A,mA19 (Leader et al., 1985). The predicted stop codons are boxed. 
Gaps that have been introduced to optimise alignment are indicated by 
hyphens. Vertical lines between nucleotides indicate identity. The numbering
of sequences are as follows : cDNA is as in Figure 5.3; XmA119 is as in Figure
3.10; XmA19 is as in Leader et al., (1985).
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4ANALYSIS OF INSERTED SEQUENCES 
IN ACTIN-LIKE GENES
The e lec tron  m icroscopic heteroduplexes formed between the actin 
regions of A.mA36, XmA118, and A.mA119 and the reference clones (Figure 1.4), 
demonstrated that the DNA of each of these clones was interrupted by a single­
stranded loop. The genomic regions corresponding to these loops were 
subjected to structural analysis in order to characterise them further.
4 .1  Analysis of the Inserted Sequence in Clone tan A l l  8
4 .1 .1  Nucleotide Sequence of the Inserted Sequence in 
Clone XmA118
Figure 3.5 shows a detailed partial restriction map of clone A.mA118 in the 
vicinity of the actin-like gene. Further subclones containing the inserted 
sequence in this gene were derived using an internal PstI site in the original 
parent subclone 118Y1-1, and were designated 118P2 and 118P3 (section 3.2.1). 
In order to further investigate the nature of the inserted sequence, the
nucleotide sequence of the regions containing the inserted sequence in
subclones 118P2 and 118P3 was determined.
The inserted sequence in clone 7,mA118 was sequenced as follows.
Sequencing from the PstI, EcoRI, BamHI, and AccI sites (Figure 3.7 ; sequences
number 5 to 10, and 24 to 29) allowed the determination of a total of 600
nucleotides of the inserted sequence. In order to identify further restriction 
sites for sequencing, a 0.6 kb Bglll-PstI fragment was isolated from subclone
118P3 (see section 2.7.3), and subjected to extensive restriction analysis. The 
eventual identification of the restriction sites Drall and Hinfl enabled further
sequencing from these sites (sequences number 3, 4, and 30), and allowed the
completion of the determination of this inserted sequence.
1 0 0
The complete nucleotide sequence of the inserted sequence in clone
A,mAl 18 is shown in Figure 4.1. The start of the inserted sequence begins at 
nucleotide number 443 and ends at nucleotide number 1307, with a total length 
of 865 nucleotides.
The inserted sequence starts after the second base of the codon for L eu l40  
of the y-actin-like gene of X mAl 18. The actin-like gene appears to resume at 
the third nucleotide of the codon for Ala^38- this particular nucleotide, plus 
those o f  V ail  39 and the first two of L e u l40 being repetitions of nucleotides
preceding  the start of the inserted sequence. The inserted sequence is
therefore flanked by a short direct repeat of 6 base pairs of actin sequence, 
indicating that it was inserted at a staggered break. The inserted sequence in 
clone A.mAl 18 was therefore designated IE 118 (inserted element 118).
4 .1 .2  Computer Analysis of IE 118
The nucleotide sequence of IE 118 was subjected to analysis on the VAX 
cluster at EMBL, Heidelberg, and compared with sequences in the GenBank and 
EM BL nucleotide sequence databases using the programs, WORDSEARCH 
together with SEGMENTS (see section 2.17.3), of the UWGCG sequence analysis 
software package (Devereux et a l ,  1984).
The searches of the GenBank (release 40, consisting a total of 6379
sequences) and EMBL (release 9, consisting a total of 6396 sequences) nucleotide 
sequence data banks revealed no sequence with extensive homology to IE 118. 
An example of one of the 20 best matches is shown in Figure 4.2. The alignment 
with the sequence ecotgyl (E .c o l i  Tyr-tRNA-1 sequence from GenBank) has a 
low 'quality' (17.2) and the ratio (0.273) is not outstanding. This is not 
surprising in view of its bacterial nature. The highest quality recorded was 
from the sequence alignment with ptglbl.mbl, which gave a value of 72.3, but 
had an extremely poor ratio of 0.096 (this was a chimpanzee beta-globin 
sequence from EMBL). Other sequences contributing to the best diagonals 
included sequence humhbb (human beta-globin sequence from GenBank), with 
quality of 49.0 and ratio of 0.090 ; sequence yscg3pdc. (yeast glyceraldehyde-3- 
phosphate dehydrogenase sequence from GenBank), with quality of 41.0 and 
ratio of 0.090 ; and sequence musafp (mouse alpha-foetoprotein sequence from 
GenBank), with quality of 38.7 and ratio of 0.050. The relatively poor quality 
and ratio values for these matches together with visual inspection suggested 
that in no case did one of the 20 best matches represent biologically significant
1 0 1
El£Ur£ 4J_ Nucleotide sequence of TF. 11S
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aV alL e D r a l l
.....................................GGTGCTTGGTCACGGACTGGGGCTCTGTGGGCCCTCTTCGGTCT 480
................................................. b cACGAIACCAGTGCCTGACCCCGAGACACCCGGGAGAAGCCAGA
H in fI  H in fI
481 GCGGAATCAGAGTCTCAGACAGATGGGCATAGAGTGGGCGAGTGACAAACAGACGTGACA 540  
CGCCTTAGTCTCAGAGTCTGTCTACCCGTATCTCACCCGCTCACTGTTTGTCTGCACTGT 
H in f l
541 AG AG AAC G T G T T G AAT CTGAGTGT AAT T T AT C AAAT C C AGC AT C AAAC T T T T TAT AC AG A 600
TCTCTTGCACAACTTAGACTCACATTAAATAGTTTAGGTCGTAGTTTGAAAAATATGTCT
601 ATAACAAGAAACCAGGCGAACACATCCGCTAAGTTACAGTGACACAAAACAAAAGGAATG 660
TATTGTTCTTTGGTCCGCTTGTGTAGGCGATTCAATGTCACTGTGTTTTGTTTTCCTTAC
661 CATACATCAAAAGATGGCGGGGACCAAGCTCATTACCACTAGAAGGAACAGGTGTAATGC 720
GTATGTAGTTTTCTACCGCCCCTGGTTCGAGTAATGGTGATCTTCCTTGTCCACATTACG
721 TAGTCTATTGTTAAACCCACCACCAAGGGGTTCTTAGTAAATGCCTGATTATGCTGTTCC 780
ATCAGATAACAATTTGGGTGGTGGTTCCCCAAGAATCATTTACGGACTAATACGACAAGG
H in f l
781 TTTGGGCCTAGTGAAGAAACCTGTCCAAGGGGGATTCCCTAACTCTTTCATGGTTACCCC 8 40
AAACCCGGATCACTTCTTTGGACAGGTTCCCCCTAAGGGATTGAGAAAGTACCAATGGGG
P s t I
841 ACCTATTTGCTAGGCCATTGTGTCCTAAGGCTACTGTCCTAAATAATCACTCTGCAGACT 900
TGGATAAACGATCCGGTAACACAGGATTCCGATGACAGGATTTATTAGTGAGACGTCTGA
901 AGCCCTGAGCTATTCTAGCTCCGTTCGGAGCACTGGGTGCTCCTCAGGGGCCACACACAC 9 60
TCGGGACTCGATAAGATCGAGGCAAGCCTCGTGACCCACGAGGAGTCCCCGGTGTGTGTG
EcqRI
961 GCTTCTCTACTAGAAGTAAATTTGAATGTTACTGAATAGGTAACCTTCTCACTGAATTCC 1020  
CGAAGAGATGATCTTCATTTAAACTTACAATGACTTATCCATTGGAAGAGTGACTTAAGG
Taql
1021 CACTAAATTCCAAGCTCCTCGGCGTCGAGGATTTTCTAGGACATTGCAACACTGGCGAAG 10 80 
GTGATTTAAGGTTCGAGGAGCCGCAGCTCCTAAAAGATCCTGTAACGTTGTGACCGCTTC
1081 GCTTAGCTATGTCAAGCAATCAAATCTTAAAGGCACTTATAATAAAACAATACTGAAAGA 108 0 
CGAATCGATACAGTTCGTTAGTTTAGAATTTCCGTGAATATTATTTTGTTATGACTTTCT
RamHI Afi.Cl _
1141 GAGCACGTGGATCCATACACCAAACTAACACGGGAAAAGGGTTTGAGTATACGGGCTATG 1200 
CTCGTGCACCTAGGTATGTGGTTTGATTGTGCCCTTTTCCCAAACTCATATGCCCGATAC
12 01 GGAATGCCAAGGTTCCAGGAGGCATAGTTTCCTTGAAACTCATTGCCTCGTGAGTGTTTC 12 60 
CCTTACGGTTCCAAGGTCCTCCGTATCAAAGGAACTTTGAGTAACGGAGCACTCACAAAG
12 61 caggcctcttggccagtcaagcagacttcaccggagtgggcgtaggaggtgcT
GTCCGGAGAACCGGTCAGTTCGTCTGAAGTGGCCTCACCCGCATCCTlCCACG.A
1313
aValLeu
The nucleotide sequence of both strands of the inserted sequence in 
genomic clone XmA118 is shown. Restriction sites used in sequencing are 
indicated, as are the amino-acid equivalents of the flanking nucleotides of the 
actin processed pseudogene. The boxed sequences are direct repeats flanking 
the inserted sequence. The numbering of the sequence is as in Figure 3.8.
1 0 2
f ig u r e  4.2. E x a n m le _ o f  o u tp u t  o f  w o  r  r s f . a n  r  h  /s  e g  m f .n t s  on tF . t i «
SEGMENTS from  : IN S118.SE C  8-JU L -8 6 2 2 :4 3
WORDSEARCH o f  : d i s k $ u s e r s  : [ l e h r a c h . d a v i d ] i n s l l 8 . r f t ;1  ch eck : 5608
fro m : 1 t o :8 65
ASSEMBLE 1 4 -J U N -8 5  1 2 :3 0
Sym bols: 1 t o  : 865 from : m a l l 8 . r f t  ck : 3 2 5 5 . 811 t o :  1675
TO: SEARCHDATA: GENBANK. S ST F i l e s : l  S eq u en ces : 637 9 T o t a l - l e n g t h : 5516947  
W o r d -s iz e  : 7 Words : 1 3 3 3 4 0 9  D ia g o n a l s :1135702  T o ta l-d ia g o n a ls :2 2 0 5 6 8 0 6  
I n t e g r a l - w i d t h : 3 A lp h a b e t:  4 L i s t - s i z e :  20 8-JU L-8 6 2 2 :4 3
AvMatch: 1 .0 0  A vM isM atch: - 0 .6 0  G apW eight: 3 .5 0  L en gth W eigh t: 0 .1 0
i n s l l 8 . r f t  c h e c k :  5608 from : 222 t o :  865
g e n b a n k .s s t  e n t r y :  318 c h e c k : 318 from : 1 t o :  1949  
ENTRY: 318 SEARCHSET o f  : e c o t g y l . c h e c k : 318 from : 1 t o : 1949  
d i s k $ u s e r s :  [p u b d a ta  . g en b an k _40  . u w g cg . ] [ b a c t e r ia l ]  e c o t g y l .
Gaps: 1 Q u a l i t y :  1 7 .2  R a t io :  0 .2 7 3  Words: 9 W idth: 3 L im its :  + / - 4
224  ATCAAAAGATGGCGGGGACCA. AGCTCATTACCACTAGAAGGAACAGGTG 272
I I I I I I I I I I I I I I I I II  I I  I I I I I I I I I I I
2 a t c a a a a g a t g g c g g a t g c c a t t g a t g c t t a t c a a c c t g a c t a c g t g g t g  51
273 TAATGCTAGTCTAT 28 6
I I I I I I
52 c t g g c g a a g t a t a t  65
The exam ple shown is part of the output of comparison program, 
WORDSEARCH/SEGMENTS (see section 2.17.3), to compare the sequence of IE 118 
(filename: in s l l8 . r f t )  to the GenBank (release 40) nucleotide sequence database 
(filename: GENBANK.SST). The GenBank contains a total number of 6379 
sequences, totalling 5516947 nucleotides in length. The word-size chosen is 7, 
in a total number of 1333409 words. There are 1135702 diagonals which
represent segments of similarity, in a total number of 22056806 diagonals. Each
match scores a value of 1.00, while each mismatch scores -0.60. The gap weight 
is 3.50, and the length weight is 0.10. The output is for one of the 20 best 
diagonals, that of IE 118 compared with the sequence ecotgyl (this represented
an E.coli Tyr-tRNA-1 sequence from GenBank), a quality of 17.2 and a ratio of 
0.273 was scored. This is derived from the definitions given in Section 2.17.3 as 
follows :
Quality = 37 - (0.60 x 27) - (3.50 x 1) - (0.10 x 1) = 17.2
Ratio = 17.2/64 = 0.273
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homology. Nor did the identity of any of the sequences give grounds for
th ink ing  o therw ise .
4 . 1 .3  Genomic Southern Blotting of IE 118
In order to investigate the occurrence of sequences related to IE 118 in 
the mouse genome, Southern blotting of digests of mouse genomic DNA was 
p e r f o r m e d .
Mouse liver DNA from the inbred strain Balb/C was isolated (see section
2.15.1), digested with the restric tion enzymes EcoRI, H indlll ,  and BamHI,
subjected to gel electrophoresis in 1% agarose, and transferred to nitrocellulose
filters (see section 2.9.1). Two 32p_iabelled DNA probes from different parts of 
IE 118 (Figure 3.7) were prepared. These were from a 0.43 kb Drall-PstI 
f ragm en t  (des igna ted  118a), and a 0.25 kb Pstl-BamHI (designated 118b) 
respectively (see section 2.9.2), and hybridised to the restricted genomic DNA 
attached to the filter (see section 2.9.3).
Figure 4.3 shows the genomic Southern blots of mouse DNA against the 
two probes from IE 118. It can be seen that a large number of hybridising 
bands were obtained, indicating that IE 118 is repeated in the mouse genome. 
Both probes 118a and 118b gave a similar hybridisation pattern with the 
digested genomic DNA, indicating that they occur together in these multiple
sequences.
4 .1 .4  Estimation of Copy Number of IE 118 by Plaque 
H y b r id i s a t io n
In order to obtain an estimate of the copy number of IE 118 in the mouse
genome, a bacteriophage lambda mouse genomic library was screened with the
IE 118 probes.
A DBA/2J mouse genomic lambda library (kindly provided by Dr A. M.
Frishauf) was used to infect the bacterial host E . c o l i  Y1090, producing 
approx im ate ly  1,000 p laques per plate, and these were transferred  to 
nitrocellulose filters (see section 2.16.1). Two 3 2 p - ]abelled probes, 118a and
1 1 8 b ,  were prepared from IE 118 as in section 4.1.3, and hybridised to the 
plaques attached to the filters (see section 2.16.2).
Figure 4.4 shows the plaques of the mouse genomic lambda library which 
hybridised to one or both probes from IE 118. It can be seen that 118b
1 0 4
Figure  iJL  <jcnom ie  S o u th e rn  blot of mouse DNA hybridised to
p robes  from  IE 118
DO □ L m Z D
CO o
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Mouse liver DNA (Balb/C strain) was digested with restriction enzymes 
EcoRI, Hindi II, and BamHI as indicated, subjected to electrophoresis, 
transferred to nitrocellulose filters, and hybridised to P labelled
of (a) Drall-PstI, designated 118a, and (b) Pstl-BamHI, designated 118b
1 1 8 .
1 0 5
i 1 \ b r i d i s a t i o n  o f  probes from IK 1 IS to 
r e c o m b i n a n t  lambda inuuse genomic
- D  la o n e s  o f  n 
l ibrary
A DBA/2J mouse genomic library in bacteriophage lam ^  ^
with 3 2 P-label led  fragm ents of (a) Drall-PstI,  designate ^
Pstl-BamHI, designated 118b, from IE 118. Autoradiograp y o 
(number 3) hybridised with the two probes are presented (see
1 0 6
hybridised to the majority of plaques to which 118a hybridised, although there 
were significantly more plaques to which only 118b hybridised than those to 
which only 118a hybridised. The possible implications of this result are
discussed in section 5.2.3ii. The frequencies of positive plaque hybridisation of 
the two probes 118a and 118b to the lambda library is shown in Table 4.1. 
Probes 118a and 118b hybridised with a total of 42 and 78 plaques, respectively, 
out of a total number of 8056 plaques.
The copy number of IE 118 sequences in the mouse genome is calculated
as follows :
Let n = sum of the hybridising plaques, and t = total number of 
plaques (= 8056). Then there are n copies of IE in t recombinant plaques 
containing mouse genomic DNA. The average size of the X insert in the
mouse genomic library is assumed to be 15kb (+ 5kb), so there are n copies
of IE in t X 15kb of the mouse genome. Assuming the size of the mouse 
haploid genome to be approximately 3 X lO^kb, 
then there are :
n X 3 X ,10,6,, kb. copies of IE per mouse genome
t X 15 kb
or :
Genomic Copy No. of IE = sum of positive plaques X size of mouse genome.
total number of plaques average size of X in se r t
Hence :
Copy number of IE 118a per mouse haploid genome = 42 . X 3 X 1Q6 = 1040
8056 15
Copy number of IE 118b per mouse haploid genome = _78_ X 3 X I Q6 = 1940
8056 15
4.2 Analysis of the Inserted Sequence in Clone A,mA119
4 .2 .1  Nucleotide Sequence of the Inserted Sequence in
Clone ?tmA119
Figure 3.6 shows a detailed partial restriction map of clone XmA119 
vicinity of the actin-like gene containing the inserted sequence. Subclones
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Table 40. Frequency of planne hybridisat ion with nm hes  fm m  
d ifferen t  inser ted  elements
Plate number Plaques/plate Plaques hybridising to IE probes
IE 118a IE 118b IE 119c IE 36d
I 1275 5 9 12 13
II 1446 11 11 10 11
II I 1357 9 16 22 11
IV 1331 6 14 17 12
V 1330 6 12 17 14
VI 1317 5 16 14 14
Total 8056 42 78 92 75
The number of the positive plaques hybridised to the probes IE118a, 
IE 1 18b, IE119c, and IE36d per plate of the bacteriophage lambda mouse genomic 
library (DBA/2J) is presented.
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containing the inserted sequence were derived from its internal EcoRI and SstI 
sites, and were designated 119XR and 119RX, and 119SS, respectively (see section 
3.2.2). In order to further investigate the nature of the inserted sequence, the 
nucleotide sequence  o f  the regions containing the inserted sequence in 
subclones 119XR, 119RX, and 119SS were determined.
Sequencing o f  the inserted sequence in clone XmA119 was as follows. 
Sequencing from the EcoRI and SstI sites (Figure 3.9; sequences number 6 to 8, 
13, and 14) allowed determination of a total of 450 nucleotides of the inserted 
sequence. In order to identify further restriction sites suitable for sequencing, 
a 0.9kb Bglll-SstI fragment was isolated from subclone 119BX (see section 2.7.3), 
and subjected to extensive restriction analysis. The eventual identification of 
the restriction sites XhoII and Styl enabled further sequencing from these sites 
(sequences number 3 to 5, and 16 to 18), and allowed the completion of the 
determination of this inserted sequence.
The com plete  nucleotide sequence of the inserted sequence in clone 
tanA119 is presented in Figure 4.5 .  The inserted sequence begins at nucleotide 
number 806 and ends at nucleotide number 1306, with a total length of 501 base 
pairs. The inserted sequence begins following the nucleotides encoding Phe265  
of the y-actin-like gene of ^mA119. The actin-like gene appears to resume at 
the third nucleotide of Ser^64 ; this particular nucleotide, and those of Phe265  
being repetitions of nucleotides preceding the start of the inserted sequence. 
The inserted sequence is therefore flanked by a short direct repeat of 4 base
pairs of actin sequence, indicating that it was inserted at a staggered break. 
The inserted sequence of XmA119 was therefore designated IE 119 (inserted
element 119).
4.2 .2  Computer Analysis of IE 119
The sequence of IE 119 was subjected to analysis on the VAX cluster at
EMBL, Heidelberg, and compared with sequences in the GenBank and EMBL 
nucleotide sequence databases using the programs, WORDSEARCH together with 
SEGMENTS (section 2.17.3 and section 4.1.2) of the UWGCG sequence software
package (Devereux et al., 1984).
Computer searching of the nucleotide sequence databases revealed that IE 
119 was homologous to a sequence MS57 (Propst and Vande Woude, 1984), whic 
had been observed to have features similar to retroviral long terminal repeats.
Detailed comparisons will be made in the Discussion.
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F ig u r e  1*5. Nucleotide s e q u e n c e  o f  I E  n o
802
rPhe
CTTC TGAAAGAAAGTGAAATTTCAAGACCTGTAAGTCAT 840
gaag|actt t c tt t c a c tt t a a a g t t c tg g a c a tt c a g t a
841 ATAAAGTACTCAGAAATTGCTGGCTGTTTGTGAGCCTAGAGGCGCCTGGGGCGAGAAAAG 900
TATTTCATGAGTCTTTAACGACCGACAAACACTCGGATCTCCGCGGACCCCGCTCTTTTC
901 AGAAAAACAAACCTGGGTATGCCTCGTAGTTAAAACATTCCTGGGAACATCTTGACCATA 960
TCTTTTTGTTTGGACCCATACGGAGCATCAATTTTGTAAGGACCCTTGTAGAACTGGTAT
H in f l
961 AGATAAAGGGGACTGTGAAGACATAGCAGGGCTATCTGAACTGAGTCAACAACTCACAGA 1020
TCTATTTCCCCTGACACTTCTGTATCGTCCCGATAGACTTGACTCAGTTGTTGAGTGTCT
1021 ACTCTGACACCCTGCACGTACATGTAATTTTTCTGTTAATGTTTGAATAAGCCAATAGTG 1080
TGAGACTGTGGGACGTGCATGTACATTAAAAAGACAATTACAAACTTATTCGGTTATCAC 
EcoR I Ta
1081 TGTCGCTATGCTGAATTCCACACCCCTAAGCCCCTTACCCCATAAAACCCCCTAACTTTC 1140
ACAGCGATACGACTTAAGGTGTGGGGATTCGGGGAATGGGGTATTTTGGGGGATTGAAAG
a l  S s t I
1141 GAGCCTCGTGGCCGGCCATCCGTTATCTCCTGTGTGGGATACATGTCGGTCTGGAGCTCC 1200
CTCGGAGCACCGGCCGGTAGGCAATAGAGGACACACCCTATGTACAGCCAGACCTCGAGG
D r a l l
1201 GTAATTAAACGTCCTCATGTAATTACAGCAAGATGGGTCCTCGTGTTTCTTTGGGTGCTC 12 60
CATTAATTTGCAGGAGTACATTAATGTCGTTCTACCCAGGAGCACAAAGAAACCCACGAG
D r a l l
12 61 TCACACTCCTGAGACTAGAGTGGGGGTCCCCAAAAGGGGTCTTACApTTCj.......................  1310
AGTGTGAGGACTCTGATCTCACCCCCAGGGGTTTTCCCCAGAATGTbAAQj.......................
rPhe
I § € l f S
The nucleotide sequence of both strands of the inserted sequence in 
genomic clone A,mA119 is shown. Restriction sites used in sequencing are 
indicated, as are the amino-acid equivalents of the flanking nucleotides of the 
actin processed pseudogene. The boxed sequences are direct repeats flanking 
the inserted sequence. The numbering of the sequence is as in Figure 3.10.
1 1 0
4 . 2 . 3  Genomic Southern Blotting of IE 119
In order to investigate the occurrence of sequences related to IE 119 in 
the mouse genome, Southern blotting of digests of mouse genomic DNA was 
p e r f o r m e d .
Mouse liver DNA from the inbred strain Balb/C was isolated (see section
2.15.1), digested with restriction enzymes EcoRI, Hindlll, and BamHI, subjected 
to gel electrophoresis in 1% agarose, and transferred to nitrocellulose filters 
(see section 2.9.1). A 32p_iabelled DNA probe from IE 119 (Figure 3.9) was 
prepared from a 0.48 kb Styl-SstI fragment (designated 119c), which contained 
80 nucleotides of the actin-like sequence, as computer analysis (program 
CUTSIT, section 2.17.2) showed that there were no suitable restriction sites to 
allow a fragment of reasonable size to be isolated uniquely from IE 119. The 
labelled probe was hybridised to the restricted genomic DNA attached to the 
filter (see section 2.9.3).
Figure 4.6 shows the genomic Southern blots of mouse DNA hybridised to 
the probe from IE 119. It can be seen that a large number of hybridising bands 
were obtained. This was far more than the 10 to 20 copies seen with actin 
probes (Minty et al., 1983). Thus it is clear that IE 119 is repeated in the mouse 
genome.
4 .2 .4  Estimation of Copy Number of IE 119 by Plaque 
H y b r id i s a t io n
In order to obtain an estimate of the copy number of IE 119 in the mouse 
genome, a bacteriophage lambda mouse genomic library (DBA/2J) was screened 
(as in section 4.1.4) with the IE 119 probe. A 32p_iabelled probe 119c was 
prepared from IE 119 as in section 4.2.3, and hybridised to the plaques attached
to the filters (see section 2.16.2).
Figure 4.7 shows the plaques of the mouse genomic lambda library which 
hybridised to the probe from IE 119. The frequencies of the positive plaque 
hybridisation between the probe 119c and the lambda library is shown in Table 
4.1. Probe 119c hybridised with a total of 92 plaques, out of a total number of 
8056 plaques. The copy number of IE 119 sequences in the mouse genome is 
calculated by the equation given in section 4.1.4.
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A D B A / 2 J  m o u s e  g e n o m i c  l ib ra ry  in b a c te r io p h a g e  la m b d a  was  sc r eened  
with a 3 2 P - l a b e l l e d  S t y l - S s t I  f r a g m e n t ,  d e s ig n a te d  119c ,  f rom IE 119. T w o  such 
p l a t e s  I a nd  III ,  c o n t a i n i n g  p o s i t i v e  h y b r i d i s a t i o n  p l a q u e s  a re  p r e s e n t e d  (see
T ab le  4.1) .
1 1 3
Thus
Copy number of IE 119 per mouse haploid genome = 92 X 3 X 106 = 2280
8506 15
4 .3  Analysis of the Inserted Sequence in Clone X m A 3 6
4 . 3 . 1  Subcloning and Sequencing of the Inserted
Sequence in Clone >,mA36
Figure 4.8 shows the partial restriction map of XmA36 in the vicinity of 
the actin coding region and the interrupting sequence. An original subclone, 
constructed from a 2.4 kb Kpnl fragment, and designated 36KK was obtained 
from  Miss C.E. Begg of this department. Two further subclones from the 
original parent subclone 36KK, were derived from an internal SstI site, each
containing part of the interrupting sequence. The subclones were constructed 
using a 1.4 kb KpnI-SstI fragment and a 1.0 kb Sstl-Kpnl fragment, and were
designated 36KS and 36SK respectively (Figure 4.8).
The sequencing strategy is summarised in Figure 4.9, from which it can 
be seen that the region was finally found to contain four SstI sites, rather than 
the one o r ig ina lly  assumed. This together with o ther factors , caused 
considerable difficulty in determining the sequence. Sequences number 1 to 5 
was carried out in the subclone 36SK without any problems. Sequencing from 
polylinker sites adjacent to the flanking SstI site and from the internal EcoRI
site in the subclone 36KS was more difficult because there was no known 
secondary restriction site in between these (see section 2.11.3). This problem 
was dealt with by isolating the 0.8 kb EcoRI-SstI fragment from the subclone
36KS (see section 2.7.3), and performing detailed restriction analysis on it. The 
restriction enzyme Fnu4HI was found to cleave the 0.8 kb fragment into two, 
producing 0.15 kb and 0.65 kb fragments. However when sequence number 6 
was performed from the SstI (polylinker EcoRI) site on the subclone 36KS, a 
further two SstI sites were identified 40 base pairs apart. Thus, together with 
the previously identified SstI site, a total of three SstI sites were observed. A 
sim ilar sequence (number 7) was carried out on the opposite strand and 
confirmed this finding.
At this point it was felt necessary to check the relationship between the
1 1 4
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A partial restriction map of a portion o f  genomic clone A.mA36 is 
presented with reference to its derived subclones. The solid blocks represent 
the presumed positions of actin coding regions, the open blocks represent the 
presumed position of 3' non-coding regions, and the vertical lines indicate the 
approximate positions of the restriction sites. The derived subclones 36KK, 
36KS, and 36SK are indicated.
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The strategy for determ ining the nucleotide sequence in the region 
from the Fnu4HI site at the 5' of the interrupted DNA to the 3' Bglll site in the 
actin pseudocoding area of clone A.mA36 is shown. Sequencing of the coding 
and non-coding strands are indicated by arrows below and above the broken 
line, respectively. Fragments are numbered for ease of reference. The arrows 
represent the portion of sequence read from a particular restriction site.
1 1 6
40 base pair 'SstI duplication' in 36KS and the situation in XmA36. Further 
restriction analysis of the original 36KK subclone was therefore performed as
this clone encom passed the whole of the inserted  sequence and flanking
regions. This dem onstra ted  the presence o f  a small SstI f ragm ent of
approximately 40 base pairs. However it was not possible to determine whether
there were multiple copies of the sequence, and if so, how many. If there were 
indeed multiple copies in AmA36 (and in 36KK) the subclone 36KS might not 
have contained all of these. Subsequent work was therefore carried out on the 
original subclone 36KK. This was not at all easy, however, as the insert of 36KK 
was 2.4 kb in length, and there was a lack of suitable infrequent restriction
sites that produced 5' protruding ends for sequencing by the method of Maxam 
and Gilbert, while there were so many common restriction sites within this
region that mapping was not easily accomplished.
A 1.6kb PstI fragment was isolated from the 36KK subclone and extensive 
restric tion  analysis was carried out on this isolated fragment. No useful
restriction sites for sequencing were found, except for the known Fnu4HI site. 
Sequences number 8 and 9 were carried out by initially isolating the 1.6 kb PstI 
fragm ent from  subclone 36KK, res tric ted  with Fnu4HI, labelling  with a
selection of a32p_dN TPs and y32p_ATP at the 5' protruding end of Fnu4HI, and 
performing the sequencing reaction (see section 2.12). This established that 
there were in fact four internal SstI sites in 36KK, rather than the one 
originally identified by mapping, or the three that were previously found in
3 6K S . The sequence to the left of the Fnu4HI site, covering the region towards 
the 5' end of the inserted sequence, could not be obtained by the above method, 
though a selection of radioactive labels were used. The reason for this was
never d iscovered.
A further attempt to obtain the sequence of the region between the 
Fnu4HI site and the start of the inserted sequence was made by constructing 
smaller subclones derived from 36KS but with fewer SstI sites. Thus it was
hoped that a single sequencing gel would allow reading along a shorter 
distance than in 36KS to the start of the inserted sequence. The smaller 
subclones were constructed by completely digesting 36KS with SstI, separating 
the bulk  of the clone from the 40 base pair SstI fragm ents by gel
electrophoresis , and religating the remainder of the subclone. The smaller 
subclones were made successfully, but detailed restriction analysis on the 0.7 
kb EcoRI-SstI insert did not detect suitable restriction sites for secondary 
cleavage in the sequencing reaction.
1 1 7
Because of this a totally different strategy was employed, that o f  the
Sanger Chain Termination method (see sections 2.13 and 2.14). A 0.7 kb EcoRI
fragment of 36KS (one of the EcoRI sites was provided by the vector pUC18) was 
ligated into the EcoRI sites of the vectors M 13m pl8 and M 13m pl9 (Figure 2.5), 
transformed into E.coli JM109 'competent' cells, single-stranded templates were 
prepared, and the sequence determined (sequence number 10; Figure 4.9). A 
total o f  250 bases pairs were determined from sequence number 10 which
enabled the complete covering of the inserted sequence in X.mA36.
The complete nucleotide sequence of the inserted sequence in clone
tanA36 is shown in Figure 4.10. The start of the inserted sequence is numbered 
1, and the end numbered 500, with a total length of 500 base pairs.
The inserted sequence starts after the nucleotides encoding Ile71 of the y- 
actin-like gene of ^mA36. The actin-like gene appears to resume at nucleotides 
encoding Pro70 ; these three nucleotides, and those of Ile71 being repetitions of 
nucleotides preceding the start of the inserted sequence. The inserted sequence 
is therefore flanked by a short direct repeat of 6 base pairs of actin sequence, 
indicating that it was inserted into a staggered break. The inserted sequence of 
A.mA36 was therefore designated IE 36 (inserted element 36).
4 . 3 . 2  Computer Analysis of IE 36
The sequence of IE 36 was subjected to analysis on the VAX cluster at 
EMBL, Heidelberg, and compared with sequences in the GenBank and EMBL 
nucleotide sequence databases using the programs, WORDSEARCH together with 
SEGMENTS (see sections 2.17.3 and 4.1.2) of the UWGCG sequence software 
package (Devereux et al., 1984).
Computer searching of the nucleotide sequence databases revealed that IE 
36 was rela ted  to the long terminal repeat of the retroviral- like  mouse 
intracisternal A-particles. Detailed comparisons will be made in the Discussion.
4 . 3 . 3  Genomic Southern Blotting of IE 36
In order to investigate the occurrence of sequences related to IE 36 in the 
mouse genome, Southern blotting  of digests of mouse genomic DNA was 
p e r f o r m e d .
Mouse liver DNA from the inbred strain Balb/C was isolated (see section
2.15.1), digested with restriction enzymes EcoRI, Hindlll, and BamHI, subjected
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Eisnr.e— ULU Nucleotide sequence of IE 36
®@ 7® 71
A la G ln S e r L y sA r g G ly lle L e u T h r L e u L y sT y r P r o I le
iTCTACACGCGTCACGACC 18
AGATGTGCGCAGTGCTGG
GCCCAGAGCAAGAGGGGTATCCTGACCCTGAAGTACjCCTATC" 
CGGGTCTCGTTCTCCCCATAGGACTGGGACTTCATqRflATAfiP
H in f l  Fnu4HI
19 GGCCAGAAGAACACAGCAAACGAGAATCTTCTGCGGCAAAACTTTATAGCTTACATCTTC 78
CCGGTCTTCTTGTGTCGTTTGCTCTTAGAAGACGCCGTTTTGAAATATCGAATGTAGAAG
S s t I
7 9 AGGAGCAAGAGTGCAAGAGAGCAAGAGCTCTATTGCTTACATCTTTAGGAGCCAGAGCGC 138
TCCTCGTTCTCACGTTCTCTCGTTCTCGAGATAACGAATGTAGAAATCCTCGGTCTCGCG 
S s t I  S s t I
139 AAGAGAGCAAGAGC TCTATTGCTT ACAT C T T TAGGAGCAAGAGAGCAAGAGAGCAAGAGC 198
TTCTCTCGTTCTCGAGATAACGAATGTAGAAATCCTCGTTCTCTCGTTCTCTCGTTCTCG 
  S s t I
199 TCTATTGCTTACATCTTTAGGAGCCAGAGCGCAAGAGAGCAAGAGCTCTATTGCCTACAT 258
AGATAACGAATGTAGAAATCCTCGGTCTCGCGTTCTCTCGTTCTCGAGATAACGGATGTA
259  CTTTAGGAGCAAGAGAGAGATAGTGGCGTAACACCGTCCCCTTTAAGGAGAATTATTCTC 318
GAAATCCTCGTTCTCTCTCTATCACCGCATTGTGGCAGGGGAAATTCCTCTTAATAAGAG 
S t y l  P s t I
319 GGCCTAGGACGTGTCACTCCCTGATTGGCTGCAGCCCATCGGCCGAGTTGTCGTCACGGG 37 8
CCGGATCCTGCACAGTGAGGGACTAACCGACGTCGGGTAGCCGGCTCAACAGCAGTGCCC
S t y l
37 9 GAAGGCAGAGCACAGGGAGTGAAGAACTACCCTTGGCACATGCGCAGATTATTTGTTTAC 438
CTTCCGTCTCGTGTCCCTCACTTCTTGATGGGAACCGTGTACGCGTCTAATAAACAAATG
Fnu4HI
439 CAATTAGAACACAGGATGTCAGCACCATCTTGCAACGGTGAATGTGAGGGCGGCTTCCCA 498
GTTAATCTTGTGTCCTACAGTCGTGGTAGAACGTTGCCACTTACACTCCCGCCGAAGGGT
.Teqi
AACACGGCAT T G T C AC T AAC T GGG ACG AC AT G................................................
TTGTGCCGTAACAGTGATTGACCCTGCTGTAC................................................
4 99 CACCTATC 
GTIGGATAG
P r o I le G lu H isG ly lle V a lT h r A sn T r p A sp A sp M e t
The nucleotide sequence of both strands of the inserted sequence in 
genomic clone XmA36 is shown. Restriction sites used in sequencing are 
indicated, as are the amino-acid equivalents of the flanking nucleotides of the 
actin processed pseudogene. The boxed sequences are direct repeats flanking 
the inserted sequence.
to gel electrophoresis in 1% agarose, and transferred to nitrocellulose filters
(see section 2.9.1). A 3 2 p _ iabelled DNA probe from IE 36 (Figure 4.9) was
prepared from a 0.31 kb Hinfl-PstI fragment (designated 36d), and hybridised
to the restricted genomic DNA attached to the filter (see section 2.9.3).
Figure 4.11 shows the genomic Southern blots of mouse DNA hybridised to 
the probe from IE 36. It can be seen that a large number of hybridising bands 
were obtained, indicating that IE 36 is repeated in the mouse genome.
4 . 3 . 4  Estimation of Copy Number of IE 36 by Plaque 
H y b r id i s a t i o n
In order to obtain an estimate of the copy number of IE 36 in the mouse
genome, a bacteriophage lambda mouse genomic library (DBA/2J) was screened
(as in section 4.1.4) with the IE 36 probe. A 3 2p_ iabelled  probe 36d was 
prepared from IE 36 as in section 4.3.3, and hybridised to the plaques attached to 
the filters (see section 2.16.2).
Figure 4.12 shows the plaques of the mouse genomic lambda library 
which hybridised to the probe from IE 36. The frequencies of the positive 
plaque hybridisation between the probe 36d and the lambda library is shown in 
Table 4.1. Probe 36d hybridised with a total of 75 plaques, out of a total number
of 8056 plaques. The copy number of IE 36 sequences in the mouse genome is
calculated by the equation given in section 4.1.4.
Thus :
Copy number of IE 36 per mouse haploid genome = 75 X 3 X lp6 = 1860
8506 15
1 2 0
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Mouse liver DNA (Balb/C strain) was digested with restriction enzymes 
EcoRI, H in d l l l ,  and BamHI as indicated , subjec ted  to e lec trophoresis ,  
transferred to nitrocellulose filters, and hybridised to a 3 2 P-labelled  H infl-Pstl 
fragment, designated 36d, from IE 36.
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A D B A / 2 J  m o u s e  g e n o m ic  l ib ra ry  in b a c te r io p h a g e  la m b d a  was  sc reened  
3 2 P - l a b e l l e d  H in f l - P s t l  f r a g m e n t ,  d e s ig n a te d  3 6 d ,  f rom IE 36. T w o  such 
I and  VI.  c o n t a i n i n g  p o s i t iv e  h y b r id i s a t i o n  p l a q u e s  are p r e s e n t e d  ( see
4.1) .
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GENERAL DISCUSSION
5 .1  Actin-like Pseudogenes in XmA118 and X m A 1 1 9
The actin-like sequences of clones ^ m A 118  and ^ m A 1 1 9  have been 
determined, and both of these resemble that of the cytoplasmic y-actin isoform. 
However, the actin-like DNA sequences in clones ?imA118 and A.mA119 were 
observed to possess many mutational changes that clearly indicate them to be 
functionless, and establish them to be pseudogenes. Furthermore, the actin- 
like sequences in A,mA118, and ?tmA119 were shown to be uninterrupted by 
introns (see sections 3.4.1 and 3.4.2). The lack of any introns, including those 
that have been conserved in mammalian actins, and others which are specific
for different isoforms (Carroll et al., 1986; Chang et al., 1984; Hamada et al., 
1982; Ng et al., 1985; Bergsma et al., 1985; Foran et al., 1985), is consistent with 
the pseudogenes in A,mA118 and A,mA119 being of the processed type.
5 . 1 . 1  Possible Origins of Actin-like Genes in 2 ,m A 1 1 8  and 
Xm A l  19
P rocessed  pseudogenes are thought to be genera ted  from  reverse 
transcripts of the mRNA, as they normally contain DNA copies of the whole of 
the mRNA, including the 3' and 5' untranslated regions. Target-site direct 
repeats flanking the pseudogene clearly define its extent. As mentioned in 
section 3.4.1, the actin-like coding amino-acid sequence in clone XmA118 
appears only to extend in the 5' direction to the residue at position 5 (Figure
3.11 and Figure 3.12), and thus lacks the region corresponding to the 5' end of
the mRNA. This divergence from a typical processed pseudogene could have 
been caused by a deletion after the presumed reverse transcript was integrated
into the genome. An alternative explanation is that clone ^m A 118 may have 
originated from either a 5'-truncated mRNA, or from an incomplete or partially 
degraded reverse transcript of a full length mRNA. However, since the
1 2 3
sequence  o f  the 3' un transla ted  region of clone Xm A118 has not been 
determined, thus preventing the identification of its presumed flanking direct 
repeat, it is uncertain which explanation is correct. A human cytoplasmic y- 
actin processed pseudogene has recently been sequenced and shows no sign of 
5' truncation (Leube and Gallwitz, 1986). However, two examples of such 5' 
truncation have been reported : in the mouse y-actin processed pseudogene in 
clone A,mA19 (MyA-\}/l; Leader et al., 1985), where the actin-like coding amino- 
acid sequence extended up to the Ala at position 7 ; and in the processed 
pseudogene derived from mouse cellular tumor antigen p53, where at least 80
nucleotides are missing from a long 5'-untranslated region (Zakut-Houri et al.,
1983). In both these cases the presence of one member of the direct repeat 
immediately adjacent to the truncated 5' end indicates that these pseudogenes 
are derived  from incom plete  or partially  degraded transcripts. However, 
reports  have suggested that the 5 ! truncation  in certa in  other processed 
pseudogenes may be a result of insertion of a transposon into the 5' end of these 
(S h im id a  et al., 1984; Scarpulla, 1984). In the case of XmA118, the 40
nucleotides sequenced preceding the start of the pseudogene do not correspond 
to any sequence in the EMBL or GenBank databases, thus ruling out a possible 5' 
insertion of known mobile mouse sequences such as B1 or LIM d. In other cases, 
the p rocessed  pseudogenes appear to be derived from aberrant transcripts 
generated by faulty splicing or by initiation down-stream from the normal cap 
site. Examples of these are the human immunoglobulin lambda light chain 
(Hollis et al., 1982), and the human im m unoglobulin  epsilon heavy chain
(Battey et al., 1982; Ueda et al., 1982) processed pseudogenes. These processed
pseudogenes are unusual in being derived from mRNA not normally expressed
in the germ line. Their derivation from aberrant transcripts may well be 
related to this fact, and there is no reason to expect that the pseudogene in 
A,mA118 will resemble these.
In the case of clone A,mA119, the actin-like coding amino-acid sequence 
extended at least to the initiating Met codon at position 1 (Figure 3.13). As the 
sequence of the 5' untranslated region of mouse y-actin mRNA has not yet been 
determ ined , it is not possib le  to say how much further the processed 
pseudogene in ?.mA119 extends. The 3’ untranslated region also resembles that
of mouse y-actin (see section 3.4.2 and Figure 3.14), but only extends to 
nucleotide 1750 (ie for 108 out of approximately 700 nucleotides), after which 
the sequence diverges from that of y-actin mRNA. No poly A tail or identifiable 
3' flanking direct repeat to sequences near the 5 end of the pseudogene are
1 2 4
evident. Nor do the 3' sequences bear any relationship to known retroposons.
It therefore seems probable that this 3' divergence o f  the actin-like gene in
clone XmA119 from the y-actin mRNA is the result of a deletion of the 3’ 
untranslated  region after the presum ed reverse transcript was integrated into 
the genome.
5 . 1 .2  Evolution of Actin-like Genes A,mA118 and A,mA119
In order to determine the nature of the processed pseudogenes A,mA118
and A,mA119, and their relatedness to the functional actin gene, a comparison 
betw een their y-actin region and that of the y-actin cDNA was made. The 
nucleotide sequences of the actin-like DNA in clones XmA118 and A,mA119 were 
compared with the partial sequence of a mouse y-actin cDNA containing the
region from amino-acid 8 to 375 (Peter and Leader, unpublished; Figure 5.1 and 
Figure 5.2). The comparison was made by using the computer program BESTFIT 
(see section 2.17.3), where alignments depended on the introduction of gaps for 
maximal homology.
The actin-like coding sequence of ^m A 118  showed a high degree of 
homology of 94.0% to the cDNA (Figure 5.1). There were 67 base changes, of 
which 26 were at silent sites, 35 altered the amino-acid residue, and 6 were base 
deletions. Comparison of the nucleotide sequence in the actin-like coding 
region in ?imA119 showed a homology of 96.1% to the cDNA (Figure 5.2). There 
were 43 base changes, of which 20 were at silent sites, 22 altered the amino-acid 
residue, and 1 was a base insertion. The differences of these processed 
pseudogenes (as well as that of the previously published pseudogene of A.mA19) 
from the cDNA are shown in Figure 5.3.
A numerical estimate o f  the divergence time of pseudogenes can be 
ob ta ined  from  their  percen tage  d ivergences  from  the func t iona l  gene,
assuming that, being inactive since their formation, changes accumulate in 
processed pseudogenes at a constant rate in all positions, free from any 
selection. The percentage divergence can be related to evolutionary time using
the value of 0.7 for the unit evolutionary period (UEP), the time in millions of
years required for the fixation of 1% change between two sequences (Perler et  
al., 1980). However, to estimate the time of divergence of a pseudogene from 
the active y-actin gene, allowance must be made for the fact that effectively 
only 24.4% of the nucleotides in the coding region of this gene can undergo
(neutral) mutation as the amino-acid sequence has been absolutely conserved.
1 2 5
F igure  5*1 A com parison  between ac tin -like  sequences of clone
A,mA118 and the partial sequence o f  mouse Y-actin cDNA
cDNA : 
A,mAl 18 :
19
79
69
113
119
163
169
213
219
263
269
313
319
363
8 10
LeuVa1 I le A sp A sn G ly  
CTCGTCATTGACAATGGC 
II I I I I I I I I II I I I I I 
CTAGTCATTGACAATGGC
S erG ly M etC ysL ysA laG lyP h eA laG lyA sp A sp A laP roA rgA laV a
TCCGGCATGTGCAAAGCCGGCTTTGCTGGTGACGACGCCCCCAGGGCCGT
I I I I I I I I II I I I I I I I I I I I I I I I I I
TCCGGCACG— TCAAT-GACAACGCCCTCAGGGCCAT
Thr A sn Leu Me
lP h e P r o S e r lle V a lG ly A r g P r o A r g H isG ln G ly V a lM e tV a lG ly M
GTTCCCTTCCATCGTAGGGCGCCCCCGACACCAGGGCGTCATGGTGGGCA
I I I II I I I I I I I I I I I I I I I I I I I I I I I I I I I I I III I I I I II I II
GTTCCCTTCCATCATAGGGCGCCCCCGACACCAGGGTGTCTTGGTGGGCA 
t  H e  Leu I
5@ S@
etG ly G ln L y sA sp S erT y rV a lG ly A sp G lu A la G ln S erL y sA rg G ly  
TGGGCCAGAAAGACTCATACG T GGGT GACGAGGCCCAGAGCAAGAGGGGT
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I
TTGGCCAGAAGGACTCCTACGTGGGTGATGAGGCCCAGAGCAAGAGGGGT
l e
78
I le L e u T h r L e u L y sT y r P r o I le G lu H isG ly lle V a lT h r A sn T r p A s
ATCCTGACCCTGAAGTACCCTATCGAACACGGCATTGTCACTAACTGGGA
I I I I I I I I I I I I II I I I I I I I I II II I I I I I I I I I I I I I I I I I I I
ATCCTGGCCCTGAAGTACCCTGTCGAGCATGGCATTGTCACCAACTGGGA 
A la  V a l
§©
p A sp M etG lu L ysIleT rp H isH isT h rP h eT yrA sn G lu L eu A rgV alA
CGACATGGAGAAGATCTGGCACCACACCTTCTACAATGAGCTGCGTGTGG
I | | | | I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I M I M I I M
CGACATGGAGAAGATCTGGCACCACACCTTCTACAATGAGCTGCGTGTGG
laP roG lu G lu H isP ro V a lL eu L eu T h rG lu A la P ro L eu A sn P ro L y s
CTCCTGAGGAGCACCCGGTGCTTCTGACCGAGGCCCCCCTGAACCCCAAA
| | | | II I I I I I I I II I I II I I I I I I I I I I I I I I I I II I I I I II I I I I I
CCCCTGAGGAGCACCCGGTGCTACTGACCGAGGCCCCCCTGAACCCCAAA
AlaAsnArgGluLysMetThrGlnlleMetPheGluThrPheAsnThrPr
GCTAACAGAGAGAAGATGACGCAGATAATGTTTGAAACCTTCAATACCCC
| | | | | | |  I I I I I I I I M I M I I 1 I I > I I I I I I I I I I I I II II I I I I I I I
GCTAACAGAGAGAAGAT GACGCAGAT AAT GT T T GAACCCTTCAAT ACCCC
Pro
18
78
68
112
118
162
168
212
218
262
268
312
318
362
368
412
continued overleaf.
continued. .
369
413
419
1334
469
1384
519
1434
569
1484
619
1527
669
1577
719
1627
769
1677
14®
o A la M e tT y r V a lA la lle G ln A la V a lL e u S e r L e u T y r A la S e r G ly A  
AGCCATGTACGTGGCCATTCAGGCGGTGCTGTCCTTGTATGCATCTGGGC 
I I I I I I I I I I I I I I I I I I I I  I I I I I  I I I I I I I I I I  I I I  I I I I I I 
a g c c t t g t a c g t c a c c a t t c a g g t g g t g c T c t c c t t g t a t g t a t c t g g g c
Leu Thr V a l^ ^  ^ 1313 V a l
IS® ISO
rg T h rT h rG ly lleV a lM etA sp S erG ly A sp G ly V a lT h rH isT h rV a l  
GCACCACTGGCATTGTCATGGACTCTGGTGACGGGGTCACACACACAGTG 
I I I I I I I I I I I I I I I I I II II I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
GCACCACTGGCATTGTCATGGACTCTGGTGACGGGGTCACACACACAGTG
11® 110
P r o I le T y r G lu G ly T y r A la L e u P r o H isA la lle L e u A r g L e u A sp L e  
CCCATCTATGAGGGCTACGCCCTTCCCCACGCCATCTTGCGTCTGGACCT 
I I I  I I I I I I I I I I I I I I I I  I I  I I I I I I I I I I  I I I  H I I I I M  I
GCCATCTATGACAGCTACACCCTTCCTCACGCCATCTTGTGTCTGGACTT 
A la  A spA rg Thr Cys
1§@
u A laG lyA rgA spL euT hrA spT yrL euM etL ysIleL euT hrG luA rgG  
GGCTGGCCGGGACCTGACAGACTACCTCATGAAGATCCTGACTGAACGGG 
II I I I I I I I I I I I I I I I I I I I I I I I I I I I  I I I I I I I I I I I I
GGTTGGCTAGGACCTGACAGAGTACCTCATGAATTCCTTGACTGAACGGG 
V a l End G lu A sn S er
2@@ 2@S 213
ly T y r S e r P h e T h r T h r T h r A la G lu A r g G lu I le V a lA r g A sp I le L y s  
GCTACAGCTTTACCACCACTGCTGAGAGGGAAATTGTTCGTGACATAAAG 
I I I I I I I I I I I I I I I I I I I I I I II I II II I I I I I I II III III
GCTACAGCTTTACCACCACTGCTGAGAGGGAAATTGT------GAC------- AAG
22® 23©
G lu L ysL eu C ysT yrV alA laL eu A sp P h eG lu G ln G lu M etA laT h rA l 
GAGAAGCTGTGCTATGTTGCCCTGGATTTTGAGCAAGAAATGGCTACTGC
I I I I I I I I I  I I I I  I I I I I I I I I I I I I I  I I I I I I I I I I I I I  I I I I I I I I I
GAGAAGCTGTGCTATGTTGCCCTGGATTTTGAGCAAGAAAAGGCTACTGC
Lys
231® 21®
a A la S erS erS erS erL eu G lu L y sS erT y rG lu L eu P ro A sp G ly G ln V  
TGCATCATCTTCCTCCTTGGAGAAGAGTTACGAGCTGCCCGACGGGCAGG
I I I  I I I I I I I I I I I I I  I I I I I I I I  I I I  I I I  I I I I I  I I  I I I I I I I I I I I
TGCATCATCTTCCTCCTTGGAGAAGAGTTACCAGCTGCCCGATGGGCAGG
G in
21®
a llle T h r lle G ly A sn G lu A r g P h e A r g C y sP r o G lu A la L e u P h e G ln
TGATCACCATTGGCAATGAGCGGTTCCGGTGTCCGGAGGCACTCTTCCAG
| I I  I I I  I I I I  I I I I I I I I I  I I I I I  I I I  I I I I I I I I I I  I I I  I I I I I  I I I I I
TGATCACCATTGGCAATGAGCGGTTCCGGTGTCCGGAGGCACTCTTCCAG
P ro S erP h eL eu G ly M etG lu S erC y sG ly lleH isG lu T h rT h rP h eA s
CCTTCCTTCCTGGGCATGGAGTCCTGTGGTATCCATGAGACCACTTTCAA
| | I I I I I I I I I I I I I M  I I I I I I I I I I  I I I  I I I I  I I I I I  I I I I I
CATTCCTTCCTGGGCATGGAATCCTGTGGCATCTACGAGACCACCTTCAA 
H is  Ty r
418
1333
468
1383
518
1433
568
1483
618
1526
668
1576
718
1626
768
1676
818
1726
continued overleaf.
continued.
n S er lleM etL y sC y sA sp V a lA sp IleA rg L y sA sp L eu T y rA la A sn T  
819 CTCCATCATGAAGTGTGATGTGGATATCCGCAAAGACCTGTATGCCAATA 8 68
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I
1727  CT CCAT CAT GAAGTGT GATGT GGATAT C T GCAAAGACC T GTAT GCCAATA 1776
Cys
338 313
h rV a lL eu S erG ly G ly T h rT h rM etT y rP ro G ly lleA la A sp A rg M et  
8 69 CAGTGCTGTCTGGTGGTACCACCATGTACCCAGGCATTGCTGACAGGATG 918
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
1777  CAGTGCTGTCCGGTGGTACCACCATGTACCCAGGCATTGCTGACAGGATG 182 6
G ln L y s G lu I le T h r A la L e u A la P r o S e r T h r M e tL y s I le ly s I le l l  
919 CAGAAGGAGATCACAGCCCTAGCACCTAGCACGATGAAGATTAAGATCAT 968
I I I I I I I I I I I II I I II I I I I I I I I I I I I I I I I I I I I I II I I I I I I i 
1827  TAGAAGGAGAT CACAGC C C T AGCACCCAGCACAAT GAAGAT T AAGAT CAT 187 6
End
e A la P r o P r o G lu A r g L y sT y r S e r V a lT r p I le G ly G ly S e r lle L e u A  
969 TGCTCCCCCTGAGCGCAAGTACTCAGTCTGGATCGGTGGCTCCATTCTGG 1018
I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I I  I  I  I  I  I  I  I  I  I  I I  I  I  I  I  I  I I  
1877  TGCTCCCCCTGAGCGCAAGTACTCAGTCTGGACCTGCGGCTCCATCCT-A 1925
ThrCys T
laS erL eu S erT h rP h eG ln G L n M etT rp IleS erL y sG ln G lu T y rA sp  
1019  CCTCACTGTCCACCTTCCAGCAGATGTGGATCAGCAAGCAGGAGTATGAT 10 68
I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I I  I  I I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I
192 6 CCTCACTGTCCACCTTCCAGCAGATGTGGATCAGCAAGCAGGAGTATGAT 1975
h r
G lu S e r G ly P r o S e r lle V a lH isA r g L y sC y sP h e E n d  
10 69 GAGTCAGGCCCCTCCATCGTCCACCGCAAATGCTTCTAG 1107
I I I I I I II  I I I I I I I I I I I I I I I I I I I I I I I I I I 
197 6 GAGTCGGGC CCATCGTCCACCGCAAATGCTTCTAG 2011
The nucleotide sequences that correspond to the predicted y-like-actin in 
clone A,mAl 18 is aligned to the corresponding regions of the partial sequence of 
mouse y-actin cDNA (Peter and Leader, personal communication). Vertical lines 
betw een  nucleo tides  indicate  identity , and hyphens indicate  deletions in 
sequence. The replacement amino-acids are listed below the sequence in 
question. The inserted sequence is not shown, but the arrow between 
nucleotides 442 and 1313 indicate its position.
Eigwre— £j2. a  co m p a r ison betw een actin - like  sequences of clone
km AlZ9 and the partial sequence of  mouse v - a c t in  cDNA
cDNA: 
XmAl1 9 :
19
47
69
97
119
147
169
197
219
247
269
297
319
347
® 1© 
L e u V a llle A sp A sn G ly  
CTCGTCATTGACAATGGC 
I I I I I I I I I I I I I I I I I 
CTCGTCATTGTCAATGGC 
V al
2© 3(5)
S erG lyM etC ysL ysA laG lyP h eA laG lyA sp A sp A laP roA rgA laV a  
TCCGGCATGTGCAAAGCCGGCTTTGCTGGTGACGACGCCCCCAGGGCCGT 
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
TCCGGCATGTGCAAAGCTGGCTTTGCTGGAGACGACGCCCCCAGGGCCGT
43
lP h e P r o S e r lle V a lG ly A r g P r o A r g H isG ln G ly V a lM e tV a lG ly M  
GTTCCCTTCCATCGTAGGGCGCCCCCGACACCAGGGCGTCATGGTGGGCA 
I I I I I I I I I I I I I II I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
GTTCCCTTCCATCGTAGGGTGCCCCCGACACCAGGACGTCATGGTGGGCA
Cys Asp
I© @@
etG ly G ln L y sA sp S erT y rV a lG ly A sp G lu A la G ln S erL y sA rg G ly  
TGGGCCAGAAAGAC T CATACGT GGGT GACGAGGCCCAGAGCAAGAGGGGT 
I I I I I I I I I I I I I I I I II I I I I I I I I I I I I I I I I I II I I I I I I I I I I
TGGGCCAGAAAGACTCGTATGTGGGTGACAAGGCCCAGAGCAAGAGGGGT
Lys
7©
I le L e u T h r L e u L y sT y r P r o I le G lu H isG ly lle V a lT h r A sn T r p A s
ATCCTGACCCTGAAGTACCCTATCGAACACGGCATTGTCACTAACTGGGA
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I
ATCCTGACCCTGAAGTACCCTATCGAACACGGCATTGTCACCAACTGGGA
f  ©
p A sp M etG lu L ysIleT rp H isH isT h rP h eT yrA sn G lu L eu A rgV alA
CGACATGGAGAAGATCTGGCACCACACCTTCTACAATGAGCTGCGTGTGG
II I II I I I I I II I I I I I I I I I I I I I I I I I I M I I I I I I I I I I I I II I I
TGACATGGAGAAGATCTGGCACCACACCTTCTACAATGAGCTGCGTGTGA
T
100 11®
a lP ro G lu G lu H isP ro V a lL eu L eu T h rG lu A la P ro L eu A sn P ro L y s
CTCCTGAGGAGCACCCGGTGCTTCTGACCGAGGCCCCCCTGAACCCCAAA
| | | I I I I I I II I I II I I I I I I I I I I I I I I M I I I I I I I I I I I I I I I I I I
CCCCTGAGGAGCACCCGGTGCTTCTGACCGAGGCCCCCCTGAACCCCAAA
h r
11© 13®
A laA sn A rgG lu L ysM etT h rG ln lleM etP h eG lu T h rP h eA sn T h rP r
GCTAACAGAGAGAAGATGACGCAGATAATGTTTGAAACCTTCAATACCCC
| | I I I I I I I I II I I I II I I I I I I I II I I I I I I I I I I I I I I I II I I I I I I I
GCTAACAGAGAGAAGATGACGCAGATAATGTTTGAAACCTTCAATACCCC
18
46
68
96
118
146
168
196
218
246
268
296
318
346
368  
3 96
continued overleaf.
continued.
140
o A la M e tT y r V a lA la lle G lu A la V a lL e u S e r L e u T y r A la S e r G ly A  
369 AGCCATGTACGTGGCCATTCAGGCGGTGCTGTCCTTGTATGCATCTGGGC 
I I I I I I I I I I I I I I I I I I II I I I I I I I I I I I I I I I I I I I I I | | | | | | | | 
397 AGCCATGTACGTGGCCATTCAGGCGGTGCTGTCCTTGTATGCATCTGGGT
C
r g T h r T h rG ly lleV a lM etA sp S erG ly A sp G ly V a lT h rH isT h rV a l  
419 GCACCACTGGCATTGTCATGGACTCTGGTGACGGGGTCACACACACAGTG 
I I I I I I I I I I I I I I I I I I I I I I I I I I I I! I I I I I I I I I I I I I I II I I I I I 
447 GCACCACTGGCATTGTCATGGACTCTGGTGACGGGGTCACACACACAGTG 
y s
P ro I le T y r G lu G ly T y r A la L e u P r o H isA la lle L e u A r g L e u A sp L e  
469 CCCATCTATGAGGGCTACGCCCTTCCCCACGCCATCTTGCGTCTGGACCT 
I I I I I I I I I I I I I I I I I I I I I II I II I I I I II  I I I I I I I I I I I I I I I I 
497 CCCATCTATGAGGGCTACGCCCTTCCCCATGCCGTCTTGCGTCTGGACCT
V al
uA laG lyA rgA spL euT hrA spT yrL euM etL ysIleL euT hrG luA rgG  
519  GGC TGGCCGGGACC TGACAGAC TACC T CAT GAAGATCC TGAC T GAACGGG
I I I I I I I I I I I I I I II I I I I I I I I I I I I II I I I I I I II I I I I I I I II I 
547 GGCTGGTCGGGTCCTGACAGACTACCTCATGAAGATCCTGACTGAACGGG 
V a l
1®@ 11®  
ly T y r S e r P h e T h r T h r T h r A la G lu A r g G lu I le V a lA r g A sp I le L y s  
569 GCTACAGCTTTACCACCACTGCTGAGAGGGAAATTGTTCGTGACATAAAG 
I I I I I II I I I II I I I I I I I I I II II I I I I I I I I I I I I I I I II I I II II
597 GCTACAGCTTTACCACCACTGCTAAGAGGGAAATTGTTCGAGACATAAAG
Lys
11® 13£
G lu L ysL eu C ysT yrV alA laL eu A sp P h eG lu G lu G lu M etA laT h rA l 
619 GAGAAGCTGTGCTATGTTGCCCTGGATTTTGAGCAAGAAATGGCTACTGC 
I I II I I I I I I I I I I I I I I I I I I I I I II I I I I I I I I I I I I I II I I I I I I I 
647 GAGAAGCTGTGCTATGTTGCCCTGTATTTTGAGCAAGAAATGGCTACTGC
Tyr
1 3 1 ®  11®
a A la S erS erS erS erL eu G lu L y sS erT y rG lu L eu P ro A sp G ly G ln V  
66 9 TGCATCATCTTCCTCCTTGGAGAAGAGTTACGAGCTGCCCGACGGGCAGG
I I II II I I I I I I I I I I I I I I I I II II I I I I II I II II I I II II II I I I
697 ' TACATCATCTTCCTCCTTGGAGAAGAGTTACGAGCTGCCCGATGGGCAGG 
Thr
I I ®  1@@
a llle T h r lle G ly A sn G lu A r g P h e A r g C y sP r o G lu A la L e u P h e G ln  
719 TGATCACCATTGGCAATGAGCGGTTCCGGTGTCCGGAGGCACTCTTCCAG
| | II I I I I I I I I I I II I I I I I II I I I I I II II I I II II I I II I I I I I
747 TTATCACCATCGGCAATGAGCGGTTCCGGTGTCCAGAGGCACTCTTCCAG
P ro S erP h eL eu G ly M etG lu S erC y sG ly lleH isG lu T h rT h rP h eA s  
7 69 CCTTCCTTCCTGGGCATGGAGTCCTGTGGTATCCATGAGACCACTTTCAA
| | | | M I I I I I I I II I I I I I I I I I I I I I I I I I I I I I I I H I I I I I I
7 97 ACTTCCTTCCTGGGCATGGAGTCCTGTGGTATCCACGAGATCACCTTCAA
Thr 3 0 5  ft 1310 I l e
418
446
468
496
518
546
568
596
618
646
6 6 8
696
718
746
768
796
818
1351
continued overleaf.
continued.
n S e r lleM etL y sC y sA sp V a lA sp IleA rg L y sA sp L eu T y rA la A sn T  
819 CTCCATCATGAAGTGTGATGTGGATATCCGCAAAGACCTGTATGCCAATA 8 68
I I I I I I I I I I I I I I I I I II I I I I I I I I I I I I I I I I I I I I I I I II I I I I I I 
1352  CTCCATCATGAAGTGTGATGTGGATATCCGCAAAGACCTGTATGCCAATA 1401
310
h rV a lL eu S erG ly G ly T  h rT h rM etT yrP roG ly lleA laA sp A rgM e  
8 69 CAGTGCTGTCTGGTGGTA*CCACCATGTACCCAGGCATTGCTGACAGGAT 917
I I M I II I I I I I I I I I I I I I I I I II I I I I I I I I I I I I | | | I | | | | | | | |
1402  CAGTGCTGTCTGGTGGTACCCACCATGTACCCAGGCATTGCTGACAGGAT 1451
918
1452
968
1502
1018
1552
tG ln L y s G lu I le T h r A la L e u A la P r o S e r T h r M e tL y s I le L y s I le l
GCAGAAGGAGATCACAGCCCTAGCACCTAGCACGATGAAGATTAAGATCA
I I I I I I I I I I I I I I II I I I I I I I I I I I I I I I I I I I I I
GAAGAAGGAGATCACAACCCTAGCACCCAGCACAACGAAGATTAAGATCA
Lys Thr Thr
le A la P r o P r o G lu A r g L y s T y r S e r V a lT r p I le G ly G ly S e r l le L e u  
TTGCTCCCCCTGAGCGCAAGTACTCAGTCTGGATCGGTGGCTCCATTCTG 
I I I I I I I I I I I I II I I I I I I I I I I I I I I I I I I II I I I I II I I I I I I I I 
TTGCTCCCCCTGAGCGCAAGTACTCAGTCTGGTTCTGTGGCTCCATTCTG
PheC ys
350 3@©
A la S erL eu S erT h rP h eG ln G ln M etT rp IleS erL y sG ln G lu T y rA s  
GCCTCACTGTCCACCTTCCAGCAGATGTGGATCAGCAAGCAGGAGTATGA
I I I II I I I I I I I I I I I I I I II I I I I I I II I II I II I I I I I I I I I I II I I I
GCCTCACTGTCCACCTTCCAGCAGATGTGGATCAGCAAGCAGGAGTATGA
967
1501
1017
1551
1067
1601
p G lu S e r G ly P r o S e r lle V a lH isA r g L y sC y sP h e E n d  
10 68 TGAGTCAGGCCCCTCCATCGTCCACCGCAAATGCTTCTAGATGGACTGA* 1116
I I I I I II I I I I I I III  I I I I I I I I I I I I I II I I I I I II I I I
1602  TGAGTTGGGCCCCTCTATCATCCACATCAAATGCTTCTAGATGGACCGTG 1651
Leu l i e  l i e
1117  GCAGGTGCCAGGCATCTGCTGCATGAGCTGATATTGAAGTATCAATTTGC 1166
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I
1652 GCAGGTGCCAAGCATCTGCCGCATGAGCTGATATTGAAGTATTGATTTGC 1701
1167 CCTGGCAAATGTACACACCTCATGCTAGCCTCATGAAACTGGAATAAG 1214
I II II I II I I I I I I I I I I I I I I II I I I I I I I I I I I I I I I I I I I I I I I I
1702  CCTGGCAAATGTACACACCTCATGCTAGCCTCATGAAACTGGAATAAG 17 4 9
The nucleotide sequences that correspond to the predicted y-like-actin in 
clone A.mAl 19 is aligned to the corresponding regions of the partial sequence of 
mouse y actin cDNA (Peter and Leader, personal communication). Vertical lines 
between nucleotides indicate identity. The replacement amino-acids are listed 
below the sequence in question. The inserted sequence is not shown, but the 
arrow between nuclectides 805 and 1310 indicate its position. Gaps introduced 
in the cDNA sequence for maximal homology are indicated by asterisks.
F igure  5.3 Com parison  between actin -like  sea.U.en.C-£S o£ clones L m A l l v
A,mA118. and km A119 and the partial sequence of mouse v-actin cDNA
® l i  
L e u V a llle A sp A sn G ly  
cDNA: CTCGTCATTGACAATGGC 18
XinAl 9: .............................................
tanAl1 8 : . . A ......................................
XmA119:  T .................
2 0  3 i
S erG lyM etC ysL ysA laG lyP h eA laG lyA sp A sp A laP roA rgA laV a  
cDNA: TCCGGCATGTGCAAAGCCGGCTTTGCTGGTGACGACGCCCCCAGGGCCGT 68
XmAl9:  T ..........
XmAl 18 :  C .- -T C . .T ---------------------------- . . . A ..............T .................. A.
JmAl 19 :  T .....A ...................................................
40
lP h e P r o S er lleV a lG ly A rg P ro A rg H isG ln G ly V a lM etV a lG ly M  
cDNA: GTTCCCTTCCATCGTAGGGCGCCCCCGACACCAGGGCGTCATGGTGGGCA 118
tanAl 9:................. ..................................................................................................................................
tanA118:  A ........................................................ T . . . T ......................
tanAl 19 :  T . . ..................................A ...................................
S i  60
e tG ly G ln L y sA sp S erT y rV a lG ly A sp G lu A la G ln S erL y sA rg G ly  
cDNA: TGGGCCAGAAAGACTCATACGTGGGTGACGAGGCCCAGAGCAAGAGGGGT 168
XmA19:  G.....................................................................................
X.raA118 : .T ....................G............C ............................T ......................................................
X.mAl 19 :  G . . T .A ...................................................
7 0
I le L e u T h r L e u L y sT y r P r o I le G lu H isG ly lle V a lT h r A sn T r p A s  
cDNA : ATCCTGACCCTGAAGTACCCTATCGAACACGGCATTGTCACTAACTGGGA 218
X,mAl9 :  C ....................
A.mAll8 :  G................................... G-------G . . T ........................... C ....................
X.mA119 :  C ....................
S i
p A sp M etG lu L ysIleT rp H isH isT h rP h eT yrA sn G lu L eu A rgV alA  
cDNA : - CGACATGGAGAAGATCTGGCACCACACCTTCTACAATGAGCTGCGTGTGG 2 68
^m A l9:................. .................................................................................................................................
tanAl 18 :.............. .................................................................................................................................
tanA119: ................................................................................................................................A
100 11®
laP roG lu G lu H isP roV alL eu L eu T h rG lu A laP roL eu A sn P roL ys  
CDNA: CTCCTGAGGAGCACCCGGTGCTTCTGACCGAGGCCCCCCTGAACCCCAAA 318
XmAl9:  T ........................................................................................
XxnA118: -C ................................................... A .....................................................................
A,mAl 19 :.............. .................................................................................................................................
continued overleaf. . . .
1 2 8
continued.
cDNA: 
Xmhl9:  
XmAl 18 : 
XmAl1 9 :
cDNA: 
A,mA19: 
X m A 118:  
XmAl1 9 :
cDNA: 
XmA19:  
A,mAll8 : 
XmAl19:
cDNA: 
A,mA19 : 
X,mA118 : 
X m A ll9:
cDNA: 
Xm A l9: 
tanA ll8  : 
tanAH9 :
cDNA: 
?tmAl9: 
A.mAll8 : 
X m A ll9:
cDNA: 
A,mAl9: 
X m A ll8 : 
tanAl19 :
cDNA: 
Xm Al9: 
ta n A ll8 : 
X m A ll9:
11® 13®
A la A sn A rgG lu L ysM etT h rG ln lleM etP h eG lu T h rP h eA sn T h rP r  
GCTAACAGAGAGAAGATGACGCAGATAATGTTTGAAACCTTCAATACCCC
C
140
o A la M e tT y r V a lA la lle G ln A la V a lL e u S e r L e u T y r A la S e r G ly A
AGCCATGTACGTGGCCATTCAGGCGGTGCTGTCCTTGTATGCATCTGGGC
..................... A ................................... AA............................................A ..............
. . . . T ................ CA...................... T ...............C ......................... T ....................
................................................................................................................................ T
IS® l i®
rg T h rT h rG ly lleV a lM etA sp S erG ly A sp G ly V a lT h rH isT h rV a l  
GCACCACTGGCATTGTCATGGACTCTGGTGACGGGGTCACACACACAGTG
17® IS®
P r o I le T y r G lu G ly T y r A la L e u P r o H isA la lle L e u A r g L e u A sp L e  
CCCATCTATGAGGGCTACGCCCTTCCCCACGCCATCTTGCGTCTGGACCT
G........................ CA............A .................T .............................. T .....................T.
l i ®
u A laG lyA rgA spL euT hrA spT yrL euM etL ysIleL euT hrG luA rgG
GGCTGGCCGGGACCTGACAGACTACCTCATGAAGATCCTGACTGAACGGG
..................... c ................... ................G....................................C ............................
. . T . . . . TA..................
1®® 11® 
ly T y r S e r P h e T h r T h r T h r A la G lu A r g G lu I le V a lA r g A sp I le L y s  
GCTACAGCTTTACCACCACTGCTGAGAGGGAAATTGTTCGTGACATAAAG
.......................................................... A .........................................A ......................
21© 13®
G lu L ysL eu C ysT yrV alA laL eu A sp P h eG lu G ln G lu M etA laT h rA l 
GAGAAGCTGTGCTATGTTGCCCTGGATTTTGAGCAAGAAATGGCTACTGC
....................................................... A ......................
............. T .................................................................
2€@
a A la S erS erS erS erL eu G lu L y sS erT y rG lu L eu P ro A sp G ly G ln V
TGCATCATCTTCCTCCTTGGAGAAGAGTTACGAGCTGCCCGACGGGCAGG
............................................................................ T ............................T .................
...............................................................................C .........................T .................
.A .......................................................................................................T .................
368
418
468
518
568
618
668
718
continued overleaf.
continued.
CDNA: 
tanA19: 
XmAl1 8 :  
XmA119:
cDNA: 
tanA19: 
tanA 118: 
tanA119:
cDNA: 
Xm Al9: 
XmA118: 
X,mAl 19 :
cDNA: 
A,mAl9: 
X,mAl 18 : 
X m A ll9 :
cDNA: 
tan A l9: 
ta n A ll8 :  
X m A ll9 :
cDNA: 
XjnAl 9 : 
XmA118: 
tanA119:
cDNA: 
Xm Al9: 
?imAll8 : 
XmA119:
cDNA: 
XmAl9: 
A.mA118: 
X,mAll9 :
is® i m
a llle T h r lle G ly A sn G lu A r g P h e A r g C y sP r o G lu A la L e u P h e G ln  
TGATCACCATTGGCAATGAGCGGTTCCGGTGTCCGGAGGCACTCTTCCAG 
........................ C ......................................................................................................
-T ...................C ............................................................ A.
P ro S erP h eL eu G ly M etG lu S erC y sG ly lleH isG lu T h rT h rP h eA s
CCTTCCTTCCTGGGCATGGAGTCCTGTGGTATCCATGAGACCACTTTCAA
..................................................................................................................C ............
• A ...............  A .....................C. . . T . C ....................C ............
A ........................................................................................ C. . . .T . . .C ............
n S er lleM etL y sC y sA sp V a lA sp IleA rg L y sA sp L eu T y rA la A sn T
CTCCATCATGAAGTGTGATGTGGATATCCGCAAAGACCTGTATGCCAATA
T
h rV a lL eu S erG ly G ly T h rT h rM etT y rP ro G ly lleA la A sp A rg M et
CAGTGCTGTCTGGTGGTACCACCATGTACCCAGGCATTGCTGACAGGATG
C
G ln L y s G lu I le T h r A la L e u A la P r o S e r T h r M e tL y s I le L y s I le l l
CAGAAGGAGATCACAGCCCTAGCACCTAGCACGATGAAGATTAAGATCAT
.................................................................. C ............. A ..........................................
T ............................................................... C ............. A ..........................................
A ...................................A .........................C ............A . C ......................................
e A la P r o P r o G lu A r g L y sT y r S e r V a lT r p I le G ly G ly S e r lle L e u A
TGCTCCCCCTGAGCGCAAGTACTCAGTCTGGATCGGTGGCTCCATTCTGG
.......................................................................................C ......................................
...................................................................................C . T . C .....................C . . -A
............................................................................... T . . T ......................................
33® Si®
la S erL eu S erT h rP h eG ln G ln M etT rp IleS erL y sG ln G lu T y rA sp  
CCTCACTGTCCACCTTCCAGCAGATGTGGATCAGCAAGCAGGAGTATGAT
37@ 374
G lu S e r G ly P r o S e r lle V a lH isA r g L y sC y sP h e E n d  
GAGTCAGGCCCCTCCATCGTCCACCGCAAATGCTTCTAGATGGACTGAGC
  ......................................................................................................
 G. . .   / / / / / / / / / / /
. . . .  TG....................T . . . A ............AT . . ............................................C .G . .
768
818
868
918
968
1018
1068
1118
continued overleaf.
continued.
cDNA: AGGTGCCAGGCATCTGCTGCATGAGCTGATATTGAAGTATCAATTTGCCC
X.mA19:  G....................
XmAl1 8 : / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / /
XmA119:  A ....................C .........................................................TG....................
1168
cDNA:
XmA19:
XmA118
A,mA119
cDNA: 
XmA19: 
X.mA118 
X,mA119
cDNA: 
tanA19: 
X,mA118 
Xm All9
TGGCAAATGTACACACCTCATGCTAGCCTCATGAAACTGGAATAAGCCTT 1218
...........................T ...................................................................................................
/ / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / /  
........................................................................................................................ TCCC
TGAAAAGAAATTTAGTCCTTGAAGCTTGTATCTGATATCAGCACTGGATC 12 68
/ / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / /  
CCCCCCCTTTCC. TT. TA. . TTTTA. . CAC. TAACATC. CAG. . ACAGC.
GTAGAACTTGTTGCTGATTTTTGACCTTGTATTCAAGTTAACTGCTCCCT 1318
/ / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / /
CCC. CC. C . T . . CAGAG. . CC. CCTT. ACA. G. TCCT. CC. . CAT...........
cDNA: 
XmAl9: 
tanA118  
XjmA119
TGGTATATGTTTAATACCCTGTGCATATCTTGATTTCTCCTTAGTTCATG 1368
/ / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / /
. TTCTCT. TG. CTC. TAGAAA. . GGACC. G. TTG. GTA. . ACTTAC.
cDNA: TGGCTCGGTCACTTGGGGCTGGGGAGAGCACGCTGTAGATGAGAAAGCCC 1418
X.mAl9 :  A .................................G.GC................A . . .
XmAl1 8 : / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / /
cDNA: CAGCCTGGTTGATCTCTGTGAGCACCACTGAGTGATCTGTGCAGGGTATT 14 68
tanAl9:  T . . G .........................................A -------
tanAl18: / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / /
The nucleotide sequences that correspond to the predicted y-like-actin in 
clones X mA19 (Leader etal.,  1985), A,mA118, and km A 119 are aligned to the 
corresponding regions of the partial sequence of mouse y-actin cDNA (Peter 
and Leader, personal communication). Dots below the cDNA sequence indicate 
identity, and hyphens indicate deletions in the sequence. Strokes below the 
cDNA sequence indicate sequence not determined. The positions of insertions 
are not shown.
(The calculation of the percentage of possible neutral mutations in the y -a c t in  
gene sequence, was according to Leader et al., 1986b). Correction for this fact 
gives a value of 1 .13  for the UEP. Therefore assuming neutral drift for the
actin-like sequences in clone ?imA118 and A,mA119 since their formation from 
the active y -ac t in  gene, it can  be es tim ated  that this event occurred  
approximately 6.8 million years ago in A,mA118 (6.0% with a UEP of 1.13) and 4.4 
million years ago in XmA119 (3.9% with a UEP of 1.13). The times of formation 
of these actin processed pseudogenes are relatively recent compared with the 
divergence of the two lines leading to rat and mouse, which is assumed to have 
occurred 15 million years ago (Alonso et al., 1986). The evolutionary time of 
formation of the actin-like sequence in clone ^m A 118 is significantly  longer 
ago than that of clone A,mA119, and that of clone A,mA19 (1.9 million years; 1.7% 
divergence with a UEP of 1.13).
The above calculation assumes a similar rate for the accumulation of 
mutations in neutral positions in a functional gene and pseudogene. However 
the comparison shown in Figure 5.3 allows one to identify the mutations in the 
functional gene since the divergence of the younger pseudogenes, A.mA119 and 
XmA19. Differences from the cDNA common to all three pseudogenes are 
s tatistically  most likely to have occurred in the functional gene since the 
origin of ^mA19, and differences common only to XmA118 and XmA119 are more 
likely to have occurred in the functional gene since the origin of A,mA119 but 
before the origin of A,mA19. There are 6 in total in the former case and a total 
of 2 in the latter case. All these changes have taken place in silent positions of 
the cDNA sequence. The occurrence of 6 functional gene changes out of a total 
of 19 base changes for the comparison with ^m A 19 , and 8 functional gene 
changes out of a total of 43 base changes in A,mA119 are approxim ately  
consistent with the proportion of total neutral positions (24.4%) found in the 
cDNA sequence. This is in contrast with the results of others who found that 
globin pseudogenes evolve faster at neutral positions than do functional genes 
(Miyata and Yasunaga, 1981; Miyata and Hayashida, 1981; Li et al., 1981).
In order to determine whether the actin-like sequences in >.mA118 and 
?unA119 have evolved at a neutral rate, as assumed for the calculations above, 
the R/S (replacement changes / silent changes) ratios were calculated. The 
replacement changes in a functional coding sequence are more likely to be 
detrimental, and therefore be selected against, than silent changes. As a 
consequence, the R/S ratio allows one to discriminate between functional genes 
and pseudogenes. Pseudogenes are in general expected to have 2.5 to 3.0 times
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as many R as S changes because in this case these are not detrimental 
(Czelusniak et al ., 1982). The R/S ratio of the y-actin-like genes in A,mA118 and 
kmA119 were determined to be 1.6 and 1.15 respectively, both ratios seeming 
inappropria te  fo r  p rocessed  pseudogenes evolv ing  under neutral selection. 
Because the y-actin amino-acid sequence is totally conserved (ie no R changes 
in the functional gene) the values of Czelusniak et al (1982) are too high. 
Having identified the changes in the functional gene occurring since XmA119 
originated it is possible to eliminate these and identify the R/S changes in the 
pseudogene itself where the 24.4% of silent positions predicts an R/S ratio of 3.0 
for a pseudogene. In fact the corrected number of 23 replacement changes and 
12 silent changes gives a R/S ratio of 1.9 for A,mA119 (a similar value of 2.0 is 
obtained for A,mA19). With 6.8 million years of divergence from the functional 
gene, A,mA118 is the ’oldest' mouse y-actin  pseudogene identif ied  to date. 
Therefore it is not possible to estimate the number of changes the functional 
gene had acquired since the formation o f  A,mA118. However, eliminating 
changes that the functional gene had acquired since the origin of A.mA119, the 
corrected values o f  41 replacement changes to 18 silent changes give rise to a 
R/S ratio of 2.3. This might suggest that during part of its existence, this gene 
was evo lv ing  under a se lec tive  pressure for a protein  coding sequence. 
However, this seems unlikely as most processed pseudogenes are thought to 
become inactive as soon as they are inserted into the genome. Therefore other 
factors were sought as possible explanations for these deviations of the R/S 
ratio from that expected.
Bulmer (1986) analysed mutations in a number of processed pseudogenes 
and pointed out that the frequency of transition in CG doublets in vertebrates is 
ten times that expected on a random basis. This can be attributed to the high 
frequency o f  m ethylated  cytosine in this doublet, and the correspondingly 
high level of deam ination  of this 5-methyl cytosine (mC) into thymine
(Coulondre et al., 1978; Bird, 1980; Razin and Riggs, 1980). Thus the doublet CG 
is converted via mCG to TG and its complement CA. The reduction in frequency 
of occurrence of the doublet CG is indeed often accompanied by corresponding 
increases in the doublets TG and CA (Setlow, 1976; Russell et al., 1976). 
Examination of the functional y-actin gene (cDNA) in Figure 5.3 allowed the
identification of 40 such CG doublets with the possibility of methylation and
then deamination into the doublets TG and CA. In A,mA119, there have been 9 of
these changes, where 4 were replacement changes and 5 silent changes. If one 
chooses to discount the CG transitions, one can obtain a corrected R/S ratio for
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XmA119 of 2.7 (with 19 replacement changes to 7 silent changes). In km A118, a 
total of 10 base changes can be accounted for by deam ination of CG doublets,
consisting o f 5 replacem ent and 5 silent changes, and allowing a corrected R/S
ratio  o f 2.8 (with 36 replacem ent changes to 13 silent changes). Thus it would 
seem  m ost likely that the actin-like genes in km A 118 and A,mA119 have been 
inactive since their origin, the bias of CG to TG transitions in the silent position 
accounting for the deviation o f R/S ratio from  that expected for a pseudogene. 
The explanation for this bias is, however, unclear.
5 .2  Insertion Elements IE 36, IE 119 and IE 118
5 .2 .1  Analysis of IE 36
The nucleotide sequence of IE 36 indicated that it is related to a solo long
term inal repeat (LTR) o f the re tro v ira l-lik e  m ouse in traciste rnal A -particle
(IA P), as illustrated  by the sequence com parison shown in Figure 5.4a. A
duplication of the target-site (6 base pairs of actin DNA coding for Pro^O and
I le 7  1) flanking IE 36 indicates that IE 36 arose follow ing an insertion at a 
staggered break in the actin processed-pseudogene. This mode of insertion is 
typical o f retroviruses and transposable elem ents and is also consistent with 
o ther IAP insertions which generate 6 base-pair target-site  duplications. As 
the LTRs of IAPs do not them selves contain  the genetic inform ation for
retro transposition , it is assum ed that the original insertion was of a complete 
IAP gene, the LTRs of which subsequently underw ent unequal crossing-over.
The solo IAP LTR of IE 36 is 500 base pairs in length. This includes a
duplicated region, not found in other IAPs and discussed below. Ignoring this
duplication, in comparison with the most related IAP LTR nucleotide sequence 
in the EMBL and GenBank databases, 5'rc-mos (Canaani et al., 1983), IE 36 shows 
a sequence hom ology of 87% (Figure 5.4a). Several conserved sequence motifs 
which are essential for transcriptional regulation have been used to subdivide 
LTRs into three functional dom ains, U3-R-U5 (Temin, 1981). The sequence 
CCAAT (CAAT box) usually occurs in the U3 region 75 base pairs 5' to R ; the 
sequence G /c T /a  a t T / a T /a  AAG (Goldberg-Hogness box, TATA) usually occurs 
23 base pairs before R. These sequences are thought to be im portant for 
tran sc rip tio n a l prom otion (B reathnach and Cham bon, 1981). The R region
always starts at the capping nucleotide, G, and ends with the polyA addition site,
131
continued
FJgurg SAfr. Com parision of members of 46 base pair repeat in IE 36
2 2 8 CTCTTGCTC---------------------------------CTAAAGATGTAGGCAATAGAG
*
257
2 5 8 CTCTTGCTCTCTTGCGCTCTGGCTCCTAAAGATGTAAGCAATAGAG 
* *
3 0 3
3 0 4 CTCTTGCTCTCTTGCTCTCTTGCTCCTAAAGATGTAAGCAATAGAG
k k
3 4 9
3 5 0 CTCTTGCTCTCTTGCGCTCTGGCTCCTAAAGATGTAAGCAATAGAG
■k k k k k
3 9 5
3 9 6 CTCTTGCTCTCTTGCACTCTTGCTCCTGAAGATGTAAGCTATAAAG 441
(a) Com parision of IE 36 with the related IAP LTR, 5'rc-mos (Canaani et 
al.,  1983) is shown. Vertical lines between sequences indicate identity, target
site d irect repeats are boxed, and sequences of possible functional importance
are underlined . Gaps in troduced  to optim ise alignm ent are ind ica ted  by 
hyphens. The am ino-acid equivalents of the opposite strand of the flanking 
nucleotides o f the actin processed pseudogene are indicated, and numbered for 
the protein  sequence (Vandekerckhove and W eber, 1979a). The LTR putative
regions U3, R and U5 are indicated. The numbering of the sequence is only for 
the inserted  elem ent. (b) Com parision of the m em bers o f the 46 base-pair
repeat in IE 36 is shown. Asterisks indicate the position at which differences 
occur.
CA. Twenty base pairs to the start o f the U5 region, there is the polyadenylation 
signal sequence, AATAAA. In U5, 10 to 25 base pairs after the end of R, there is 
TTGT or some closely related sequence, which is thought to be im portant in 
term ination of viral RNA synthesis. Some retroviral LTRs have been found to 
con tain  core enhancer sequences (TG G T / A T / A T /A )s which are thought to be 
involved in activation o f RNA transcrip tion  of nearby genes (W eihler et al ., 
1983). The enhancer sequence appears to be part of the LTRs of all IAPs , and is 
usually associated with a potential Z-DNA form ing sequence, which is located 3' 
to the core enhancer. A consensus g lucoco rtico id  reco g n itio n  sequence 
(TGTTCT), first detected in mouse mammary tumour virus and the LTRs of an 
IAP associated with the mouse ren in  gene (Burt et al., 1984; Scheidereit and 
Beato, 1984), is also a feature of some retrovirus LTRs. This segment is usually 
located 5' to the core enhancer.
W ith reference to the sequence hom ology of IE 36 to rc-m os, and data 
obtained from other IAP LTRs (Christy et al., 1985), the boundaries betw een the 
putative U3, R, and U5 dom ains within the IAP LTR have been indicated in 
Figure 5.4a, as well as several of the functionally  im portant sequence motifs 
found in  some, although not all, retroviral LTRs (Temin, 1981; Varmus, 1982) . 
The solo IAP LTR in IE 36 contains : (a) an imperfect version of the 4 base pair 
te rm ina l in v erted  repea t, 5 'T G T G /T A G A 3', w hich is unusual since m ost 
retroviral-like LTRs have been found to be flanked by perfect inverted repeats, 
5'TGTT/AACA3' (Ono and Ohishi, 1983). However, im perfect inverted repeats 
have been reported in IAP LTRs characterised by Christy et al. (1985) ; (b) a 
g lucocortico id  recognition  sequence (TGTTCT at position  52) ; (c) a core
enhancer (TGGTAA at position 61) ; (d) a potential stretch of Z-DNA consisting of 
11 base pairs in reasonably close proximity to the enhancer (at position 77) ; (e) 
a CAT box (CCAAT at position 155) ; (f) a potential TATA box with 5 out of 9 
m atches to the consensus (CGAGAATAA at position 182) ; (g) a potential
polyadenylation / processing signal with 5 out of 6 matches to the consensus 
(TATAAA at position  435) ; and (h) a potential transcrip tional term ination
signal with 3 out of 4 matches to the consensus (TGCT at position 465). It 
appears that the solo IAP LTR in IE 36 contains sim ilarly arranged putative 
n u c le o tid e  se q u en c e s  fo r  p ro m o tio n , in it ia t io n , p o ly a d e n y la tio n , and 
term ination of viral RNA transcrip tion to those of other retroviral-like LTRs 
(Temin, 1981). Of course there is no evidence that these sequences in the LTR 
ever fu n c tio n  as tran sc rip tio n a l prom oter and po lyadeny lation  signals in 
XmA36.
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As already mentioned, it can be seen from Figure 5.4a that IE 36 contains 
an additional region of DNA, 165 nucleotides in length. This appears to have 
arisen  by successive duplication  o f the 46 nucleotide reg ion  represented by 
nucleotides 396 to 441 in Figure 5.4a, generating five copies, one o f which 
su b seq u en tly  u n d e rw en t an in te rn a l d e le tio n  (F igu re  5 .4 b ). Sequence 
differences due to single base changes between four o f the five repeats indicate 
that these were not genera ted  during  cloning . The lack  o f even short
hom ologous regions flanking  the pro to type o f the repeat m akes it unclear 
w hether the in itial duplication was a result of non-hom ologous recom bination, 
or slippage during rep lication . It should be rem arked that other form s of 
expansion and rearrangem ents have been observed in the LTRs of some other 
IAPs. The LTR regions o f m ouse IAP genes have been found to be very 
heterogeneous (C hristy  et al., 1985). However, this particular heterogeneity is 
confined to the R region of the LTR, IAP genes with longer R regions having 
been shown to consist o f several repeated oligonucleotide stretches which are 
absent in LTRs with shorter R regions. IE 36 also conforms to this pattern, with 
the rep ea ted  stre tch  o f nuc leo tides  (a lthough  d iffe ren t from  the o thers
described previously) falling into the putative R region.
Although solo LTRs have not previously been reported for IAPs, they 
have been described fo r o ther m ouse retrov irus-like  elem ents (W irth et al., 
1983). The ratio of full-sized elements to their solo LTR counterparts is highly 
variable in d ifferent cases. For exam ple, in the fam ily of murine retrovirus- 
related  sequences (M uRRS), the 5.7 kb long elem ents with their corresponding 
LTRs are repeated 50 to 100 times in the mouse haploid genome, whereas their
identical solitary LTR-like counterparts are found to repeated 500 to 1000 times 
in the mouse haploid genome (Schmidt et al., 1985). In contrast, in VL30 DNAs 
there are at least twenty times more full-sized elem ents than solo LTRs (Rotman 
et al., 1984). How ever, the factors that determ ine this variability  are not 
k n o w n .
H ybridisation of a probe obtained from IE 36 to Southern blots of mouse 
liver DNA (Figure 4.11) revealed numerous hybridising bands, indicating that 
the IAP LTR is highly repeated in the mouse genome. It has been estimated (see 
section 4.3.4) that there are approxim ately 1,900 copies of IE 36 per mouse
haploid genome, which is consistent with the 1,000 to 2,000 integrated copies of 
IAP genes per mouse haploid genome estimated by others (Kuff, et al., 1983a).
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5 .2 .2  Analysis o f  IE 119
Sequence analysis of A,mA119 showed that IE 119 was flanked by a four 
base pair duplication, which is part of the actin cDNA coding for Ser264 and 
P he265 .  As before, this suggests that IE 119 was integrated at a staggered break
into the actin processed-pseudogene. The structure of IE 119 (501 nucleotides in
length) is related  to a previously  reported retroviral-like  LTR elem ent, MS57 
(Propst and Vande W onde, 1984), as illustrated  by the sequence com parison 
shown in  Figure 5.5. The methods used for distinguishing the putative U3, R,
and U5 regions in LTRs (outlined in section 5.2.1) were adopted for the solo LTR 
in IE 119; and it was found to contain : (a) a 7 base pair im perfect inverted
repeat, 5 'TG A A A G A /TC TTA C A 3', flanking  the LTR nucleo tide sequence (at 
positions 805 and 1300) ; (c) a potential core enhancer with 4 out of 6 matches to
the consensus (TGATAC at position 1025) ; (d) an 8 base pair stretch of Z-DNA
which is in close proxim ity  w ith the enhancer (at position  1035) ; (e) a
potential CAT box with 3 out o f 5 matches to the consensus (CTGAAT at position 
1091) ; (f) a potential TATA box with 7 out of 9 m atches to the consensus 
(CCA TAA AA A at position  1120) ; (g) a po lyadeny lation /p rocessing  signal
(AATAAA at position 1204) ; and (h) a potential transcriptional term ination 
signal with 3 out of 4 matches to the consensus (TTCT at position 1247). It is 
clear that IE 119 is a solo LTR, despite the absence of the glucocorticoid
recognition  sequence, which is not always present in all retroviral-like LTRs 
(Scheidereit and Beato, 1984).
F igure 5.5 shows that considerable hom ology exists betw een IE 119 and 
MS57, although large gaps need to be introduced to allow sequence alignment. 
If one scores each gap (or deletion) and each base change as a single 
m utational event, the alignment indicates a sequence homology of 70% with the 
LTR element, MS57. The large gaps of DNA missing from the putative U3 region 
of the IE 119 (totalling approxim ately 120 nucleotides), may be due either to
several insertions in the MS57 LTR or, alternatively, deletions in the IE 119 
sequence. A full-length retroviral-like gene, GLN-3, has recently  been shown 
to have an LTR related to MS57 (Itin and Keshet, 1986). This is only 430 base 
pairs in length (compared with 501 for IE 119) and contains none of the long
sequences present in MS57 but absent from IE 119. Thus these latter most likely
arose by insertion or expansion; and this suggests that in the GLN-3 LTR it is
the U3 region that is particularly  susceptible to alteration, rather than the R 
region, as was the case for the IAP LTRs. It is worth recalling that the variation
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Figure— 5 ^  Comparision- of IE 119 with related retroviral-like LTR
ta n A ll9 : . . CAG ACT TdC TTrt 
. .G in  Thr S e r  Phe
tanAl1 9 : TGAAAGAAAG-TGAAATTTCAAGACCTGTAAGTCATATAAAGTAC-TCAGAAATTGCTGG 8 63 
III I I I I I I I I I I I I I I I Mi l l  II t i l l  I I I I II I I I I I I I
MS57 IQ^QAGAAAGATGAAATTTTAGGACCTACAATTCATGTAAAATATACCAGAAAGT  55
(a)
tanAl1 9 : CTGTTTGTGAGCCTA-GAGGC-GCCTGGGGC-GAGAAAAGAGAAAAACAAACCTGGGTAT 92 0 
I I I I II I I I I I I I I I I I I I I I II I I I I I I I I I II I I I I I II I I I I 
MS57 : -TGTTTGTGAGCCTAAGAGGCTGCCTGAGACTGAGAACAAAGAGGAACAGGCCCAGGCAT 114
tanAl1 9 : G-CCTCGTA--------------- GTTAAAACATTCCTGGGAACATCTT— GACCATAAGATAAAGG 969
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I
MS 5 7 : GTCCTAGCAGGCCGGTCGTTAAGGTATTCCTAAGAACAGCTAAAGATCATAAGATAAAAG 174
tanAl 19 : G--------------------------------------------------GACTGTGAAGACATAGCAGGGCTATCTGAACTGA 1004
I I I I I I I I I I I I I I I I I I I I I I I I 
MS57: ATCCTAAGATCATAAAGATAAAAAAAGAGTGCAAGGACAGAACAAGGCTATCTCAGCTTA 234
X.raAll 9 : GTCAACAA---------------------------------------------------------------------------------------------------------- 1012
I I I I I I
M S57: GTCAATACCATCTGGCCCAGCACCTCCCTCTGCCCACTGACCTTCTGAGCCAGTTCAGAG 2 94
X m A ll9 : --------------------------------------------------------------------CTCACAGAACTCTGACACCCTG------- 1034
II I I I I I I I I I II I
MS57 : TCATATATTAACCAGATGTTCCAAGCACCCAGCCCTCAGA-CTTCCTGATACCCCGATCT 353
tanA119:-CACGTACA- -TGTAATTTTTCTGTTAATGTTTGAATAAGCCAATAGTGT 1081
MS57 : ATACGTACACTTTTACTAGTGTATAACTATTCTGTTGAAGTTTAAATTGTCCAATTGTGT 413
(d)
Jtm All9: GTCGCTATGCTGAATTCCACACCCCTAAGCCCCTTACC-------- CCATAAAACCCCCTAAC 1136
| | |  | I I I I I I I I I  I I I I I I I N I I I I I I I I I I I I I I
MS 5 7 : GAAACCACAC—CAATTCCTTCCCC AGCCCCAGACCCTTTTCTATAAAAACCCCTAGC 4 69
(e) ( f )
< U3 li R >
A,m All9: TTTCGAGCCTCGTGGCCGGCCATCCGTTATCTCCTGTGTGGGATACATGTCGGTCTGGAG 119 6
| | | |  I I I I I I I I I I I I I I M I I II III II I I I I I I I M I I M I
M S57: TTTCAAGCCTCGAGGCCGACTA-CCGCTGTCCCCTATGGGAGATATGTATAGGCCCGGAG 52 8
continued overleaf.
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continued.
< R li U 5  >
XmAl1 9 : CTCCGTAATTAAACGTCCTCATGTAATTACAGCAAGATGGGTCCTCGTGTTTCTTTGGGT 1256  
I I I I I I I I I I I I I I I I  I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I
MS57: CTCCGTCATTAAACTACCTCACGTGTTTGCATCAAGACGGTr.TCTClGTGATTr.TTTGGGT 588
(g) (h)
XmAl1 9 : GCTCTCACACTCCTGAGACTAGAGTGGGGGTCCCCAAAAGGGGTCTTACA 1306
I I I I I I I  I I I I I I I I I I I I III I I I I I I
MS57 : GCACGCCGAATCGGG--------- AATGGGGGTTTCCCCACTAGG-CTCTTTCA 632
(a)
XmAl 1 9 : 1C tT d  CTG GGC ATG. . .
Phe Leu G ly  M e t . . .
2§S 2S® 2 0  2 0
Com parision of IE 119 with the related retroviral-like LTR, MS57 (Propst 
and Vande W oude, 1984) is shown. Vertical lines between sequences indicate 
id en tity , target site  d irec t repeats are boxed, and sequences of possib le  
functional im portance are underlined. Gaps introduced to optim ise alignm ent 
are ind ica ted  by hyphens. The am ino-acid  equ ivalen ts o f the flanking  
nucleotides of the actin processed pseudogene are indicated, and numbered for 
the protein sequence (Vandekerckhove and W eber, 1979a). The numbering of 
the sequence is as in Figure 3.10. The LTR putative regions U3, R and U5 are 
in d ic a te d ,
in size of the LTRs of different retroviruses generally reflects variations in the 
size of their U3 regions (Temin, 1981).
It has been estim ated that there are approxim ately 2,300 copies o f IE 119 
per m ouse haploid genome (see section 4.2.4), which conforms with the figures 
obtained for solo retroviral-like LTRs from  MS57 and GLN-3 (Propst and Vande 
W onde, 1984; Itin and Keshet, 1986).
5 .2 .3  Analysis of IE 118
(i)  Relationship to Introns
It is u n lik e ly  that the sequences in te rrup ting  the pseudogenes and 
designa ted  as inserted  elem ents (IE) rep resen t in trons fo r several reasons 
other than the overwhelm ing evidence that IE 36 and IE 119 are retroviral-like 
LTRs. None of the inserted elements is situated at a predicted intron position for 
y-actin. Table 1.2 shows the position of introns in the actin genes of various 
organism s. A lthough the gene for the m am m alian y-actin actin has yet to be 
identified , a num ber of conserved intron positions in different actin isoform s
of vertebra tes, nam ely 41, 267 and 327, have been identified . From the 
sequencing data, it can be seen that the three inserted elements IE 118, IE 119
and IE 36, do not occupy any of these positions. The data also show that they are
flanked by short direct repeats, which are not a feature of introns but are a 
com m on fea tu re  o f the in teg ra ted  sta te  o f tran sp o sab le  e lem en ts and 
retrov iral-like  elem ents. Figure 5.6a illustrates the flanking direct repeats of 
IE 118 at V all39 and L e u l4 0 5 the 6 base pair GGTGCT. Thus the proposed mode of 
insertion of IE 118 is via a staggered break in the mouse processed pseudogene 
in this region, resulting in a target site duplication.
W hen the consensus sequence of the in tron-exon  splice sites were
compared with the boundaries of IE 36 and IE 119, little sim ilarity was evident.
However, in the case of IE 118 surprising sim ilarity of the flanking regions to 
the in tron /exon  consensus were observed (Figure 5.6b). The sequences of 
exon-intron boundaries (the splice site at the 5' end of the intron which is also 
known as the donor site) and intron-exon boundaries (the splice site at the 3'
end o f the intron which is also known as the acceptor site) are very well
conserved, so that deviations are sm all, if  any (M ount, 1982). The most
invariant aspect of the consensus sequence is the GT doublet at the beginning 
of the intron transcript and AG at the end of the transcript (the so-called GT/AG
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Figure 5.6 F lanking direct repeat of  IE 118 and comparison with
the intron splice  sit£ consensus s e q u e n t  al position
V a l l3 8
( a)
135 136 137 138
T h r I le G ln V a ] j______
ACCATTCAGGlfaOSECTtTGGTCAC. . .
. - • • 1
(b)
..• / TGGGCGTAGGESyTGCTjCTCCTTG
y a lL e u S e r L e u
139 140 141 142
5  ' .exontranscript.  .  .
intron transcript
exon transcript 3  T
The flanking regions of IE 118 are shown in (a), the predicted 6 base pair 
target site direct repeat being boxed with broken lines. Numbering of amino- 
acid is as in Figure 3.11. The intron splice site consensus sequence is shown in 
(b). The splice point of the intron and the exon boundary is indicated by the 
vertical hyphenated line, and this is extended to IE 118 at position V ail 38 . 
H om ologous nucleo tides betw een the consensus sequence and those of the 
flanking regions of IE 118 at the same positions are outlined by solid boxes.
1-38
ru le w hen applied to the genom ic DNA). W hen the consensus sequence is
aligned w ith the flanking regions o f IE 118 close to the direct repeat, two
regions o f distinct sequence hom ology can be seen (Figure 5.6a). At position
V a i l  38  there are 4 out of 8 nucleotides which m atch the donor consensus, 
C /^ A G G T A /q AG, (GTGGTGCT at position 435 to 442), and 4 nucleotides matching 
the last 5 of the acceptor consensus, (T /Q )n N C /^A G G , (AGGAGG at position 1308 
to 1313). Furthermore, when the alignment is shifted 3 base pairs upstream to
position  Glnl37  (Figure 5.7a), 6 out of 8 nucleotides match the donor consensus 
(CAGGTGGT at position 432 to 439), and the last 5 nucleotides of the acceptor 
consensus are com pletely m atched (CGTAGG at position 1305 to 1310). (This 
creates Glu at position 138 instead of the previous Val. However, this is equally 
acceptable as Ala is the am ino-acid actually at this position  in the y -a c t in  
sequence.) N evertheless the sim ilarity to intron/exon splice sites breaks down 
at the sequence im m ediately before the in tron-exon junction. The consensus 
sequence here is always pyrim idine-rich and devoid of the dinucleotide AG, and 
this is not the case in either position of alignment of IE 118.
A lthough neither position  Glnl37 and Vail  3 8 corresponds to a known 
in tron position in the actins of vertebrates (Table 1.2), there are actin genes 
w hich have their own unique in tron positions. For exam ple, the hum an 
sm ooth m uscle actin (aorta) contains an intron at codon position 84, which is 
not found in others (Table 1.2; Ueyama et al., 1984). For reasons discussed 
below, it is considered likely that IE 118 is the remenant of a retroposon rather 
than a residual intron in a processed pseudogene of the type apparently found 
in the preproinsulin I gene (Soares et a l ,  1985). However, this sim ilarity to an 
in tron raises the possibility that m ammalian retroposons could, by chance, give 
rise to new introns. Although the dominant view is that introns evolved early 
in evolution and are gradually being elim inated (Zakut et al., 1982; Blake et 
al.,  1983; Nudel et a l ,  1984; Carroll et a l ,  1986), Rogers (1985) has argued for 
the opposite possibility.
( i i )  Possible Identity of IE 118
The sequence of IE 118 and part of the flanking actin pseudogene are 
shown in Figure 5.8. IE 118 is flanked by a 6 base pair duplication of actin 
sequence, indicating that it is inserted at a staggered break. Computer searches 
of GenBank (release 40) and EMBL (release 9) nucleotide sequence databanks 
have not revealed any sequence having extensive hom ology to IE 118 (see
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Figwre LZ. F lanking direct repeat of IE 118 and comparison with
lll£—intr.Q.n—splice—sits—consensus sequence at position
GJjl 137
(a)
135 136 137
T h r l l e G l i  
ACCATTf IQTGCT{TGGTCAC..........
. • : :  ’TGGGCCOTOGADGTGlCTtTCCTTG
G lu V a lL e u S e rL e u
I 138 139 140 141 142
(b)
5  1 .exon transcript.
intron transcript
exon transcript 3  1
The flanking regions of IE 118 are shown in (a), the predicted 6 base pair 
target site direct repeat being boxed by broken lines. Num bering o f amino- 
acid is as in Figure 3.11. The intron splice site consensus sequence is shown in
(b). The splice point of the intron and the exon boundary is indicated by the 
vertical hyphenated line, and this is extended to IE 118 at position G ln l3 7 . 
Hom ologous nucleotides betw een the consensus sequence and those of the 
flanking regions of IE 118 at the same positions are outlined by solid boxes.
1 4 0
Figure— L K  N u cIe o t id e _ se a u e n c e  _ o f  IE 118 and f lanking regions
1 3 1 7  GGAG 
CCTC
AGCACCIT££2ACGCCCACTCCGGTGAAGTCTGCTTGACTGGCCAAGAGGCCTGGAA 1 2 5 8
TCGTGG (a)
S erL eu V alV
1 3 9
1 2 5 7  ACACTCACGAGGCAATGAGTTTCAAGGAAACTATGCCTCCTGGAACCTTGGCATTCCCAT 1 1 9 8
BamHI
1 1 9 7  AGCCCGTATACTCAAACCCTTTTCCCGTGTTAGTTTGGTGTATGGATCCACGTGCTCTCT 1 1 3 8
1 1 3 7  TTCAGTATTGTTTTATTATAAGTGCCTTTAAGATTTGATTGCTTGACATAGCTAAGCCTT 1 0 7 8
1 0 7 7  CGCCAGTGTTGCAATGTCCTAGAAAATCCTCGACGCCGAGGAGCTTGGAATTTAGTGGGA 1 0 1 8
1 0 1 7  ATTCAGTGAGAAGGTTACCTATTCAGTAACATTCAAATTTACTTCTAGTAGAGAAGCGTG 9 5 8
9 5 7  TkTGTGGCCCCTGAGGAGCACC(jjlAlGl'GC'rbCGAACGGAGCTAGAATAGCTCAGGGCTAGT 8 9 8
, P S - t l
8 97  CTGCAGAGTGATTATTTAGGACAGTAGCCTTAGGACACAATGGCCTAGCAAATAGGTGGG 8 3 8
8 3 7  GTAACCATGAAAGAGTTAGGGAATCCCCCTTGGACAGGTTTCTTCACTAGGCCCAAAGGA 7 7 8
7 7 7  ACAGCATAATCAGGCATTTACTAAGAACCCCTTGGTGGTGGGTTTAACAATAGACTAGCA 7 1 8
7 1 7  TTACACCTGTTCCTTCTAGTGGTAATGAGCTTGGTCCCCGCCATCTTTTGATGTATGCAT 6 5 8
(b) (C) (d)
6 5 7  TCCTTTTGTTTTGTGTCACTGTAACTTAGCGGATGTGTTCGCCTGGTTTCTTGTTATTCT 5 9 8
< U3 11 R > <-------R li U 5------->
5 8 7  GTATAAAAAGTTTGATGCTGGATTTGATAAATTACACTCAGATTCAACACGTTCTCTTGT 5 3 8
( f )  ( g )
5 3 7  CACGTCTGTTTGTCACTCGCCCACTCTATGCCCATCTGTCTGAGACTCTGATTCCGCAGA 47 8
(h )
4 7 7  CCGAAGAGGGCCCACAGAGCCCCAGTCCGTGACCA1AGCACC1ACCTGAATGGTGACGTACA 4 1 8
TCGTGGD r a l l  (a) TGGACTTACCACTGCATGT 
e u V a lV a lG ln lle T h r V a lT y r L e
4 1 7  AGGCTGGGGTATTGAAGGGTTCAAACATTATCTGCGTCATCTTCTCTCTGTTAGCTTTGG 3 5 8
TCCGACCCCATAACTTCCCAAGTTTGTAATAGACGCAGTAGAAGAGAGACAATCGAAACC 
u A la P r o T h r A s n P h e P r o G lu P h e M e t I le G ln T h r M e t L y s G lu A r g A s n A la L y s P r
11® IS®
3 5 7  GGTTCAGGGGGGCCTCGGTCAGTAGCACCGGGTGCTCCTCAGGGGCCACACGCAG  2 93
rr.AACTCCCCCCGGAGCCAGTCA^CGTGlG^CCACGAGGAGTCCCCGGTGTGCGTC............
o A s n L e u P r o A la G lu T h r L e u L e u V a lP r o H is G lu G lu P r o A la V a lA r g L e u
The nucleotide sequence o f IE 118 and flanking regions is shown. Target 
site direct repeats are boxed and sequences of possible functional im portance 
are underlined . The am ino-acid equivalents of the opposite strand o f the 
flank ing  nucleo tides o f the actin  processed pseudogene are ind icated , and 
num bered for the protein sequence (Vandekerckhove and W eber, 1979a). The 
num bering of the sequence is as in Figure 3.8. The LTR putative regions U3, R 
and U5 are indicated.
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section 4.1.2). Thus it is not a known retroposon or part thereof.
A map of all the potential open reading frames on both strands of the DNA
of IE 118 has been constructed (Figure 5.9). The distances betw een the AUG
start codons and the stop codons are such that the longest possible open reading 
frame in IE 118 is 130 base pairs in length. This open reading frame could only 
code for a protein a little over 40 amino-acids long, which seems too small to be 
of any significance. Thus it is unlikely that IE 118 is a protein coding sequence.
Because IE 36 and IE 119 had been shown to be solo LTRs of murine 
retroviral-like elem ents the possibility was addressed that IE 118 is also a solo 
LTR o f an endogenous m ouse re trov irus or re tro v ira l- lik e  sequence not
previously recognised. It can be seen from Figure 5.8 that it is possible to 
iden tify  several of the functionally  im portan t sequence m otifs o f retrov iral 
LTRs (Temin, 1981; Varmus, 1982), including the putative U3, R, and U5 domains 
within the LTR (compare also Figure 5.4a and Figure 5.5). Their status in IE 118 
is as follows : (a) the terminal 4 base pair inverted repeat (5'TCCT/ACCA3') is 
im perfect, although the first two nucleotide pairs o f the term ini TC/CA (at 
position 1307 and 447) may be related to the inverted repeat TG/CA, which is 
found in  m ost p rokaryo tic  and eukaryotic  transposab le  elem ents; (b) the
g lucoco rtico id  recognition  sequence m atches 5 out o f 6 to the consensus 
(TGGTAA at position  736) ; (c) the core enhancer m atches the consensus
(TGGTAA at position 736) ; (d) a potential stretch of Z-DNA sequence consisting 
of 10 base pairs is found in reasonably close proximity to enhancer (at position 
667) ; (g) the polyadenylation/ processing signal m atches 5 out of 6 to the 
consensus followed after 8 base pairs by a potential CA site of poly A addition 
(GATAAA at position 562) ; (h) a transcription termination signal is present at a 
suitable region (TTGT at position 528). The lack of a perfect terminal inverted
repeat need not argue against IE 118 being an LTR, as it has already been seen
that im perfect inverted repeats are present in IE 36 (see section 5.2.1), and
o ther IA P LTRs (C hristy  et al., 1985). It may also be noted that the
polyadenylation signal in IE 36 and the CAT box in IE 119 have suffered
mutation. Thus it is tentatively concluded that IE 118 is most likely to be a new
re tro v ira l-lik e  LTR.
A nother feature of IE 118 deserves comment. This is a 28 nucleotide
region (arrows in Figure 5.8) in which 27 nucleotides are identical to those in a
28 nucleotide region on the opposite strand of the actin target sequence (this
includes 22 consecutive nucleotides of perfect identity). Such a large stretch of 
hom ology seems unlikely to have arisen by chance, and raises the possibility
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Figure L I  Potential open reading frames in IE 118
r
10 200 300 400 500 600 700 800
The potential open reading fram es in IE 118 in both the 'coding' and 
'non-coding ' strands o f DNA are shown. The stop codons are indicated by
vertical lines, and the Met start codon are indicated by broken vertical lines.
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that it may be the result of a gene conversion event. The presence of a region 
of 10 base pairs of potential Z-DNA (nucleotides 952 to 962) overlapping this 
repeat may be significant in this respect, as such sequences have been found 
associa ted  w ith o ther exam ples o f gene conversion  (S lightom  et al., 1980; 
Flanagan et al., 1984).
If  IE 118 is related to a fam ily of mouse retroviral-like elements it would 
be expected to be repeated in the m ouse genome. Figure 4.3 shows genomic 
Southern blots of mouse DNA indicating that this is the case (Figure 4.3). Two 
32p_iabelled probes from IE 118 (see section 4.1.3; Figure 5.8) were used for this 
p u rpose : p robe 118a (a P s tl-D ra ll  fragm en t), con ta in ing  all the pu tative
functional m otifs, and probe 118b (a B am H I-P stI frag m en t), w h ic h  la c k e d  
these but contained the inverted  repeat sequence. W hen these probes were 
used to screen a mouse genom ic library, 118b hybridised to the m ajority of 
p laques to which 118a hybrid ised , although there were sign ifican tly  more 
plaques to which only 118b hybridised than those to which 118a hybrid ised. 
The hybrid isation  of the m ouse genom ic lib rary  with probe 118a gave a 
generally weaker signal than with the others. A possible trivial explanation of 
this is that the time for which the first filter (hybridised to 118a) was left on 
the agar plate was in fact considerably less than for the other replica filters. 
The plaque hybrid isation  allow ed the estim ation that there are approxim ately
1.000 sequences related to 118a per haploid mouse genome, and approxim ately
2.000 sequences related to 118b. These figures are consistent with those of 
retrov iral-like  LTRs. It is unclear why there appear to be more copies of 
sequences related to 118b than 118a in the mouse genome, but it is possible that 
IE 118 contains extra sequences than the putative retroviral-like elem ent from 
which it is derived, and that these are repeated in the mouse genome.
5 .2 .4  C on clu s ion
The results presented here provide further evidence for the m obility of 
endogenous m urine retroviral-like elem ents, and are consistent with the view 
that the m ajority o f processed pseudogenes are functionless. However, it does 
seem rather surprising that 3 distinct y-actin processed pseudogenes should be 
the targets of such retroviral-like elem ents. Reports of hum an (Zaberarovsky 
et al., 1984; Shim ada et al., 1984) and ra t (Lem ischka and Sharp, 1982; 
S carpu lla , 1985) processed  pseudogenes with incorporated  SINE or LINE 
m em bers have been docum ented. However, the copy num ber of the latter
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m obile elem ents is thought to be several orders of m agnitude greater than that 
o f m ouse endogenous re trov iral-like  elem ents. From  analysis o f the present 
literatu re  it appears that only about 1 in 10 of the hum an or rat processed 
pseudogenes so far exam ined have been targets for such elem ents. A lthough 
exam ples o f m ouse processed pseudogenes which are in terrupted by inserted 
elem ents are lacking, the num ber o f m ouse processed pseudogenes on which 
this assessm ent is based number no greater than a dozen. There is no reason to 
suppose that actin pseudogenes are favoured as targets, the points of insertion 
shown by the three inserted elem ents described here are all different and bear 
no sequence sim ilarity. The tendency of other retroposons to insert into one 
ano ther has been  m entioned  (R ogers, 1985), but th is genera lly  involves
sequences close to regions which are adenylate-rich.
The h igh incidence of insertions into the m ouse y -a c tin  p ro c e sse d  
pseudogenes may reflect only the small sample of processed pseudogenes so far 
in vestiga ted . H ow ever, an a lternative  exp lanation  is that the num ber of
d ifferen t classes of endogenous retroviral-like  elem ents in the mouse genome 
is, in fact, much greater than currently estim ated. Although close exam ination
of other related genom ic sequences is still required, IE 118 may in fact be a 
p o rten t o f such possib le  m urine re tro v ira l genom ic ubiquity . The m ost 
pressing task em erging from the work described in this thesis will be to look
for a retroviral-like element, the LTRs of which could be related to IE 118.
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